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ABBREVIATIONS 
AGE advanced glycation end-product 
Alix ALG-2-interacting protein X 
axin axis inhibition protein 
Arg arginine 
Asn asparagine 
ATP adenosine triphosphate 
Bam32 B lymphocyte adaptor molecule of 32 kDa 
bax bcl-2-associated X protein 
bcl-2 B cell lymphoma 2 
CD cluster of differentiation 
cDNA complementary deoxyribonucleic acid 
CEA carcinoembryonic antigen 
CG chicken galectin 
CRD carbohydrate recognition domain 
DMBT-1 Deleted in malignant brain tumors 1 protein 
DNA deoxyribonucleic acid 
EST expressed sequence Tag 
Gal galactose 
GalNAc N-acetylgalactosamine 
Gemin4 Gem-associated protein 4 
Glc glucose 
Glu glutamate 
Gly glycine 
GRIFIN galectin-related interfiber protein 
GRP galectin-related protein 
H hydrogen 
His histidine 
hnRNP heterogeneous ribonucleoprotein particle 
hsp90 heat shock protein 90 
Ig Immunoglobulin 
kDa kilodalton 
LacNAc N-acetyllactosamine 
lamp-1 lysosomal-associated membrane protein 1 
Lys lysine 
Mac macrophage antigen 
mRNA messenger ribonucleic acid 
mSufu mouse suppressor of fused 
MAG myelin-associated glycoprotein 
Mdm2 mouse double minute 2 homolog 
MUC mucin 
Neu5Ac N-acetylneuraminic acid 
Nup nucleoporin 
NG2 neuron-glial antigen 2 
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OCA-B Oct co-activator from B cells 
PBMC peripheral blood mononuclear cell 
pCIP p300/CBP-cointegrator protein 
PDB protein data bank 
PIAS1 protein inhibitor of activated STAT1 
PP13 placental protein 13 
Pro proline 
RNA ribonucleic acid 
RPTP receptor protein-tyrosine phosphatase 
RT-PCR reverse transcription polymerase chain reaction 
Ser serine 
TCR T-cell receptor 
TgMIC4 Toxoplasma gondi microneme protein 4 
Thy-1 thymocyte differentiation antigen 1 
Trp tryptophan 
TTF-1 thyroid transcription factor-1 
Val valine 
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1. INTRODUCTION 
 
“To an observer trying to obtain a bird’s eye view of the present state of biochemistry, life 
may until very recently have seemed to depend on only two classes of compounds: nucleic acids 
and proteins” [1]. This classical statement by Prof. Dr. N. Sharon serves to introduce the 
necessity of considering complex carbohydrates as intrinsic part of the dogma of molecular 
biology in relation to the flow of genomic information (Fig. 1). 
 
 
 
 
Fig. 1: Schematic illustration of the change in our view on the flow of genetic information. Modified from [2], 
with permission. 
 
Intuitively, Saul Roseman, a pioneer of glycobiology, reasoned that “these complex 
structures must serve essential roles in cell surface phenomena, but we are only beginning to 
understand what some of these functions are” [3]. As illustrated in [4] and [5], sugars (the third 
alphabet of life) are truly “ideal for generating compact units with explicit informational 
properties” [6]. A key route to translate the sugar-encoded information into cellular responses 
is via sugar receptors (lectins). Examples for emerging physiological importance of lectin-
glycan recognition are shown in Fig. 2. 
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Fig. 2: Schematic illustration of examples of functional consequences of lectin-glycan recognition. From [2], with 
permission. 
 
Obviously, research efforts on glycans and lectins are complementary within the quest to 
crack the sugar code. In order to address this challenge, by working on the protein side, a focus 
on a particular lectin group will be mandatory. The respective work should reach the status of 
thorough structural analysis and functional assessment. At best, the group size should be of 
manageable complexity, and the lectins should have physiological importance. 
These prerequisites are fulfilled by the family of galectins, potent effectors of various cell 
activities such as adhesion, anoikis/apoptosis, cytokine induction and release or cell migration 
[2,7]. Of particular importance, the carbohydrate recognition domain (CRD), whose 
characteristics are shared by all members of this family, is presented in three phylogenetically 
conserved forms of topological display (Fig. 3). 
 
 
Fig. 3: The three types of natural design of galectins. 
 
In principle, the galectin CRD can form i) non-covalently associated homodimers 
(proto-type) or ii) linker-peptide-connected heterodimers (tandem-repeat-type) and iii) occur 
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associated to an N-terminal stalk consisting of a peptide with two sites for serine 
phosphorylation and non-triple-helical (collagen-like) repeats [7]. These three types of CRD 
presentation are common to all organisms expressing galectins, with changes in numbers of 
proteins in each subgroup (Fig. 4).  
The comparatively small chicken galectinome with five proteins enables comprehensive 
galectin biochemical and immunohistochemical studies with focus on monitoring the network 
of galectins in biorelevant processes as done in [8] and [9] (for a review on roles in 
immunity/tumor growth control please see [10]). The discovery of two new non-canonical 
members of the galectin family in this organism prompted us to pursue their characterization 
and, therewith, fill these gaps in the galectin network puzzle of Gallus gallus. 
 
 
Fig. 4: Schematic representation of occurrence of galectins on the level of the gene (Roman number), of the mRNA 
(Arabic number) and of the protein (as word) in selected (model) organisms. From [2], modified and updated, with 
permission. 
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2. LITERATURE REVIEW 
 
2.1. Galectins: structural requirements 
The term lectin (from Latin legere, to choose) is rooted in the works with plant proteins 
that presented specificity for a certain blood-group [11]. It emerged in order to fulfill the 
necessity of finding a new word for substances which are proteins and bind a determined 
antigen but are not produced in response to this antigen [12]. Nowadays, the term lectin is the 
generic name for (glyco)proteins that recognize and bind to carbohydrates, different from sugar-
specific antibodies and enzymes as well as from sensor/transport proteins for free mono- and 
oligosaccharides [11].  
Structural analysis of these proteins by crystallography allowed characterization of their 
active site. The structure of the folds that are able to accommodate a ligand proved to be very 
rich and varied, with more than a dozen folds being seen in vertebrates [13,14]. Of note, a 
certain type of fold can present its contact site in different places, resulting in a wide range of 
proteins structurally related but functionally diverse, being able to bind different carbohydrates 
or even to recognize different presentations of the same molecule. The complex architecture of 
the CRD and its network of interactions with the ligand ensure specificity of lectins and enable 
them to act both as precise readers and translators of the sugar code [15].  
Three different types of CRDs are exemplarily depicted in Fig. 5. The C-type fold (Fig. 5a) 
teams up with a Ca2+-ion in order to guarantee the correct ligand specificity, adding a further 
degree of complexity to its interaction with the protein [16,17]. The β-sandwich motif shown 
in Fig. 5b is the common structural feature of galectins, a family of proteins with carbohydrate 
specificity to β-galactosides and their derivatives [18,19]. Here, several loops connect two 
antiparallel β-sheets of six and five β-strands, building a β-sandwich structure [20].  
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Fig. 5: (a) C-type CRD of human E-selectin with its Ca2+ (yellow sphere) in complex with the tetrasaccharide 
sialyl Lewis x (CD15s) (PDB code 1G1T), (b) β-sandwich of human galectin-1 in complex with lactose (PDB 
code 1GZW), (c) the I(gG)-type CRD of murine siglec sialoadhesin (siglec-1) in complex with the trisaccharide 
3’-sialyllactose (PDB code 1QFO). From [15], modified, with permission. 
This group of lectins has a conserved sequence signature in which a Trp residue plays a 
crucial role in asserting the correct binding of the β-galactoside ligand (please see Fig. 6 for 
typical binding partners) by allowing C-H/π interactions [16,18,19,21]. The amino acid residues 
that constitute this signature are shown in the structural environment of the CRD of three 
homodimeric chicken galectins (CGs) (Fig. 7a), as well as marked in the alignment of the 
CRD’s sequences of the whole set of five canonical CGs in Fig. 7b. Hereby, we have just 
described the three defining characteristics of the galectin family: specificity to β-galactosides, 
β-sandwich fold structure, and amino acid sequence containing the typical conserved signature. 
 
Fig. 6: Illustration of three β-galactoside ligands. a) LacNAc (Galβ1,4GlcNAc), b) 3’-O-sulfated LacNAc (3’-O-
sulfo-Galβ1,4GlcNAc)1 and c) LacdiNAc (GalNAcβ1,4GlcNAc)2. 
 
                                                 
 
 
1 Allen, H.J. et al., Binding of synthetic sulfated ligands by human splenic galectin 1, a beta-galactoside-binding 
lectin. Glycoconj J, 1998. 15(7): p. 691-5 
2 van den Berg, T.K., et al., LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune 
recognition. J Immunol, 2004. 173(3): p. 1902-7 
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Fig. 7: Comparison of the carbohydrate-binding sites (A) of the proto-type chicken galectins CG-1A (a, PDB code 
1QMJ), CG-1B (b, PDB code 3DUI) and CG-2 (c, PDB code 2JMZ). Alignment of the section of the amino acid 
sequences of the CRDs of the five canonical chicken galectins (amino acid 6 of CG-1A is set to position 1 for 
alignment) (B). Strictly conserved (red background) and homologous residues (>70% conservation; boxed red 
letters) are highlighted by coloring. The amino acids in contact with the canonical ligand lactose are marked by an 
asterisk. From [15] extended and modified, with permission. 
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When taking a closer look into the CRD structure, it is noted that “certain amino acids 
show a strong propensity to be in the binding site. This applies in particular to the aromatic 
rings, which can pack against the hydrophobic face of the sugar, and arginine, aspartate and 
glutamate residues, which can all form bidentate interactions, with adjacent hydroxyls on the 
sugar” [22]. This assessment, referring to lectins in general, holds true for galectins as depicted 
exemplarily in Fig. 8 for the case of chicken galectin 2 (CG-2). The lactose molecule is packed 
inside a cavity in the CRD of the protein, the amino acids present there create a network of H-
bonds and CH/π interactions (please note the aromatic chain of amino acid Trp65 facing the 
hexose ring of the galactose residue) that assures specificity and constitutes the base of the 
molecular interaction mechanism between the protein and its ligand [16]. 
 
Fig. 8: Close up view of the CRD region of CG-2 accommodating the canonical ligand lactose. The H-bond 
network interactions between the amino acid residues and the hydroxyl groups of the lactose molecule are shown 
as yellow dashed points. The 4´-OH group of galactose interacts with the side chains of the key amino acids His45, 
Asn47 and Arg49, whereas Asn58 and Glu68 are bonded to the 6´-OH group. The hydroxyl group at the 3´position 
of the glucose ring forms hydrogen bonds with the Arg49, Glu68 and Arg70 residues [20]. PDB code 2YMZ. 
 
In order to successfully complete their varied tasks, galectins must not only possess 
carefully designed CRDs, but also present them in a suitable way. Three different topological 
modes of CRD presentation have been described: the proto-type (mono- or homodimeric), the 
tandem-repeat-type (up to four different CRDs covalently connected by a linker) and the 
chimera-type, (with the CRD associated with a tail consisting on collagen-like repeats and a 
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peptide with two sites for Ser phosphorylation) [13,15,19,23,24]. The functional significance 
of these three ways of presenting the CRD is a fundamental issue, underlined by the observed 
fact that (ga)lectins with identical ligand specificity but different molecular architecture can 
initiate different processes or even neutralize the signal triggered by an homologous protein 
[16], as seen for the case of galectin-1 and galectin-3 (described later). Alternatively, 
cooperation between galectins is possible as well, as reported for galectins-1 and -8 while 
promoting plasma cell formation [25] and for galectins-1 and -3 in osteoarthritis pathogenesis 
[26]. Such occurrences highlight the necessity of studying not only the nature of galectins as 
individual entities but as part of an interconnected network within the different organisms [9]. 
In this sense, mapping of galectin presence in vertebrates, first by protein isolation and, more 
recently, by genomic database mining, has allowed to trace sequences of individual proteins 
belonging to the three galectin structural groups through the branches of the metazoa 
phylogenetic tree, disclosing diverse degrees of diversification for each family and number of 
detected genes. 
 
2.2. Occurrence of galectins  
The first member of the galectin family was discovered in 1975, by traditional 
haemagglutination assays and later purification from the electric organ of Electrophorus 
electricus (electric eel) [27]. Since then, widespread advances in mass sequencing of genomes 
and screening have surpassed and substituted the traditional galectin identification methods and 
subsequently expanded our scope over the presence of this protein class among eukaryotic 
organisms. As such, it is nowadays acknowledged that the galectin family is “evolutionarily 
ancient with representatives in vertebrates, invertebrates, and even protists” [19]. 
Although not a bona fide galectin, the fifth apple domain of the TgMIC4 microneme 
complex of Toxoplasma gondii (a parasitic protist) possess lectin activity [28], which can be 
considered a precursor of the galectin family in the higher eukaryotic kingdoms. An example 
of a fungus with galectin presence is the mushroom Coprinopsis cinerea. Two isolectins with 
the capacity of binding to lactose have been described [19,29], one of them capable of binding 
N-glycans of invertebrates as previous step to exerting its toxicity over this organisms [30].  
However, it is among metazoans where lectins with affinity to β-galactosides are more 
ubiquitously found. Starting from the lowest clade of this kingdom, two galectin genes have 
been described for the sponge Geodia cydonium [31-33], although only one of the gene products 
proved to be functional [34]. This protein, termed LECT1, is able to oligomerize to di- and 
tetrameric complexes. 
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In nematodes, galectin genes seem to be highly represented. For instance, the genome of 
Caenorhabditis elegans contains in the order of 20,000 genes, of which 26 are candidate for 
encoding galectin specific information [19]. Twelve mRNAs have been recorded and binding 
to the canonical ligand lactose has been ascertained in seven cases (Lec-1, -2, -3, -4, -6, -10 and 
-12 (DC2.3)) [35-37]. Haemonchus contortus, one of the most pathogenic gastrointestinal 
nematodes of small ruminants, presents seven cDNAs associated to the tandem-repeat type 
galectins [38,39], and an isolated galectin (Hco-gal-m) has been seen to contribute to modulate 
the immune response of its host organism by binding peripheral blood mononuclear cells [40]. 
Within the phylum Mollusca, galectins have been identified in various species. The case 
of CvGal, a protein expressed by the Eastern Oyster (Crassostrea virginica), is special because 
of its CRD architecture, with four of them arranged in a tandem-repeat mode, a unique case 
among the galectin family [41]. The genome of Drosophila melanogaster (fruit fly) encodes 
five tandem-repeat-type genes and another one, which seems to be very distantly related to the 
proto-type group [19], and serves to illustrate presence of galectins in arthropods. The mRNAs 
for five of these sequences have been isolated but only one galectin, belonging to the tandem-
repeat group, has been described on the protein level [42,43].  
Turning to vertebrates, several galectin-like genes were detected in diverse fish species 
such as the already mentioned first isolated galectin from electric eel (Ectrophorus electricus) 
[27]. Further examples are found in the conger eel (Conger myriaster) [44], catfish (Ictalurus 
punctatus), flounder (Paralichthys olivaceus), trout (Oncorhynchus mykiss), medaka (Oryzias 
latipes), zebrafish (Danio rerio) and two pufferfish (Takifugu rubripes and T. nigroviridis) [19]. 
In the case of D. rerio, its genome includes eight candidate genes, having already been 
characterized three proto-type, one chimera-type and two tandem-repeat type galectins, all of 
them presenting notable similarities with mammalian galectins [45,46]. In amphibians like 
Xenopus laevis (frog) examples of the three groups of galectins are also found [47] as well as 
in birds like Gallus gallus [8]. 
As to mammals, galectins are commonly found through the branches of the phylogenetic 
tree. Taking mouse (Mus musculus) as an illustrative case, three proto-type proteins have been 
characterized, together with one chimera-type and four tandem-repeat-type proteins, here with 
the special occurrence of intra-species variation for galectin-6 [48-50]. Rattus norvegicus (rat) 
has also an exceptional difference, an apparently unique proto-type galectin-5 [51]. Names of 
animal galectins are given in accordance to their similarities to human galectins (for instance, 
the mouse galectin-4 is related to the homonymous human galectin, i.e. human galectin-4), 
presented for the three structural groups: eight proto-type, one chimera-type and four tandem-
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repeat-type, all of them characterized both on the level of their genes and protein expression 
[19]. 
Having briefly summarized presence of galectins in the animal kingdom, establishment 
of a model organism to achieve comprehensive coverage of the galectin network is necessary. 
This organism should fulfill the following requirements: i) comparatively low degree of 
complexity of galectin presence and ii) close evolutionary relationship to mammals [52]. In this 
sense, the easily accessible Gallus gallus (chicken) bird meets these criteria by presenting a set 
of only five canonical CGs with members of the three (proto-, chimera- and tandem-repeat-) 
structural groups [8,52] as shown in Fig. 9: three proto-type CGs (CG-1A, CG-1B and CG-2) 
present as homodimers in solution [20,53-60], one chimera-type (CG-3) with four alternative 
splicing variants but same CRD [61-64] and one tandem-repeat-type (CG-8) with two possible 
linker lengths [8,65]. 
 
 
Fig. 9: Schematic illustration of modular organization of the five CGs: homodimeric (proto-type) CG-1A, 
CG-1B, CG-2; chimera-type CG-3 (with two serine phosphorylation sites in the N-terminal peptide and a 
collagenase-sensitive section of ten Gly/Pro-rich sequence repeats which consist of either five (one repeat), 
seven (five repeats) or eight (four repeats) amino acids) and tandem-repeat-type CG-8S/L (linker lengths of 
nine/28 amino acids). From [10], modified with permission. 
2.3. Expression and localization of galectins 
Already in the year 1985 it was hypothesized that “families of electrolectin genes could 
be under the control of different promoters” [66]. This would evidently lead to a diverse 
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expression profile of galectins [15]. Comparative mapping of genomic sequences disclosed a 
higher presence of deviations in the promoter regions [8,59,65], a fact that also points into this 
direction. However, early studies depicted expression of similar amounts of three different 
galectins during rat tissue maturation [67]. Furthermore, detection of specific mRNA by RT-
PCR has taught us that, in general, a cell type does not express a single, but rather a 
characteristic pattern of co-expressed galectins [68], which prompted questions on identical or 
overlapping purposes of these proteins. 
 The possibility of a redundant role is quickly dismissed by the production of specific 
antibodies and their application in immunohistochemical fingerprinting [69]. 
Immunohistochemistry is a powerful technique for mapping this expression network, because 
it allows distinction between different cells types, subcellular localization and histological 
structures within a tissue. Of note, strict controls and successive purification steps are necessary 
in order to exclude any cross-reactivity between galectins, as they are homologous proteins with 
sequence and structural similarities [70-73]. Examples of selectivity of galectin presence are 
shown in Fig. 10 and Fig. 11. They can be found extracellularly, e.g. galectin-3 in epithelium 
of murine esophagus (Fig. 10a), possibly related to the well-studied role of galectins as cellular 
bridges and adhesion molecules [74]. Some galectins mainly are expressed in certain tissues, 
like galectin-4 in the gastrointestinal tract (Fig. 10c) [75]. Presence in cytoplasm and even in 
nuclei of very different types of cells is also a standard case encountered while performing 
immunohistochemical screening of galectin expression (Fig. 10a-f), which prompts the 
conclusions that a galectin is “variably expressed by different cells and tissues” and “its cellular 
localization is not restricted to the cell surface” [76]; being each signal presentation 
characteristic for a given protein. 
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Fig. 10: Immunohistochemical staining profiles revealing subcellular and cell-type selectivity of galectin presence 
in sections of murine and chicken tissues. a) Extracellular presence of galectin-3 in keratinized, stratified 
epithelium of mouse esophagus (inset: section through the esophagus showing the folds of the mucosa lined by 
the galectin-3-positive epithelium). b) Strong apical positivity for galectin-7 in the cytoplasm of epithelial cells in 
glandulae intestinales of mouse ileum (inset: section through the ileum´s wall showing the position of galectin-7-
positive glandulae intestinales relative to villi intestinales and muscle layers). c) Cytoplasmic staining of epithelial 
cells in glandulae intestinales in mouse jejunum by anti-galectin-4 IgG. d) Nuclear presence of galectin-3 in 
epithelial cells of a respiratory bronchiole in a section through mouse lung. e) Positivity with the antibody against 
galectin-4 in cell nuclei (arrowheads) and cytoplasm of pyramidal acinar cells in a section through the exocrine 
part of a mouse pancreas. f) Longitudinal section through a sebaceous gland in mouse skin. Positivity with anti-
galectin-9 IgG was intense in nuclei (arrowhead) and weak in cytoplasm of maturing polygonal cells. Basal 
(asterisk) and degenerating cells (with pyknotic nuclei, arrow) were negative. The inset, showing sebaceous glands 
as appendages of hair follicles in the dermis of mouse skin, documents that the epidermis (asterisk) and epidermis-
derived cells of the hair-follicle (arrow) were strongly positive. From [10], modified with permission. 
 
As mentioned before, interplay of functionality makes the study of galectin expression as 
a network an obvious neccessity. Efforts in this direction have been made for different 
organisms like mouse [77,78] and also in the medical study of human tumors, reviewed in [79]. 
The production of specific antibodies against the whole set of chicken galectins has made their 
analysis in a series of anatomic systems possible, highlighting the distinct and specific nature 
of their co-expression profile (Fig. 11) [9,15,80]. 
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Fig. 11: Expression pattern of the five canonical chicken galectins in sections of fixed adult chicken ureter.CG-3 
positivity was confined to the infranuclear portion of epithelial cells, CG-1B/CG-8 to connective tissue, while CG-
1A was detected in all three layers. No expression of CG-2 was observed (bar = 25 µm). From [15], modified with 
permission. 
 
2.4. Functional pairing with counterreceptors 
Strategically positioned at the cell surface, glycans are readily accessible to endogenous 
lectins. For galectins, LacNAc repeats (with/without sulfation) or the pentasaccharide of GM1 
(Fig.12) are common suitable binding partners. The interaction with these lectin receptors 
triggers a cell-type-specific panel of responses (please see Introduction, Fig. 2) relevant for 
diverse aspects of cellular physiology. It is already known that this class of lectins is capable of 
regulating cell adhesion growth [81,82] and apoptosis/anoikis [83,84].  
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Fig. 12: Dynamic glycan remodeling by the (cell surface) ganglioside neuraminidase (Neu3). The hydrolytic 
removal of the branch-end sialic acid converts GD1a to GM1. From [98], with permission. 
 
In carcinoma cells, distinct glycan epitopes (glycobiomarkers, please see Table 1 for 
exemplarly listing) occur, signaling the nature of the aberration on the cellular level and playing 
active roles in disease progression, by serving as docking points for galectins to induce 
anoikis/apoptosis or promote tumor invasion. For example, pro-apoptotic galectin-1 can exert 
its effect on prostate cancer cells only when core 2 -1,6-N-acetylglucosaminyltransferase 
(C2GnT) is upregulated [85], resulting in the formation of core 2-branched O-glycans 
(Gal1,3(GlcNac1,6)GalNAc-Ser/Thr) which switch on galectin reactivity. A key factor for 
switching off galectin reactivity is 2,6-sialylation of N-glycans. Its regulation can work at the 
level of expression of the responsible enzyme (ST6Gal-I, -galactoside-2,6-sialyltransferase) 
and/or at the level of the limiting enzymatic step in sialic acid biosynthesis (i.e. epimerization 
of UDP-GlcNAc to UDP-ManNAc by the bifunctional UDP-GlcNAc 2-epimerase/ManNAc 
kinase, GNE). Similarly, Galectin-1 has been identified as a growth regulator as anoikis 
inductor in susceptible carcinoma cells by recognizing glycan signals and exerting a G1-arrest, 
effect that can also be inhibited by N-sialylation [86]. It has also been described to be a central 
invasive factor in U87 glioblastoma cells [87,88]. This observation was supported by knock-
down experiments [89]. Galectin-1 also regulates neuroblastoma cells growth by binding the 
GM1 ganglioside. The appearance of this molecule on the cell surface is the consequence of 
the increase of activity for a cell membrane ganglioside sialidase that shifts higher gangliosides 
toward ganglioside GM1 (Fig. 12). Galectin-3, not active as growth regulator in neuroblastoma 
cells, has been observed to exert functional antagonism to galectin-1 by competing for the 
binding to the GM1 ligand present in these cells [72,90,91]. A further example of this opposing 
activity is found by looking into regulation of tumor supressor p16INK4a. Galectin-1 expression 
was shown to control the reconstitution of p16INK4a with consequent restoration of susceptibility 
to anoikis in Capan-1 pancreatic cancer cells [84,92] (Fig. 13). Of note, down-regulation of 
galectin-3, which functions as an inhibitor of galectin-1 in anoikis induction, has been detected 
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in p16INK4a reconstituted Capan-1 cells [93] (Fig. 13). Interestingly, the C-H/π-interactions in 
the contact site of galectin-3 allow binding not only to β-galactosides, but also to the anti-
apoptotic Bcl-2 protein and pro-apoptotic Bax [94-96].  
 
Fig. 13: Scheme depicting orchestrated regulation of cell-surface associated fibronectin receptor, galectin-1 (Gal-
1) and galectin-3 (Gal-3) by tumor suppressor p16INK4a in Capan-1 pancreatic carcinoma cells. Gal-1 induces via 
fibronectin receptor anoikis, antogonizing Gal-3 is down-regulated (with permission [93]).  
 
As mentioned before in section 2.1, this functional diversity for galectins that share a 
primary affinity for the same ligand, i.e. β-galactosides, is derived from the existence of three 
topological presentations of CRD domain. In order to elucidate how these differences in 
molecular arrangment (as well as defined changes in the density of cell surface glycans) affect 
the functionality of galectins, new test systems have been developed using vesicle-like 
glycodendrimersomes (vesicles formed by self-assembly of amphiphilic Janus glycodendrimers 
that contain two identical carbohydrates in their hydrophilic part) and enigineered/natural 
variants of galectins [97,98]. In this way, enhancement of capacity of galectin-1 for trans-
interactions (as in haemagglutination) was asserted by covalent connection of its two CRDs 
[99,100], while presence of a natural sequence deviation reduced it in the case of galectin-8 
[101,102].  
Equally important to understand the implications of galectin/glycan interactions is the 
mapping of glycan epitope presence in cells and tissues [98,103-108]. This can be done using 
specific monoclonal antibodies, plant lectins and, possibly mimicking physiological or 
pathophysiological interactions, endogenous lectins [109-112]. Furthermore, combination of 
immuno- and labeled galectin staining, easily analyzable by fluorescence microscopy, allows 
to detect or exclude co-localization of galectin presence together with its binding sites [9, 113]. 
Selection of tissue fixation protocols must be done carefully when working on detection of 
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lectin ligands, as masking or depletion of counterreceptor molecules may occur, prompting to 
misleading conclusions as noted in [98,114-116]. 
 
Table 1: Overview of documented binding partners for mammalian galectins-1 and -3 reactive with the glycan 
part of cellular glycoconjugates or with proteins. 
Type of binding 
partner 
Galectin-1 Galectin-3 
Glycoconjugate Ovarian carcinoma antigen CA125, CD2, 
CD3, CD4, CD6, CD7, CD43, CD45, 
CD69, CD95(Fas), CD146, CD166 
(ALCAM),carcinoembryonic antigen 
(CEA), fibronectin (tissue), 
gastrointestinal mucin, hsp90-like 
glycoprotein, 1-integrin (CD29), 
1/4/5/71-, M3- and 47-
integrins, cell adhesion molecule L1, 
keratan sulfate, laminin , lamp-1, Mac-
2-binding protein, nephrin, neuropilin-
1, receptor protein-tyrosine 
phosphatase (RPTP),thrombospondin, 
Thy-1, tissue plasminogen activator, 
von Willebrand factor, chondroitin 
sulfate proteoglycan, distinct neutral 
glycolipids, ganglioside GM1 
CD6, CD7, CD11b of CD11b/CD18 (Mac-1 
antigen, CR3), CD131(01000 
aminopeptidase N), CD32, CD43, CD44, 
CD45, CD66a,b, CD71, CD95, CD98, 
CD147, CD166 (ALCAM), CEA, colon 
cancer mucin, corneal mucin (MUC16), 
pancreas cancer mucin-4 and MUC1-D 
(N-glycan at Asn36), cubilin, C4.4A 
(member of Ly6 family), desmoglein-2, 
epidermal growth factor receptor, 
glycoform of IgE, haptoglobin -subunit 
(after desialylation), hensin (DMBT-1), 
insulin-like growth factor-1 receptor, 1-
integrin (CD29), 4/5/1- and 3-
integrins, keratan sulfate, LI-cadherin, 
laminin, lamp-1/-2, Mac-2-binding 
protein, Mac-3, MAG, MP20 
(tetraspanin), Na+/K+-ATPase, NG2 
proteoglycan, NKp30, TCR complex, 
tenascin, tissue plasminogen activator, 
transforming growth factor-receptor, 
vascular cell adhesion molecule-1, 
vascular endothelial growth factor 
receptor 2, von Willebrand factor, 
ganglioside GM1 
Protein B lymphocyte adaptor molecule of 32 kDa 
(Bam32), CaV1.2 L-type calcium 
channel (1-subunit), Gemin4, 
oncogenic H-Ras, OCA-B, pre-B cell 
receptor (human, not murine system) 
AGE products, Alix/AIP-1, ATP synthase b-
subunit, axin, bax, bcl-2, bcatenin, 
Cys/His-rich protein, Gemin4, glycogen 
synthase kinase-3, hnRNP Q, mSufu, 
Mer receptor tyrosine kinase, non-
receptor tyrosine kinases c-Abl and Arg, 
nucleoporin Nup98, nucling, oncogenic 
K-Ras, OCA-B, pCIP, PIAS1, synexin 
(annexin VII), TTF-1 
From [15] and [117], with permission. 
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2.5. Non-canonical galectins 
The term non-canonical galectin is used to describe proteins that share prominent 
sequence and structural similarities to the galectin family but have not been seen to possess 
affinity for β-galactosides [118]. A long time known example is human galectin-10, more 
commonly referred to as Charcot-Leyden crystal protein, which exhibits a very weak 
galactoside-binding activity together with a strong disposition to form intracellular crystals, and 
is present in high levels in eosinophils and basophils [19,119,120]. Though showing low affinity 
to lactose, this protein is reported to bind mannose [121], while the placental protein PP13 (also 
known as galectin-13), which shares high sequence homology with galectin-10, presents strong 
affinity for N-acetylgalactosamine and fucose [122]. Advances in genome mapping led to 
discovery of new members of galectin-related proteins in human and other species. In our model 
organism chicken, in addition to its relatively low number of canonical galectin genes, two 
expressed sequence tags (EST)s with similarity to the mammalian non-canonical galectin-
related interfiber protein (GRIFIN) and galectin-related protein (GRP) were identified. 
GRIFIN was first discovered in rat as a very abundant protein in lens that forms dimers 
in solution, presents a high amino acid homology to the galectin sequence but has no lactose-
binding activity [19, 123]. It was also shown to interact with the small heat shock protein α-
crystallin, also present in the ocular lens [124]. Lack of lactose binding can be understood when 
looking at the otherwise conserved signature sequence of the CRD: two of the key amino acids 
typically involved in contacting the ligand are changed (Asn48Lys and Arg71Val) [19,123]. 
This holds true for the mammalian sequences that have been recorded but not for the zebrafish 
(Danio rerio) GRIFIN, which lacks these deviations and is reported to bind lactose like a 
genuine galectin family member [125]. However, introduction of single, double or triple 
mutations into the cDNA of rat GRIFIN did not restore its lactose-binding activity [123]. 
A first sign of GRP presence was deduced from partial ESTs alignment with the genomic 
sequence [118] and posteriorly confirmed by detection of an mRNA isolated from human 
haematopoietic stem/progenitor cells (HSPCs), termed as HSPC159 [126]. Despite sharing an 
important degree of consensus with galectin sequences, binding to the canonical ligand was 
noted improbable due to deviations in five of the seven key contact residues of the CRD region 
[19], which was verified in the case of the human GRP-C terminal domain after co-
crystallization with lactose and N-acetyllactosamine [127]. A compelling characteristic of this 
protein is the fact that its “sequence appears to be evolutionarily ancient and highly conserved” 
through different branches of the animal kingdom [19], a sign for presumed strong positive 
selection and consequent involvement in critical interactions. 
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With the genomic sequences for both of these two non-canonical galectins having been 
detected in chicken, characterization of chicken GRIFIN (C-GRIFIN) and GRP (C-GRP), as 
done for the five canonical galectins [8,11,55,56,59,65], comes out as an evident necessity. The 
three studies presented here attempt to take initial steps into this direction, aiming for the first 
complete network analysis of the galectin family in a vertebrate organism.  
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3. OBJECTIVES 
As described, chicken offers the three topological displays combined with a minimum 
number of galectin family members and cofacilitate to unravel the role(s) of the individual 
galectins in the network. Our first objective is to run an extensive survey for further nucleotide 
sequences that may be galectin-like/-related on the genomic level. In this context, the question 
will be addressed whether the chicken homologues of the non-canonical galectins GRIFIN and 
GRP, C-GRIFIN/C-GRP are present in the chicken genome.  
Furthermore, both proteins will be analyzed (in silico and by PCR-technology) on the 
genomic level to elucidate the gene structures and chromosomal locations. A phylogenetic 
analysis to calculate the evolutionary relationships between species using alignments of 
complete sets of GRIFIN/GRP-sequences (after searching in the available genomes) will be 
performed. Calculations and tree constructions will be done according to the maximum-
likelihood method with extensive bootstrapping.  
In order to achieve the aim of a full characterization on the protein level, a bundle of tasks 
is awaiting. These include cloning of the cDNA sequences, insertion into prokaryotic 
expression vectors (i.a. pET-24a, pGEMEX-1, pGEX-6P-2) and recombinant expression, 
preferably in the E.coli strain BL21. Presumably, both proteins are not lactose-binding, thus the 
crucial step for the purification of canonical galectins, affinity chromatography on lactose-
Sepharose 4B, is not applicable. Alternatively, we have to establish a GST (glutathione-S-
transferase) fusion protein approach, with on column cleavage of the GST tag by a specific 
protease. 
In the next step, an accurate analysis of the capacities of both proteins to bind carbo-
hydrates by means of haemagglutination, cell assays and glycan arrays will be performed. 
Analysis of the crystal structures (in cooperation with F. Ruiz, A. Romero, Madrid) will 
give insights on the atomic level, the pattern of hydrogen bonds and may explain the influence 
of deviations in the contact site on carbohydrate binding. 
For the final objectives of our study, we turn from structure to biology. Our experiments 
include expression profiling for C-GRIFIN/C-GRP in extracts by RT-PCR, and Western Blots 
as well as in sections of paraffin-embedded/cryogenized tissues with immunohistochemistry. 
Currently, there are no data available on occurrence and/or bioactivity of C-GRP in chicken. 
The full set of canonical/non-canonical galectins now attained, the chicken’s bursa of 
Fabricius will be selected due to its various cell types and structures for a first complete 
histochemical analysis applying cross-purified antibodies and using the fluorescent-labeled 
proteins for detection of accessible binding sites. 
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ABSTRACT 
 
Occurrence of the adhesion/growth-regulatory galectins as family sets the challenge to 
achieve a complete network analysis. Along this route taken for a well-suited model organism 
(chicken), we fill the remaining gap to characterize its seventh member known from rat as 
galectin-related inter-fiber protein (GRIFIN) in the lens. Its single-copy gene is common to 
vertebrates, with one or more deviations from the so-called signature sequence for ligand 
(lactose) contact. The chicken protein is a homodimeric agglutinin with capacity to bind -
galactosides, especially the histo-blood group B tetrasaccharide, shown by solid-phase/cell 
assays and a glycan microarray. Mass spectrometric identification of two lactose-binding 
peptides after tryptic on-bead fragmentation suggests an interaction at the canonical region 
despite a sequence change from Arg to Val at the site, which impairs reactivity of human 
galectin-1. RT-PCR and Western blot analyses of specimen from adult chicken organs reveal 
restriction of expression to the lens, here immunohistochemically throughout its main body. 
This report sets the stage for detailed structure-activity studies to define factors relevant for 
affinity beyond the signature sequence and to perform the first complete network analysis of 
the galectin family in developing and adult organs of a vertebrate. 
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1. Introduction 
 
Rooted in the concept of the sugar code, work on receptors for glycans (lectins) has 
convincingly demonstrated the ubiquitous relevance of carbohydrate-protein recognition in a 
wide variety of physiological processes [1-7]. Consequently, more than a dozen families of 
animal lectins have been thoroughly mapped, most recently by computational database mining 
of genomic information (for a case study on C-type lectins, please see [8]). Applied to galectins 
(-galactoside-binding proteins with -sandwich fold; for detailed information, please see [2, 
9-14]), occurrence in many metazoan phyla and conservation of a set of seven key amino acids 
(the sequence signature) are revealed [15, 16]. They are known from crystallographical studies 
to contact the canonical ligand lactose by hydrogen bonding and C-H/-interactions (with Trp) 
[5, 15, 17]. In general, reflecting the assumed significance of this property for the galectins’ 
activity as bioeffector, no sequence deviation at these sites is observed for orthologues in inter-
species comparison. A notable exception is the galectin-related inter-fiber protein (GRIFIN), 
what explains the interest to study this family member. 
First detected as developmentally regulated lens-specific protein in rats, its 
immunohistochemical localization at the interface between adjacent fiber cells led to the given 
acronym [18]. In extracts of rat nuclear fiber cells, GRIFIN was found in the insoluble fraction 
by proteomic analysis [19]. Additionally, Barton et al. [20] indicated that “GRIFIN appears to 
be a cytoplasmic protein (data not shown)”, when reporting murine GRIFIN’s engagement in 
complex formation with -crystallin (at KD: 13.6 ± 5.3 µM). Looking at its signature sequence, 
two drastic changes (Asn48Lys, Arg71Val) questioned its ability to bind lactose. In fact, site-
specific mutations of these amino acids in human galectin-1, i.e. Asn to Asp and Arg to His, 
had impaired the affinity to lactose [21]. Seemingly fitting, rat GRIFIN with its natural 
sequence changes indeed lacked binding capacity [18]. In stark contrast, its orthologue in 
zebrafish (Danio rerio) presented overall conservation in all seven signature-sequence positions 
and was reported to be a “bona fide galectin family member” [22]. Obviously, despite 
maintaining its expression in lens fiber cells [18, 22], the GRIFIN gene appears to have 
undergone a fundamental sequence divergence at crucial sites after phylogenetic separation into 
the lineages that lead either to fish or to mammals. Tracking occurrence of GRIFIN genes and 
examining their sequences in organisms at different branches of the evolutionary tree was 
therefore our first step to investigate this unusual phenomenon. 
At the same time puzzling and challenging, conversion to the signature sequence for active 
galectins by introducing single, double or triple mutations into the cDNA for rat GRIFIN did 
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not establish capacity of the resulting proteins to bind to an affinity resin presenting lactose 
[18]. This clear indication for an unsuspected key involvement of other amino acids directed 
our interest to a natural GRIFIN protein with only one deviation from the sequence signature, 
i.e. chicken (C-)GRIFIN, which shares the Arg to Val substitution with rat GRIFIN. Whether 
it is active as lectin was an entirely open question. Embedded in our efforts toward the aim to 
achieve the first comprehensive network analysis of the galectin family, for which chicken is a 
suited model organism due to its relatively small number of proteins representing all types of 
galectins [13, 15, 23-30], we here report on the C-GRIFIN gene and its promoter, its expression 
and immunohistochemical localization of the protein. Moreover, we answer the question on its 
ability to bind -galactosides in solid-phase/cell-based assays, detect oligosaccharides of strong 
avidity in an array and identify lactose-binding peptides by mass spectrometry after tryptic 
digestion of C-GRIFIN bound to affinity resin. Hereby, a so far missing piece is added to the 
network puzzle of chicken galectins (CGs) and an attractive platform is made ready for ensuing 
structure-activity studies to amend the signature-sequence concept. 
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2. Materials and methods 
 
2.1. Database mining and processing of sequence information 
 
Systematic searches for sequences, which satisfy stringent criteria of functionality and 
homology, in databases of genome and expressed sequence tag (EST) information, multiple 
alignments of amino acid sequences and the delineation of the chromosomal neighborhood of 
the detected gene for an orthologue of rat GRIFIN were performed, as given in detail previously 
[27, 31]. Using the Maximum Likelihood method implemented in the MEGA6 software 
package [32], the sequences of various organisms were arranged based on highest likelihood 
into a phylogenetic tree, processing involving a bootstrap analysis (with 1000 replicates) and 
the Neighbor-Joining method applied to a matrix of pairwise distances estimated using a Jones-
Taylor-Thornton model. Multiple alignments of amino acid sequences were performed using 
the Clustal Omega software and edited in Jalview or ESPript. The computational scrutiny of 
the manually edited proximal promoter sequences (-2500 bp upstream of the translation start, 
applying the sequence text view tool of NCBI Gene [33]) to compile occurrence of putative 
sites for binding of transcription factors was carried out with the MatInspector software 
(http://www.genomatix.de/index.html) based on the TRANSFAC® database and the program-
inherent 634 matrices grouped into 279 families (Matrix Library 9.3, released March 2015), 
setting similarity thresholds as described in previous analyses on the corresponding sequence 
section of genes of chicken and human galectins [30, 34]. In detail, individual monitoring and 
comparisons were performed for respective sequences of C-GRIFIN (Gene ID: 427660) as well 
as of 10 eye-expressed chicken genes, i.e. aquaporin-0 (Gene ID: 374124), αA-crystallin (Gene 
ID: 418546), βA1-crystallin (Gene ID: 396499), βB1-crystallin (Gene ID: 374000), δ2-
crystallin (Gene ID: 417545), connexin-43 (Gene ID: 395278), connexin-46 (Gene ID: 
428084), connexin-50 (Gene ID: 395846), filensin (Gene ID: 396056) and phakinin (Gene ID: 
396141). 
 
2.2. Cloning, recombinant expression and purification 
 
Total RNA from eyes of a 14-day-old chicken embryo was isolated using an RNeasy kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s information, and SuperScript 
reverse transcriptase (ThermoFisher, Schwerte, Germany) generated cDNA used for PCR 
amplification by the sense primer 5´-CATATGGCACTGCGGTTTGAGG-3´ (NdeI restriction 
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site underlined) and the antisense primer 5´- AAGCTTCTAGTAAAGACCACGTTTGG-3´ 
(HindIII restriction site underlined). The reaction was performed with Taq DNA polymerase 
(Qiagen) at conditions recommended by the manufacturer. The amplification products were 
separated from PCR reagents by gel electrophoresis in 3% agarose, then extracted from the gel 
and finally ligated into the EcoRV-linearized pGEM®-T Easy Vector (Promega, Mannheim, 
Germany) presenting 3´T overhangs. This vector was used for transformation of the 
commercially available E. coli strain TOP10 (Promega) and ensuing amplification. Resulting 
plasmids were then purified, its cleavage with restriction enzymes (NdeI/HindIII) yielded 
digestion products, which were separated by agarose gel electrophoresis. Subsequently, the 
cDNA sequences with the appropriate restriction sites at the 5´-end (NdeI) and the 3´-end 
(HindIII) were ligated into the expression vector pGEMEX-1 (Promega) pretreated with 
NdeI/HindIII. Alternatively, a cDNA construct for a glutathione S-transferase (GST)–C-
GRIFIN fusion protein was established using the pGEX-6p2 vector (GE Healthcare, Munich, 
Germany). PCR amplification of the C-GRIFIN cDNA sequence for insertion into this vector 
was directed by the sense primer 5´- CGCTAGGGATCCTTTGAGGCTCTGTACCCA-3´ 
(BamHI restriction site underlined) and the antisense primer 5´-
CGTACGGTCGACCTAGTAAAGACCACGTTTG-3´ (SalI restriction site underlined). The 
reaction was performed with PerfectTaq DNA polymerase under conditions recommended by 
the manufacturer (5Prime GmbH, Hamburg, Germany). The combination of this sequence with 
the linearized commercial vector generated a cleavage site for a protease (please see below) to 
separate GST from C-GRIFIN, which is then inevitably N-terminally extended by the Gly-Pro 
dipeptide. Sequence reconstitution to the first three C-GRIFIN amino acids, altered to establish 
the BamH1 site, was accomplished by a modified kit-based QuikChange® site-directed 
mutagenesis protocol (Agilent Technologies, Waldbronn, Germany). 
Both expression vectors were used for protein production in E. coli BL21 (DE3)-pLysS 
cells (Promega), first in systematic test series to optimize temperature, duration of 
induction/incubation and concentration of the inducer isopropyl--D-thiogalactopyranoside. 
Pellets of cultures were frozen and cells lyzed by sonification on ice in 20 mM phosphate-
buffered saline (PBS), pH 7.3, containing 1 mM dithiothreitol (7 ml per gram of wet cell paste). 
The supernatant after centrifugation of the suspension was subjected to affinity chromatography 
either on glutathione-presenting Sepharose 4B (GE Healthcare) or home-made lactosylated 
Sepharose 4B [26, 35]. The fusion protein was cleaved by human rhinovirus 3C protease (fused 
to GST; used at a ratio of 1:100 (w/w)), and enzyme and released GST were removed by a 
second step of affinity chromatography. C-GRIFIN-containing solutions after both procedures 
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were run over PD-10 columns to remove reagents, then frozen, lyophilized and the protein was 
stored at -20 °C until use. 
 
2.3. Analytical procedures (gel electrophoresis and filtration, mass spectrometry) 
 
 One- and two-dimensional gel electrophoretic analyses were performed, as described in 
detail for other CGs [27, 28]. Mass spectrometric characterization comprised mass 
determination by matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) 
measurements of the protein and its tryptic peptides as well as in-source decay (ISD) 
processing, which led to reflectron ISD (reISD) and linear ISD (linISD) spectra on an Ultraflex® 
TOFTOF 1 instrument with respective matrices (Bruker Daltonik, Bremen, Germany), as 
described for human galectins previously [36, 37]. Tryptic peptides were also fractionated and 
analyzed after protein exposure to two types of stress conditions (addition of H2O2 up to 0.05% 
(v/v) to 50 mM PBS at pH 7 and exposure at 25 °C for 24 h or raising the temperature to 40 °C 
for up to seven days in 20 mM His-HCl buffer, pH 6, containing 100 mM NaCl) using tandem 
MS/MS on a LTQ Orbitrap Velos electrospray mass spectrometer, as described [38-40]. Gel 
filtration (100 µg of protein in 50 µl buffer) was performed on a calibrated Superose HR10/30 
column using an ÄKTApurifier 10 system (GE Healthcare) at 4 °C and a flow rate of 0.5 
ml/min. 
 
2.4. Expression profiling by RT-PCR and Western blotting 
 
Total RNA from tissue specimen of 4-week-old chickens and the respective cDNA were 
prepared and tested in PCR amplification assays with the sense primer 5´-
AAGCTTATGGCACTGCGGTTTGAGG-3´ and the antisense primer 5´- 
TCTAGACTAGTAAAGGCCTCGTTTGG-3´, as routinely done in CG expression analysis 
[26-28]. The calculated length of amplified cDNA for C-GRIFIN is 420 bp. In detail, the 
analyses were carried out in a volume of 20 μl containing 2.5 µg cDNA, 0.5 U Taq polymerase 
(Qiagen), 50 μM dNTPs, 1×PCR buffer (commercial mixture of Tris-HCl, KCl, (NH4)2SO4, 
1.5 mM MgCl2, pH 8.7), 1×Q-solution and 0.1 μM of sense and antisense primers at 20 °C. 
Amplification of the galectin-specific cDNAs was started with an initial denaturation step at 94 
°C for 4 min, then 29 consecutive cycles of the following series of steps were performed: 
denaturation at 94 °C for 45 s, annealing at 60 °C for 45 s and extension at 72 °C for 1 min. 
The final extension step was carried out at 72 °C for 10 min. PCR products and reagents were 
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separated in 2% agarose gel electrophoresis at 80 V for 40 min. The loading control with 
chicken -actin-specific cDNA was established with the sense primer 5´-
ATGGCTCCGGTATGTGC-3´ and the antisense primer 5´-ACCGTGTTCAATGGGGT-3´. 
The calculated length of amplified cDNA was 185 bp. 
Extracts of lens, retina and bursa of Fabricius were obtained and processed by SDS gel 
electrophoretic analysis and Western blotting, as described previously [27]. Polyclonal 
antibodies against C-GRIFIN were raised in rabbits, as described [41], and thoroughly checked 
for presence of any cross-reactivity against other CGs by ELISAs and Western blotting using 
the complete panel of purified CGs, which was then removed by affinity chromatography on 
resin with respective CGs. For detection in extracts, proteins (100 g of tissue lysates or 12 ng 
of purified recombinant C-GRIFIN as positive control) were separated on a discontinuous SDS 
polyacrylamide gel (4% stacking gel, 15% running gel) and then transferred by tank blotting 
onto a nitrocellulose membrane (0.2 μm pore size; Schleicher & Schuell, Dassel, Germany). 
Residual sites on the matrix for binding protein were saturated by incubation with a blocking 
solution of Tris-buffered saline (TBS, pH 7.5) containing 0.1% Tween 20 (TBS-T) and 5% 
powdered skim milk. Membranes were routinely incubated overnight at 4 °C with 
immunoglobulin G (IgG) fractions against C-GRIFIN (0.5 µg/ml) in blocking solution. 
Following a washing step with TBS-T, membranes were incubated with goat anti-rabbit IgG-
horseradish peroxidase conjugate (0.5 gml Sigma-Aldrich, Munich, Germany) in blocking 
solution for 1 h at room temperature and developed using enhanced chemiluminescence 
detection, driven by a substrate mixture with 1.25 mM sodium salt of luminol in 2 ml 0.1 M 
Tris-HCl (pH 8.6), 0.2 ml of a 6.7 mM p-coumaric acid solution in dimethyl sulfoxide and 0.6 
l H2O2 (30% vv) at room temperature. Exposure time of the processed blots to CL-XPosureTM 
X-ray film (Pierce, Bonn, Germany) was set from 2 to 10 min to yield optimal signal intensity 
at minimal background. 
 
2.5. Immunohistochemistry 
 
Tissue specimen from 4-week-old chickens were immediately fixed by immersion in 
Bouin’s solution for 24 h at 4 °C, dehydrated using solutions of increasing content of ethanol 
(70%, 80%, 96% and 100%), then isopropanol and finally xylene, embedded in paraffin wax at 
61 °C, cut into serial sections of 5 μm in thickness, and these sections were mounted on 
Superfrost slides (Menzel, Braunschweig, Germany), a protocol applied in previous studies to 
ensure comparability [28, 30, 42], following systematic titrations of the antibody concentration 
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to optimize signal-to-background ratio. Alkaline-phosphatase-labeled second-step antibody 
(goat anti-rabbit, 0.66 μg/ml; Sigma-Aldrich) was applied for 1 h at room temperature, and 
reagents of the Vector® Red alkaline phosphatase Substrate Kit SK-5100 (Enzo Life Sciences, 
Lörrach, Germany) were incubated for 20-30 min in the dark. Counterstaining with Mayer’s 
hemalaun and dehydration were followed by mounting sections in Eukitt® (Kindler, Freiburg, 
Germany). Microphotographs during light microscopy were recorded using an AxioImager.M1 
microscope (Carl Zeiss MicroImaging, Göttingen, Germany) equipped with an AxioCam MRc 
digital camera and the software AxioVision version 4.6. 
 
2.6. Binding assays 
 
Haemagglutination of trypsin-treated glutaraldehyde-fixed rabbit erythrocytes using 2-fold 
serial solutions of C-GRIFIN and proto-type CGs as positive control were performed in 96-
well (V-shaped) microtiter plates, as described [43]. Following biotinylation under activity-
preserving conditions with the N-hydroxysuccinimide ester derivative (Sigma-Aldrich), labeled 
C-GRIFIN was tested in a solid-phase system (microtiter plate wells presenting surface-
adsorbed (neo)glycoproteins after incubation of solutions (0.5 µg/50 µl of PBS) at 4 °C 
overnight, blocking residual sites for protein adsorption and thorough washing), using a 
streptavidin-peroxidase conjugate (0.5 µg/ml; Sigma-Aldrich) and the chromogenic substrates 
o-phenylenediamine (1 mg/ml)/H2O2 (1 µl/ml) as reporters, as described [36, 44]. The glycan 
array was produced by printing using solutions with glycan (50 µM) or polysaccharide (10 
µg/ml) and then applied using biotinylated C-GRIFIN and the proto-type CGs, as described 
[45]. Lectin association to glycans on the chip (total of 672 slots with about 600 different 
glycocompounds: for full representation of structures, please see 
http://csdb.glycoscience.ru/bacterial) was converted to a fluorescent signal using ALEXA 
Fluor® 555-labeled streptavidin, the signals’ intensity was monitored in an Innoscan 1100 AL 
instrument (Innopsys, Carbonne, France). The resulting data were processed using ScanArray 
Express 4.0 software, the fixed 70 µm-diameter circle method and Microsoft Excel.  
Binding to cell surfaces was quantitated using fluorescent C-GRIFIN, prepared by reacting 
fluorescein isothiocyanate (isomer I; Sigma-Aldrich) at 0.25 mg/mg protein in 0.1 M Na2CO3 
solution (pH 9.0) containing 0.9% NaCl and 50 mM lactose for 1 h at room temperature, and a 
panel of lines, i.e. Chinese hamster ovary (CHO) parental line and its Lec1, 2, 8, 19 
glycosylation mutants, kindly provided by P. Stanley (Albert Einstein College of Medicine, 
Bronx, NY), as well as human pancreatic cancer (Capan-1) line reconstituted for expression of 
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the tumor suppressor p16INK4a, kindly provided by K. M. Detjen, Charité-Universitätsmedizin 
Berlin, Berlin, Germany, as described [27, 46]. Mass spectrometric identification of lactose-
binding peptides obtained from C-GRIFIN bound to the affinity resin (0.2 ml packed volume) 
after trypsin treatment (lectin:enzyme ratio of 20:1) followed the protocol developed for human 
galectins-1 and -3 and lactose-presenting Sepharose 4B beads, with five washing steps of 0.5 
ml PBS after the in situ cleavage to remove peptides without affinity to lactose and elution with 
0.2 ml acetonitrile:trifluoroacetic acid (0.2%) (2:1; v/v) [47].  
 
3. Results and discussion 
 
3.1. The C-GRIFIN gene 
 
Systematic database mining disclosed common presence of the GRIFIN gene in vertebrates 
(please see Fig. 1 for examples; for a complete listing of the 144 species, please see 
Supplementary material, Table S1, for complete listing of the deduced amino acid sequences in 
the form of a molecular phylogenetic analysis, Fig. S1; this information thus extends the already 
reported evidence for GRIFIN gene presence in dog, guinea pig, mouse and rat, also chicken 
and zebrafish [16, 18, 19, 22, 48, 49]). In all cases, the copy number was found to be one. This 
finding excludes an inter-species variation due to duplication events. They had been found for 
other members of this family such as galectins-7 or -9 in mammals [31]. Mapping the 
chromosomal neighborhood of the C-GRIFIN gene disclosed no spatial association to any other 
gene for a CG (Supplementary material, Fig. S2A). In inter-species comparison, the 
neighborhood of the GRIFIN gene was remarkably similar in organisms from different 
branches of the vertebrate section of the phylogenetic tree (Supplementary material, Fig. S2B). 
Apparently, the gene and its chromosomal placement are of ancient origin, without having been 
subject to copy-number or positional dynamics. Looking closely at the gene’s organization, it 
has the common pattern of exon/intron distribution, as documented in Supplementary material, 
Fig. S3. Thus, the GRIFIN gene is a conserved part of the vertebrate galectin network. Having 
collected this information and retrieved sequences from the databases, it was possible to 
perform alignments and to examine in detail especially the status  
of the signature sequence on the level of amino acids, setting C-GRIFIN in relation to the other 
CGs and to its orthologues in other vertebrates
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Fig. 1. Information on the GRIFIN gene in man and 32 selected vertebrate species of different branches of the taxonomic tree as available in databases. 
Respective information on the genes, present either in forward (+) or in reverse (-) direction, is presented as chromosome or scaffold number together with 
the number of nucleotides, characterizing the precise position and length of the gen. 
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Respective calculations delineated a close evolutionary relationship to the chimera-type 
CG-3, separated by a branching point from galectin-related protein (GRP) and the C-terminal 
carbohydrate recognition domain (CRD) of tandem-repeat-type CG-8 (Fig. 2A; for complete 
listing of the CG sequences, please see Supplementary material, Fig. S4). Interestingly, the 
positions of the three proto-type (homodimeric) CG-1A, -1B and -2 were rather distant. This 
obvious separation argues against immediate origin of C-GRIFIN from this group by a 
duplication event, as is the case for the paralogue pair CG-1A and -B [50]. This result confirmed 
and extended a previously reported status of relationship [16], underscoring a genealogically 
closest vicinity of GRIFIN to CG-3. The degree of conservation in the signature sequence was 
expectably variable, rather substantial among the CGs and more diverse among GRIFIN in 
vertebrates (Fig. 2B, Fig. S4, Fig. S5). Intriguingly, a substitution at the equivalent of the Val73 
position (from Arg in the homodimeric (proto-type) CGs, which share the occurrence of a gap 
at the preceding place) appears tolerable in CG-3 and both CRDs of CG-8, which yet have an 
Arg/Lys residue adjacent to this position and bind well to -galactosides [27, 28, 51]. Because 
homodimeric (proto-type) CGs maintain Arg at this position and rat GRIFIN is a homodimer 
with Val at this site without affinity to lactose [18], it is uncertain whether C-GRIFIN is active 
as lectin, despite the conservation at the other positions. In addition to answering this question, 
it was also of interest to clarify the quaternary structure of C-GRIFIN. To address these issues 
and also obtain material for raising polyclonal antibodies, the cDNA was cloned to produce the 
protein. 
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Fig. 2. Phylogenetic family-tree diagram (A), and alignment of the section of the amino acid sequence with the 
signature region (amino acids 45-79) of C-GRIFIN with those of GRIFIN of zebrafish, rat, the rat triple mutant[18], 
mouse and man as well as human galectin-1 (B). Strictly conserved (red background) and homologous residues 
(>70% conservation; boxed red letters) are highlighted by coloring. Amino acids in contact to the canonical ligand 
lactose are indicated with asterisks. 
 
3.2. Characterization of C-GRIFIN 
 
In the first stage, a design of the expression vector was selected to facilitate the generation 
of a fusion protein. Hereby, obtaining product became independent from a carbohydrate-
binding capacity and yield in glycan-based affinity chromatography. When tested 
chromatographically for carbohydrate-binding activity with lactose-containing affinity resin, 
both the fusion protein and the purified C-GRIFIN bound to the beads and could be eluted by 
the cognate sugar. C-GRIFIN thus is a -galactoside-binding protein. As consequence, C-
GRIFIN-specific cDNA without any artificial extension in combination with this type of 
affinity chromatography, as routinely used for CGs, could be used. Production directed by the 
most efficient vector generated a yield of about 60 mg C-GRIFIN/l at 30 °C during induction 
and incubation overnight.  
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Gel electrophoretic analyses documented purity with a single spot in isoelectric focusing 
at a pI value of about 6.2 (calculated pI at 6.15) (Fig. 3). Molecular mass determination of the 
protein and its tryptic peptides as well as the information obtained by reISD/linISD sequencing, 
in combination resulting in complete coverage, revealed that C-GRIFIN was neither truncated 
nor modified posttranslationally (Fig. 4, Fig. S6, Fig. S7, Tables S2A,B). Recalling GRIFIN 
presence in rat lens and expecting a rather long half-life of the protein at this site, it was of 
interest to examine the protein’s susceptibility to chemically induced modifications, i.e. 
oxidation and deamidation. Upon exposure to hydrogen peroxide (up to 0.05% in buffer for 24 
h), modification in peptide 6-23 occurred at Met14 alone (up to a level of 15.7%) and at 
Met14/Trp18 together up to 8.9%, in peptide 26-52 up to Met32 of 45.9% and in peptide 59-70 
up to Trp68 of 18.6%. Notably, the Trp68 residue at the canonical contact site for lactose 
obviously is substantially sensitive to oxidation. For electrolectin, the first animal galectin 
purified from the electric eel, the equivalent Trp was oxidized by O2 to oxindole and lectin 
activity lost after 30 min of exposure, the reaction precluded by the protective effect of lactose 
[52]. Deamidation levels increased linearly over time, reaching 9.2%/13.5% at 25 °C/40 °C 
after seven days for Asn residue(s) in peptide 58-70 and 3.7%/5.8% in peptide 121-136. 
 
 
Fig. 3. Analysis of recombinant C-GRIFIN by two-dimensional gel electrophoresis. The relevant part of a gel after 
two-dimensional gel electrophoresis separating C-GRIFIN and the human galectins-1 (calculated pI: 5.34; 
experimentally determined pI: 5.28), -2 (calculated pI: 5.93; experimentally determined pI: 5.78) and -7 (calculated 
pI: 7.00; experimentally determined pI: 6.46) is shown after staining. 
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Fig. 4. MALDI-TOF-MS of C-GRIFIN. (A) Molecular mass determination. The two peaks represent its singly 
and doubly charged molecular ions. (B, C) Peptide mass fingerprinting. The list of detected peptides with their 
calculated (calc) and experimentally measured (exp) mass values (B) and the sequence coverage (C, shaded) are 
shown. 
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In gel filtration, the protein eluted as a single peak at the calculated position of the 
homodimer (Supplementary material, Fig. S8). Addition of lactose led to a slight shift in the 
elution volume, indicating an increase in the protein’s shape, along with the appearance of a 
minor second peak in the range of elution volume expected for a dimer of dimers (Fig. S8). Of 
note, loading the CRD of a homodimeric galectin with this disaccharide can indeed entail a 
change in the gyration radius. This had first been detected for human galectin-1 by small angle 
neutron scattering that made a reduction of the gyration radius from 19.1±1 Å to 18.2±1 Å 
measurable [53]. The hydrodynamic behavior of homodimeric CGs, too, is prone to change 
during lactose binding, CG-1B responding with an increase in the diffusion constant of 5.6%, 
CG-2 with a reduction by 3.8% [29]. In terms of activity and quaternary structure, C-GRIFIN 
thus is a homodimeric (proto-type) galectin, yet widely separated from the set of the three well-
characterized CG-1A, -1B and -2 in the alignment-based scheme showing phylogenetic 
relationships (Fig. 2A). As the acronym signals, it has a distinct (very restricted) expression 
profile in rats [18] (recently extended to white adipose tissue in obese rats and to retina after 
intravitreal sex steroid injection, as determined by proteomic mapping [54, 55]) and in 
zebrafish, where RT-PCR analysis gave signals in specimen of adult brain, intestine and oocyte 
besides the expected positivity with RNA from eyes [22]. To monitor C-GRIFIN expression in 
chicken, we performed RT-PCR and Western blotting as well as immunohistochemistry. 
 
3.3. Expression of C-GRIFIN 
 
Profiling of expression on the levels of mRNA and protein gave signals when testing adult 
eyes (Fig. 5, Fig. 6). RNA preparations from other organs (heart, jejunum, liver, lung, pancreas, 
proventriculus, spleen and thymus) were invariably negative (not shown). Material from organs 
such as bursa of Fabricius or kidney, which also contains other CGs such as CG-3, was negative 
in Western blotting as were extracts of adult retina. Here, CG-1A had been reported to be 
expressed in all layers [56, 57]. The absence of any signal in kidney or retina extracts, compared 
to the strong reaction in the specimen from lens, documented the specificities of expression and 
of the antibody preparation. As also ascertained with purified CGs, it is apparently not cross-
reactive to any other CG when testing organ extracts. Because galectin fingerprinting in the 
human eye had detected presence of all seven tested family members with regional specificity 
and characteristic profiles [58], such a cross-reactivity must be rigorously excluded. Recalling 
the alignment-based positioning of C-GRIFIN and CG-3 on the same branch of the 
phylogenetic scheme (Fig. 2A), it is noteworthy that galectin-3 immunoreactivity in 
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mammalian lens had been found in fibers of the outer cortex and also anterior epithelial cells 
with a heterogenous profile of intensity [59, 60], indicating the possibility for its co-expression 
with GRIFIN. 
 
Fig. 5. Expression profiling of C-GRIFIN by RT-PCR. The presence of C-GRIFIN-specific mRNA was detected 
in samples from tissues of 4-week-old chickens as band at 420 bp. Probing of mRNA for actin served as positive 
control. Positions of markers are indicated (left). 
 
 
Fig. 6. Expression profiling of C-GRIFIN by Western blotting. Detection of C-GRIFIN in extracts from tissue 
samples (100 µg total protein) of 4-week-old chickens using a polyclonal IgG preparation against C-GRIFIN (anti-
C-GRIFIN: 0.5 µg/ml) free of any cross-reactivity to the other five CGs and to C-GRP. Positions of molecular 
weight markers are indicated (left), a control (termed C-GRIFIN) with purified recombinant protein (12 ng) is 
included. 
 
Having ensured absence of cross-reactivity, the anti-C-GRIFIN antibody preparation could 
be used for immunohistochemistry. Respective results, together with a scheme of the avian lens, 
are presented in Fig. 7. Strong immunoreactivity for C-GRIFIN was detected in the semicircular 
fibers of the main lens body and to a weaker extent in the transition zone between the lens body 
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and the annular pads (Fig. 7). No staining was observed in the hexagonally shaped and radially 
arranged nucleated fibers of the annular pads, which form an outer ring around the equator of 
the lens body, the cuboidal cells of the epithelial layer of the lens at the anterior part and the 
capsule, which covers the whole lens (Fig. 7). When comparing this profile to data from adult 
rat lens [18], where “immunoreactivity between rows of fiber cells” in a “peripheral region 
underlying the lens epithelium” had been described, a rather uniform and strong staining 
throughout the main lens body, both between and within the fibers and with no distinction 
between peripheral or central regions, characterized C-GRIFIN localization. Thus, C-GRIFIN’s 
localization justifies the acronym as lens-specific protein, with a rather uniform expression in 
the lens body. 
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Fig. 7. Immunohistochemical localization of C-GRIFIN in fixed cross-sections through lens together with a 
scheme of the avian lens (top part). As controls, processed sections of retina and kidney from 4-week-old chickens 
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are presented (bottom part). The microphotographs of distinct regions of the chicken lens (A-D) are assigned to 
the scheme (center of top part), which defines their positions by color-coded boxes. (A) No reactivity was observed 
in the hexagonally shaped nucleated fibers of the annular pads (ap) that form an outer ring around the equator of 
the lens body and in the lumen of the cavum lenticuli (cl), a wedge-shaped structure between the equatorial-
posterior parts of the annular pads and the main lens body (mlb). (B) Strong signal for presence of C-GRIFIN in 
superficial fibers of the main lens body at the anterior region of the lens. The cells of the cuboidal epithelium (epi, 
arrowheads) were negative. (C) C-GRIFIN presence in typically flat band-like deeper central fibers of the main 
lens body at the posterior surface of the lens. (D) Transitional zone between annular pad and main lens body in 
the equatorial-posterior region of the lens. Staining intensity is gradually enhanced with increasing degree of 
differentiation of C-GRIFIN-negative curved annular pad fibers (cap) into superficial fibers of the main lens body. 
Of note, spherical nuclei (arrows) of annular pad fibers were negative, whereas the ellipsoid nuclei (arrowheads) 
of the superficial fibers were strongly positive. (E) No signal for C-GRIFIN was detected in the layers of the retina: 
choroid (ch), pigment epithelium (pe), layer of rods and cones (rc), outer nuclear layer (onl), outer plexiform layer 
(opl), inner nuclear layer (inl), inner plexiform layer (ipl), and ganglion cell layer (gcl). (F) The lack of reactivity 
for the C-GRIFIN-specific antibody in sections of kidney serves as a further negative control, thus excluding any 
antigen-independent staining. The scale bars are 25 µm. 
 
Having herewith identified this CG as lens product, we wondered whether the proximal 
promoter region may harbor sequence motifs of the respective section of genes for proteins 
exclusively or mostly produced in the lens. To address this issue i) the promoter region of the 
C-GRIFIN gene was computationally scrutinized for occurrence of putative binding sites for 
transcription factors (compiled in Table S3), ii) the same procedure was applied to a panel of 
10 genes for chicken lens proteins, i.e. aquaporin-0 [61], A-crystallin [62], A1-crystallin 
[63], B1-crystallin [64], 2-crystallin [65], connexin-43 [66], connexin-46 [67], connexin-50 
[68], filensin [69] and phakinin [70] and iii) potentially relevant transcriptions factors could be 
singled out on the basis of frequency of occurrence of sequence motifs that satisfy the stringent 
criteria for entering the list of putative sites for binding a transcription factor, when results of 
processing the C-GRIFIN sequence were set into relation to those for the lens-specific genes. 
The obtained list, presented in Table 1, presents candidates, for whom putatively matching 
sequence motifs are common to all (MARE) or most selected cases (e.g. FOXP1_ES in 10 of 
11 promoters). This information nourishes the assumption of shared regulatory mechanisms 
and provides a guideline for respective study to delineate the molecular basis of transcriptional 
regulation. 
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Table 1 
Listing of transcription factors with putative reactivity to respective sequence motifs shared by 
promoters of genes for C-GRIFIN and 10 eye-expressed proteinsa,b 
 
sequence motifs present in 
 
11/11 promoters 10/11 promoters 
(incl. GRIFIN) 
 
9/11 promoters 
(incl. GRIFIN) 
 
8/11 promoters 
(incl. GRIFIN) 
7/11 promoters 
(incl. GRIFIN) 
 
MARE 
 
FOXP1_ES 
 
GSH1, LHX3, 
MAFF, PAX6 
 
GSH2, ISL1, 
OLIG2, SIX1, 
ZIC3 
ASCL2, ISL2, 
MAFA, 
NGN/NEUROD, 
WHN, ZIC2 
 
a Full names of transcription factors: ASCL2: Achaete-scute complex homolog-like 2; FOXP1_ES: alternative 
splicing variant of FOXP1 activated in embryonic stem cells (ESCs); GSH1: homeobox transcription factor Gsh-
1; GSH2: homeodomain transcription factor Gsh-2; ISL1: pancreatic and intestinal lim-homeodomain factor; 
ISL2: ISL LIM homeobox 2; LHX3: homeodomain-binding site in LIM/homeodomain factor LHX3; MAFA: lens-
specific musculoaponeurotic fibrosarcoma oncogene homolog (Maf/MafA) sites; MAFF: transcription factor 
MafF; MARE: Maf recognition element, binding sites for homodimers of large Maf proteins; NGN/NEUROD: 
Neurogenin and NeuroD binding sites; OLIG2: oligodendrocyte lineage transcription factor 2; PAX6: PAX6 
paired domain-binding site; SIX1: sine oculis homeobox homolog 1; WHN: winged helix protein; ZIC2: Zic 
family member 2; ZIC3: Zic family member 3. 
b Listing of common names (shown in bold letters), abbreviations and synonyms of the individual chicken proteins: 
aquaporin-0 (AQP0) was formerly known as MIP (major intrinsic protein)/MP26; αA-crystallin; βA1-crystallin; 
βB1-crystallin; δ2-crystallin/ASL2 (argininosuccinate lyase 2); connexin-43/GJA1 (gap junction α1 protein); 
connexin-46/GJA3 (gap junction α3 protein) was formerly known as connexin-56; connexin-50/GJA8 (gap 
junction α8 protein) was formerly known as connexin-45.6; filensin/BFSP1 (beaded filament structural protein 
1)/CP95 (cytoskeletal protein 95); phakinin/BFSP2 (beaded filament structural protein 2)/CP49 (cytoskeletal 
protein 49).   
 
 
With respect to C-GRIFIN’s localization, complex formation of murine GRIFIN with -
crystallin, possible inside fiber cells and associated to the membrane, gave reason to propose 
“a mechanism for facilitating order and efficient packing of protein”, hereby “contributing to 
the refractive index necessary for the lens to focus light on the retina”, and an influence on “cell 
elongation and suture formation” [20]. This description evokes an analogy to a functional aspect 
of distinct plant lectins: giving structural order to the way storage proteins like vicilin are 
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arranged by carbohydrate-dependent and -independent recognition had been suggested as an 
intracellular mission of leguminous lectins, which like galectins have the -sandwich fold [71]. 
Even more intriguing, dual specificity of these di- and tetravalent lectins to storage proteins and 
the protein body membrane suggests them to be a (reversible) glue [71-73]. Molecular 
interactions by the galectin, for example between cells, vesicles or glycoproteins leading to 
bridging and aggregate formation documented for CG-1A or human galectins-1 and -3 [74-76], 
will underlie these activities, explaining the interest to characterize binding features of C-
GRIFIN. 
 
3.4. Lectin activity of C-GRIFIN 
 
As a test to reveal carbohydrate-dependent cross-linking capacity, assays for hae-
magglutination (formation of aggregates of erythrocytes) were performed. C-GRIFIN was 
active at a minimal concentration of 12 µg/ml. This value was considerably higher than those 
determined for CG-1A (at about 10 ng/ml) or CG-2 (at about 160 ng/ml) [26]. Cell bridging 
was blocked by 1.0-1.5 mM lactose but not by other tested sugars used as osmolarity control. 
Specificity of carbohydrate binding was further measured by solid-phase assays using 
(neo)glycoproteins. The glycoprotein asialofetuin with three complex-type N-glycans 
presenting galectin-reactive N-acetyllactosamine [74] and lactosylated albumin served as 
matrix for concentration-dependent and saturable binding, whereas maltose, mannose or L-
fucose as sugar part were completely inert (not shown). In order to learn about the fine-
specificity of C-GRIFIN, we tested the labeled lectin in an array. It included a total of about 
600 different glycocompounds (mono- to oligosaccharides, glycopeptides, polysaccharides, 
lipopolysaccharides and glycosaminoglycans) to cover a broad spectrum of natural structures 
and controls (for complete listing of the panel and for obtained results, please see Table S4). 
Under conditions, in which the homodimeric CG-1A, -1B and -2 generated significant results, 
C-GRIFIN, too, gave distinct signals, corroborating its activity and specificity. Its binding 
activity was best with histo-blood group B tetrasaccharides (type I/II) and the histo-blood group 
H (type I) epitope extended by N-acetyllactosamine. In comparison to the controls, C-GRIFIN 
shared reactivity with CG-2 (B tetrasaccharide) and CG-1B (H type I) (please see Table S4 for 
details).  
On the level of cells, binding, too, was dependent on the lectin concentration and 
inhibitable only by a certain sugar (i.e. lactose), as exemplarily shown for a CHO glycosylation 
mutant line (Lec2), whose N- and O-glycan sialylation is impaired (Fig. 8). As consequence, 
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these glycans have a high density of -galactoside termini. N-Acetylglucosamine, L-fucose, 
maltose, mannose and L-rhamnose were not inhibitory, underscoring the canonical specificity 
to -galactosides. Examined at the same C-GRIFIN concentration (at 10 µg/ml) under identical 
conditions, CHO wild-type and also other glycosylation mutant (Lec) cells were comparatively 
analyzed to probe into the correlation of distinct characteristics of the surface glycome and 
binding properties of C-GRIFIN. This special system of cell lines offers the opportunity to, for 
example, probe into potential preferences for N- and O-glycosylation (Lec1 mutant) and 2,3-
sialylation (Lec2 mutant), when compared to the parental line [77]. The marked extent of 
decrease upon loss of complex-type N-glycosylation (Lec1) signals only minor reactivity to the 
surface O-glycans (sialylated mucin-type core 1 and O-fucosylated structures) (Fig. 9A,B), the 
relative increase from wild-type to Lec2 cells (reduced sialylation) a negative impact by 2,3-
sialylation in wild-type cells (Fig. 9A,C) and the significant loss of signal upon reduction of 
galactosylation in Lec8 cells the importance of this sugar as docking site (Fig. 9A,D). In 
comparison to other CGs, this pattern of cell binding resembles that of CG-3 [28], whereas CG-
8 has marked reactivity with 2,3-sialylated glycans on wild-type cells via its N-terminal CRD 
[27, 78]. The binding profile of C-GRIFIN was altered, too, upon decrease in expression of 
1,4-galactosyltransferases I-VI (Lec19) (Fig. 9A,E). The ensuing consequence to incorporate 
less galactose moieties into the N-glycans, seen by mass spectrometry and of impact also for 
glycoprotein processing [79, 80], causes a mild reduction in binding relative to the parental 
cells. Flanking this series, a human line, strongly reactive with galectins-1 and -3 [81], also 
bound C-GRIFIN very well (Fig. 9F). 
These results further substantiate C-GRIFIN’s lectin property, here its reactivity with -
galactosides at N-glycan termini of cell surface glycans. In order to provide a first insight into 
the structural basis of this activity, a recently developed method based on binding of lectin to 
the resin, tryptic on-bead protein fragmentation and mass spectrometric identification of eluted 
peptides was employed [47]. Experimentally, C-GRIFIN on lactose-presenting beads was 
treated with trypsin, all peptides without affinity to lactose washed out, the remaining peptides 
eluted and identified. As shown in Fig. 10, two peptides were detected in the eluted fraction 
after thoroughly removing material no longer in contact to the beads. In line with the tryptic 
fingerprinting (Fig. 4B), they covered the sequence sections from amino acids 25-51 and 57-69 
(Fig. 10). These regions are homologous to the two peptides obtained under identical conditions 
from human galectins-1 and -3, where they are in contact to bound lactose [47]. 
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Fig. 8. Semilogarithmic representation of staining of the CHO Lec2 mutant cells with fluorescently labeled C-
GRIFIN. The control value without C-GRIFIN addition is given as shaded area. Numbers characterizing staining 
(percentage of positive cells/mean fluorescence intensity) are given in each panel. (A) Concentration-dependent 
staining using C-GRIFIN at 5 µg/ml (48% / 13.0), 10 µg/ml (66% / 18.6), 20 µg/ml (81% / 31.3) and 40 µg/ml 
(86% / 40.5). (B) Inhibition of cell surface binding of C-GRIFIN (40 µg/ml; peak with black line at 86% / 40.5) 
by 10 mM (dashed line; 67% / 31.3) and 100 mM (grey line; 42% / 21.8) lactose. 
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Fig. 9. Cell surface staining by C-GRIFIN (shaded area: control; black line: 10 µg/ml C-GRIFIN). The following 
lines were tested: (A) CHO wild-type cells, (B) CHO Lec1 mutant, (C) CHO Lec2 mutant, (D) CHO Lec8 mutant, 
(E) CHO Lec19 mutant and (F) human pancreatic carcinoma cells (Capan-1) expressing tumor suppressor p16INK4a. 
 
 
Fig. 10. Mass-spectrometric identification of two lactose-binding peptides of C-GRIFIN after tryptic 
fragmentation of the protein bound to the ligand on the affinity resin, thorough washing to remove all material 
without affinity to lactose and elution. The tryptic fingerprinting with full sequence information is given in Fig. 4. 
 
These experiments set the stage to proceed from sequence alignments to a structural 
comparison in three dimensions. Due to the availability of X-ray structures for CG-1A [82], 
CG-1B [83], CG-2 [84] and CG-8N [85] and the lessons learned from two mutants of human 
galectin-1 that a seemingly minor change (i.e. C2S and R111H) can alter loop presentations 
and cause shifts in the topological presentation of crucial residues [83], the next step to 
understand C-GRIFIN’s lectin activity despite the deviation from the sequence signature will 
be its crystallographic analysis in the presence of lactose. Equally important, the addition of C-
GRIFIN to the list of CGs, with a non-cross-reactive antibody preparation being available, 
facilitates a complete network analysis of CG expression, including developmental stages. 
After all, a gradual increase of GRIFIN presence had been reported for the rat protein over the 
period of day 22 pc to the adult stage [18]. Here, as noted above, special attention will be given 
to co-monitoring of CG-3. Besides the detection of presence of mammalian galectin-3 in lens, 
information on a binding partner for this lectin is available. In extracts of ovine lenses, the 
tetraspanin MP20 was identified to associate with galectin-3 [59, 86]. MP20 is an abundant 
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intrinsic membrane protein present in junctions between fiber cells [87]. The bovine protein 
lacks common forms of glycosylation, sugar conjugation only detected as C-mannosylation at 
Trp, here Trp 43/61 [88] so that in this case pairing with galectin-3 may engage protein-protein 
association. Sequence sections in the CRD, such as the NWGR motif (BH1 domain) for binding 
members of the bcl-2 family of proteins [89-91], or in the N-terminal tail, such as a part of the 
Gly/Pro-rich repeats for involvement in interaction with components of the splicing machinery 
[92], underlie this functional aspect. This recognition process with a counterreceptor as part of 
junctions, and galectin-3 is also a part of cell-cell junctions in breast cancer cells [93], may have 
implications for the architecture of the lens, as the mammalian tandem-repeat-type galectin-4, 
originally described as ‘adherens junction protein’ [94], is suggested to have for assembly of 
adherens junctions [95]. 
 
4. Conclusion 
 
The gene for GRIFIN is common in vertebrates without any copy-number variation. As 
illustrated by compiling the members of the galectin family for selected model organisms in a 
simplified phylogenetic tree (Fig. 11), numbers for proto- and tandem-repeat-type proteins can 
vary. But having a gene for GRIFIN and a gene for the chimera-type galectin-3, these two being 
closely related in sequence alignment, is a general feature, implying a particular functional 
meaning. Looking at the variability in lectin activity between mammalian and avian/fish 
GRIFIN, its functional significance can be further explored by cyto- and histochemically 
mapping binding sites of the labeled protein (and a C-GRIFIN mutant not reactive with -
galactosides) and characterizing binding partners. Of note, the zebrafish gene had also been 
seen expressed in adult brain, intestine and oocyte [22], and lectin activity may be relevant at 
these sites. In structural terms, the origin of the molecular compensation for the Arg-to-Val 
substitution to avoid the loss of reactivity to lactose in C-GRIFIN is presently not known. The 
same holds true for the relations to the other CGs, in terms of structural details beyond the 
amino acid sequence and in terms of tissue localization of the proteins and of binding sites 
detectable by labeled galectin. Because this report completes the individual characterization of 
all galectins in an organism, it gives chicken and its seven proteins of this family the status of 
a well-suited model to proceed to the first comprehensive analysis of the galectin network. 
 
Results Publication 1 48 
 
	
 
Fig. 11. Overview on the structure of the family of galectins in seven model organisms presented according to the 
three types of structural design and degree of homology in alignments. Evidence for presence of the gene (Roman 
number), the mRNA (Arabic number) and the protein (numerical information) determines the entries on numbers 
in each group. N-Terminal extensions of the common CRD have been described in vertebrates for GRP (36-85 
amino acids), C-terminal extensions for galectins of C. elegans (40 amino acids for Lec-7, 41 for Lec-8, 53 for 
Lec-10 and 90 for Lec-11). For galectins of this organism, binding to the canonical ligand lactose has been 
ascertained in seven cases (Lec-1, -2, -3, -4, -6, -10, and -12 (DC2.3)), the C-tailed proto-type galectins Lec-8 and 
the proto-type Lec-9 showed relatively weak binding to asialofetuin (21% / 9% relative to the activity of the 
tandem-repeat-type Lec-1 used as standard), respective activity of Lec-5, Lec-7 and Lec-11 not yet been tested 
[96,97]. GRIFIN (+) is special due to its species-dependent lectin activity, as described in this report, mouse is 
special due to the intra-species variation in occurrence of the tandem-repeat-type galectin-6 (*) that is found 
exclusively in this species [98]. 
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ABSTRACT 
 
Background: Endogenous lectins are multifunctional effectors in cell physiology. Adding the 
sixth member of the galectin family in chicken, a model organism for systematic profiling of 
these adhesion/growth-regulatory proteins, is a step toward comprehensive network 
monitoring. 
Methods: Database mining and computational data processing are applied for gene detection, 
chromosomal location and sequence alignments. Cloning, recombinant production and fusion-
protein technology gain access to the protein, mass spectrometry and gel 
electrophoresis/filtration provide analytical data. Haemagglutination, glycan microarray and 
cell assays assess binding capacity, and crystallography of a shortened variant (also analyzed 
by ultracentrifugation and small angle X-ray scattering) determines its structure. 
Results: The gene for the galectin-related protein (GRP) is present exclusively in vertebrates 
with high-level sequence conservation and similar chromosomal positioning. The chicken 
protein is monomeric and has lost the canonical galectin property of binding lactose. The crystal 
structure of the variant without the 36-amino-acid extension at the start provides explanations 
for this lack of binding. 
Conclusions: Chicken GRP is special among this family of six proteins due to absence of 
binding lactose. The documented high degree of sequence conservation among vertebrate 
orthologues confers the status of a model for delineating an assumed shared functionality to 
this GRP. 
General significance: Biochemical characterization of a product of a gene under strong positive 
selection is a prerequisite for functional characterization. It is also essential for network 
monitoring by adding a new member to this lectin family. 
 
Keywords: adhesion  crystallography  lectin  phylogenesis  proliferation 
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1. Introduction 
 
The concept of the sugar code (for recent reviews, please see [1]) rests on the existence of 
routes to turn glycan-encoded information into effects on the cellular level. In this respect, a 
broad physiological significance has been delineated for receptors of distinct sugar 
determinants (lectins), what prompted their thorough structural characterization [2-7]. 
Proceeding from the identification of a protein fold with capacity to accommodate glycans and 
a common sequence signature, the systematic search for homologous proteins in a species and 
in phylogenesis is the next step on the way toward network analysis of these effectors. The 
results of respective database mining then set the stage to characterize expression and the profile 
of localization as well as functional cooperation of all members of the corresponding family of 
lectins, which have arisen from an ancestral gene by divergence through duplications/losses 
and sequence deviations. The choice of lectin class and species for a comprehensive case study 
of general relevance is favored, if the proteins found in a species represent the full diversity of 
known types of structural organization at a relatively small number of individual proteins. 
Guided by these criteria, complete fingerprinting of biochemical properties and tissue positivity 
at the lowest degree of study complexity will be possible. Turning to the adhesion/growth-
regulatory galectins, a family of -sandwich proteins with carbohydrate specificity to -
galactosides and derivatives thereof [8-10], this general prerequisite is best fulfilled in chicken 
with a total of only five canonical proteins [11]. However, as pointed out [10], the occurrence 
of an expressed sequence tag (EST) with similarity to a mammalian galectin-related protein 
(GRP) found in chicken bursal lymphocytes indicates that a sixth member of this family is 
present in this organism (C-GRP; AJ453496) predestined for model study of the galectin 
network. Obviously, comparative biochemical characterization from the gene to the mature 
product as well as expression profiling and tissue localization of this protein are thus called for. 
The detection of GRP has its origin in cataloguing of gene expression of human CD34-
positive haematopoietic stem/progenitor cells (HSPCs) that led, among 300 cDNA clones, to 
an mRNA termed HSPC159 [12]. Systematic alignments of its predicted amino acid sequence 
disclosed similarity to galectins. It encompasses 51 positions of the set of 64 amino acids most 
likely shared among these proteins [10]. Presence of the gene was not confined to man. GRP 
sequences had been found in mammals (man, mouse), chicken, frog and fish (puffer- and 
zebrafish), and, intriguingly, initial comparison revealed evidence for an exceptionally high 
degree of similarity that implies a “very strong positive selection, as generally seen for genes 
encoding proteins with multiple aspects involved in critical interactions” [10]. Given i) this 
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feature emerging from inter-species considerations that imply special functionality and ii) the 
obvious requirement to bring characterization of this chicken protein (i.e. C-GRP) to the same 
level as has been done for the five canonical chicken galectins (CGs), i.e. the three proto-type 
(homodimeric) CG-1A, CG-1B and CG-2, the chimera-type CG-3 and the tandem-repeat-type 
CG-8 [13-17], we here take a two-step approach. First, we present an overview on occurrence 
of the GRP gene and its organization in phylogenesis, examine C-GRP’s biochemical properties 
and describe the crystallographic structure of a shortened variant. In the accompanying second 
part, details on C-GRP expression and its localization in the positive tissue as well as detection 
of reactive sites for C-GRP are given, set in relation to corresponding results with the five 
canonical CGs.  
 
2. Materials and methods 
 
2.1. Processing sequence information and constructing phylogenetic trees 
 
Gene sequences were downloaded from the Ensembl Genome Browser 
(www.ensembl.org/index.html; Ensembl release 83, December 2015) and the NCBI Genbank 
(www.ncbi.nlm.nih.gov/genbank/index.html) with its divisions CoreNucleotide 
(www.ncbi.nlm.nih.gov/nuccore), EST database (www.ncbi.nlm.nih.gov/nucest) and Genome 
Survey Sequence database (www.ncbi.nlm.nih.gov/nucgss). Information on copy-number 
variation was obtained by processing whole-shotgun sequencing data of each species, provided 
by the University of California Santa Cruz genome browser (www.genome.ucsc.edu) and by 
NCBI Genome (www.ncbi.nlm.nih.gov/genome) as contigs, unplaced scaffolds, chromosomal 
genomic scaffolds and assemblies, then analyzed for presence of distinct exon sequences, 
thereafter routinely for full-length coding sequence, as carried out for canonical galectins of 
mammals recently [18]. In addition, the Basic Local Alignment Search Tool (BLAST) 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) search algorithms were applied to cover the full range 
of sequences, which satisfy stringent criteria of homology. Information on entries for 
orthologues of the GRP gene in species of different branches of the phylogenetic tree was 
displayed applying the NCBI Taxonomy Browser 
(www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi) and the visualization software 
TreeView (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html). Genomic sequences were 
examined manually in each case for annotation errors, presence of non-sequenced stretches, 
exon/intron boundaries and completeness of the coding sequence including the presence of 
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start/stop codons, applying the sequence text view tool implemented in NCBI Gene 
(www.ncbi.nlm.nih.gov/gene; [19]). Sequences were edited using the EditSeq software version 
12.1.0 (DNAstar Inc., Madison, WI, USA). The principle to stringently apply homology criteria 
was rigorously followed in each case. Amino acid sequences of the predicted gene products 
were deduced unless available in the NCBI package retrieved by BLASTP/Position-Specific 
Iterative BLAST search algorithms from the NCBI Protein (www.ncbi.nlm.nih.gov/protein) 
and the UniProt Knowledgebase (UniProtKB, Expasy Proteomics Server; www.expasy.ch).  
Multiple alignments of amino acid sequences were performed using the Clustal Omega 
software (www.ebi.ac.uk/Tools/msa/clustalo/; [20]) and edited in Jalview (v. 2.7; [21]). 
Aligned sequences both for intra-family (C-GRP vs CGs) and inter-species (C-GRP vs GRP of 
other species) comparisons were processed manually to spot positions of highly conserved 
amino acids relevant for binding the canonical sugar ligand lactose (Lac) (sequence signature 
of galectins).  
Analysis of evolutionary relationships and construction of phylogenetic trees were done 
using the Maximum Likelihood method implemented in the MEGA6 software package ([22]). 
The tree with the highest log likelihood is presented. The test of phylogeny was performed 
using bootstrap analysis (with 1000 replicates); the percentage of tree(s), in which the 
associated taxa clustered together, is shown next to branches. Initial tree(s) for the heuristic 
search were obtained by applying the Neighbor-Joining method to a matrix of pairwise 
distances estimated using a Jones-Taylor-Thornton model. For selected organisms, the 
chromosomal environment of the GRP gene was comparatively analyzed using the Ensembl 
Genome Browser (www.ensembl.org/index.html) and the NCBI Map Viewer 
(www.ncbi.nlm.nih.gov/mapview/). 
 
2.2. Cloning, expression and purification 
 
Total RNA from kidney of a 14-day-old chicken embryo was isolated using the RNeasy 
kit (Qiagen, Heidelberg, Germany) following the manufacturer’s instructions, and 2.5 μg was 
used as a template to yield cDNAs for full-length C-GRP and the shortened version of C-GRP 
without the N-terminal section termed C-GRP-C (encoding amino acid residues 37-171). PCR 
amplification of both sequences was directed by the sense primer 5´- 
CGCTAGGGATCCGTGGCCGAGCGGGAC-3´ (BamHI restriction site underlined) for full-
length C-GRP or 5´-CTGGGATCCTGCGGGCACATCAAAGGAGGG-3´ (BamHI restriction 
site underlined) for C-GRP-C, in both cases using the antisense primer 5´-
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CGTACGGTCGACTCAGCCAAGTTTTGTAAGCTGAAG-3´ (SalI restriction site 
underlined). The reaction was performed with Phusion High Fidelity PolymeraseTM under 
conditions recommended by the manufacturer (New England BioLabs, Frankfurt, Germany). 
The amplification products were separated from PCR reagents by gel electrophoresis in 3% 
agarose, then extracted from the gel and digested with BamHI/SalI endonucleases. Insertions 
into BamHI/SalI-linearized pGEX-6P-2 vector (GE Healthcare, München, Germany) in frame 
with the present coding sequence for glutathione S-transferase (GST) directed the production 
of the respective fusion proteins that contain a cleavage site for the human rhinovirus 3C 
protease between the C-terminus of the GST and the start of C-GRP/C-GRP-C, which is then 
necessarily extended by the Gly-Pro dipeptide. Reconstitution of the first three amino acids 
(Ala, Gly and Thr for C-GRP; Val, Pro and Phe for C-GRP-C), which had to be changed to 
establish the BamHI site by a modified QuikChangeTM site-directed mutagenesis protocol 
(Agilent Technologies, Waldbronn, Germany), was applied. For recombinant production, 
pGEX-6-P-2/C-GRP or pGEX-6-P-2/C-GRP-C plasmids were transferred into E. coli BL21 
(DE3)-pLysS cells (Promega, Mannheim, Germany). Optimal yields in both cases were 
obtained with incubation at 22 °C using TB medium (Roth, Karlsruhe, Germany), at a final 
concentration of 100 µM isopropyl β-D-thiogalactopyranoside with incubation overnight. Cells 
were thereafter lysed by sonification using 7 mL 20 mM phosphate-buffered saline (PBS), pH 
7.3, containing 1 mM dithiothreitol (DTT) per gram of wet cell paste. After centrifugation of 
the suspension, the supernatant was processed by affinity chromatography on glutathione 
Sepharose 4B (GE Healthcare), using 50 mM Tris-HCl buffer, pH 8.0, containing 20 mM 
reduced glutathione for elution of bound GST. Removal of GST after the proteolytic cleavage 
of the fusion proteins in 50 mM Tris-HCl buffer, pH 7.5, containing 150 mM NaCl, 1 mM 
EDTA and 1 mM DTT by human rhinovirus 3C protease (fused to GST; working concentration 
1:100 (w/w)) was done batchwisely by incubation of the solution with glutathione-presenting 
Sepharose 4B beads for 16 h at 4 °C.  
 
2.3. Analytical procedures 
 
Gel electrophoretic analyses were carried out in SDS polyacrylamide gels with 4% 
stacking/15% running gels and in the two-dimensional system, as described previously [16,17]. 
Proteins were visualized by silver staining; measured pI values were compared to 
computationally calculated results using the respective program of the EXPASY (Expert 
Protein Analysis System) proteomics server at the Swiss Institute of Bioinformatics (Basel, 
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Switzerland; http://web.expasy.org/compute_pi/). Matrix-assisted laser desorption/ionization 
(MALDI) time-of-flight (TOF) mass spectrometry (MS) was applied for C-GRP(-C) 
characterization in a top-down approach by in-source decay (ISD) and molecular mass 
determination, using sinapinic acid (SA; Bruker Daltonik, Bremen, Germany) as matrix. 
Protein samples were dissolved in water to reach a final concentration of 100 pmol/µL, and the 
solution was diluted with 0.1% trifluoroacetic acid (TFA) to a final concentration of 40 
pmol/µL. Then, 0.5 µL of a saturated solution of SA in ethanol were pipetted on individual 
spots of the MALDI target. After drying, 1 µL of protein solution was added on top of the thin 
SA layer, immediately followed by 1 µL of a saturated solution of SA in 0.1% TFA with 30% 
acetonitrile (TA30). Spotted samples were dried at ambient temperature prior to analysis. 
MALDI mass spectra were obtained on an Ultraflex™ TOFTOF I instrument (Bruker Daltonik) 
equipped with a nitrogen laser (20 Hz), as described for engineered variants of human galectin-
3 [23]. MALDI TOF MS experiments were run in the positive-ion linear mode using the 
following settings: ion acceleration voltage at 25.0 kV and first extraction plate at 23 kV. 
Reflectron ISD (reISD) spectra were recorded in the positive-ion reflectron mode using the 
following settings: ion acceleration voltage at 25.0 kV, reflector voltage at 26.3 kV, first 
extraction plate at 21.75 kV; linear ISD (linISD) spectra were acquired in the positive-ion linear 
mode with settings for ion acceleration voltage at 25.0 kV and first extraction plate at 23.2 kV, 
as carried out for an engineered tandem-repeat-type-like galectin-1 variant [24]. Experimental 
information from up to 5000 individual laser shots was routinely accumulated. Calibration of 
spectra was performed externally by linear fit between trypsinogen and protein A using protein 
calibration standard II for molecular mass determination and by a quadratic fit using the protein 
calibration standard I in the case of linISD spectra or the peptide calibration standard II in reISD 
spectra (Bruker Daltonik). FlexControl version 2.4 was used for instrument control and 
FlexAnalysis version 2.4 for processing the data of the spectra. Annotated spectra were further 
analyzed by BioTools 3.0 (Bruker Daltonik).  
For quaternary-structure determination by gel filtration, C-GRP/C-GRP-C (100 µg in a 
volume of 50 µL PBS) were chromatographed on a SuperoseTM HR10/30 column using an 
ÄKTApurifier 10 system at a flow rate of 0.5 mL/min and 4 °C. The column was calibrated 
with the following molecular weight markers: blue dextran (Mr > 2000), aldolase (Mr = 158 
kDa), albumin (Mr = 67 kDa), ovalbumin (Mr = 44 kDa), chymotrypsinogen (Mr = 25 kDa) 
and vitamin B12 (Mr = 1.35 kDa). Small-angle X-ray scattering (SAXS) data on C-GRP-C were 
collected on BM29 at the European Synchrotron Radiation Facility (ESRF, Grenoble, France) 
using the BioSAXS robot and a Pilatus 1M detector (Dectris AG, Baden-Daettwil, Switzerland) 
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with synchrotron radiation at a wavelength  = 0.1 nm. Protein samples were prepared at a 
series of concentrations of 2, 4, 6 and 8 mg/mL in PBS containing 5 mM DTT. For each 
measurement, ten frames were obtained at 1 s exposures of a 100 mL sample flowing 
continuously through a 1 mm diameter capillary during X-ray exposure, protein-free buffer 
processed as control. The scattering images were spherically averaged and buffer scattering 
intensities subtracted using in-house software. The radius of gyration (Rg) was calculated with 
GNOM [25], which also gives the distance distribution function P(r) and the particle maximum 
dimension (Dmax). Bead models were obtained using the ATSAS software package [26]. Each 
model was produced from 20 runs of DAMMIN [27] that were combined and filtered to produce 
an averaged model using DAMAVER [28]. Analytical ultracentrifugation was run using C-
GRP-C samples at concentrations of 0.2, 1 and 2 mg/mL after clearing them by a centrifugation 
step for 10 min at 16,000 g. Sedimentation velocity experiments were run at 4 °C in an Optima 
XL-I instrument (Beckman Coulter, Krefeld, Germany) equipped with an AN50-Ti rotor at 48 
krpm. Differential sedimentation coefficients were calculated by least-squares boundary 
modeling of the experimental data using the c(s) method implemented in the program SedFit 
version 14.7 [29]. 
 
2.4. Haemagglutination, cell assay and array binding 
 
Haemagglutination assays with trypsin-treated, glutaraldehyde-fixed rabbit erythrocytes in 
2-fold serial dilution were performed in 96-well microtiter plate wells as described [16,17]. 
Binding of fluorescent C-GRP(-C) (obtained by reaction of 0.25 mg/mg dye (fluorescein 
isothiocyanate) protein for 1 h at room temperature in 0.1 M Na2CO3 buffer, pH 9.0, containing 
0.9% (w/v) NaCl) to cells (Chinese hamster ovary (CHO) Pro–5 parental line, the Lec1, Lec2, 
Lec8 and Lec19 glycosylation mutants and an 2,6-sialyltransferase-expressing variant of the 
parental line as well as human pancreatic carcinoma cells (Capan-1) expressing the tumor 
suppressor p16INK4a) was analyzed by flow cytometry as described [16,30].  
The glycan (50 µM)/polysaccharide (10 µg/mL) array was established by printing as 
described [31]. The full structure representation of the 642 glycocompounds can be found at 
http://csdb.glycoscience.ru/bacterial. Biotinylated C-GRP as well as CG-1A, CG-1B and CG-
2 as controls, all labeled by conjugation of biotin using the N-hydroxysuccimide ester derivative 
(Sigma, Munich, Germany) under activity-preserving conditions as described [16], were 
comparatively tested at 50 µg/mL in PBS containing 0.1% Tween-20, 1% bovine serum 
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albumin and 0.01% NaN3 for 1 h at 37 °C in a humidified chamber. The glass surface had been 
pretreated with PBS containing 0.1% Tween-20 for 15 min. After thorough washing to remove 
the labeled protein, probing with fluorescent streptavidin (labeled with ALEXA-555 dye) 
followed for 45 min at 20 °C. After washing with PBS-0.001% Tween-20 and then with 
deionized water, slides were scanned on an Innoscan 1100 AL scanner (Innopsys, Carbonne, 
France) using an excitation wavelength of 543 nm at 10 μm resolution. The obtained data were 
processed using ScanArray Express 4.0 software and the fixed 70 µm-diameter circle method 
as well as Microsoft Excel. Ten spots represent each oligosaccharide or polysaccharide on the 
array, and data are reported as median RFU (relative fluorescence units) of replicates. Median 
deviation was measured as interquartile range. A signal, whose fluorescence intensity exceeded 
the background value by a factor of five, was considered as significant. The solid-phase assay 
using asialofetuin and proteoglycans as surface-presented test substances was performed using 
microtiter plates from various sources in the initial phase, then working with MaxiSorp plates 
(Thermo Fisher, Darmstadt, Germany), as described [16,17]. 
 
2.5. Crystallization, data collection and refinement 
 
Protein-containing solutions were extensively dialyzed against PBS containing 4 mM β-
mercaptoethanol in a 3.5 kDa Slide-A-Lyzer™ dialysis cassette (Thermo Fisher). Any 
aggregates were removed by gel filtration as follows: the sample was loaded onto a HiPrep 
16/60 Sephacryl S-100 high-resolution column (GE Healthcare) equilibrated with 20 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA and 1 mM DTT, kept at 4 °C. Eluted fractions 
containing C-GRP-C were checked by one-dimensional gel electrophoresis, pooled and 
concentrated with Centricon devices (10 kDa cut-off; Merck Chemicals, Darmstadt, Germany) 
to a final concentration of 16 mg/mL. The protein concentration was determined measuring its 
absorbance at 280 nm using the calculated extinction coefficient of 10220 M-1cm-1 
(http://web.expasy.org/protparam/). 
Systematic screening for conditions to crystallize C-GRP(-C) were performed in 96-well 
sitting drop plates (Swissci MRC, Suffolk, England) at 22 °C using a Cartesian Honeybee robot 
(Digital; Honeybee Robotics, Brooklyn, NY, USA) and commercially available 96-well kits: 
JBScreen Classic (Jena Bioscience™), Wizard Classic Screen I-III (Emerald Bio™) and Index 
Crystal Screen (Hampton Research™). The drops were 0.4 L in volume, a mixture of 0.2 L 
of the protein solution and 0.2 L of precipitant, and they were equilibrated against 50 L of 
the reservoir solution. Diffracting crystals grew after a couple of weeks in the presence of 2.0 
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M (NH4)2SO4, 100 mM MES (pH 6.5) and 5% (w/v) PEG 400. Crystals were cryo-protected 
with the reservoir solution supplemented with a 1.0 M sodium malonate solution, mounted on 
nylon loops and flash-cooled in liquid nitrogen. 
X-Ray diffraction data were collected on a single crystal using a Pilatus 6M detector at the 
BL13 XALOC beamline at the ALBA synchrotron (Barcelona, Spain). A total of 960 rotation 
images were collected with an oscillation angle of 0.25°. The resulting data set was processed 
using XDS [32,33] and scaled using AIMLESS [34,35]. The crystals belonged to a body-
centered orthorhombic space group I212121 with cell dimensions a = 38.6 Å, b = 106.9 Å, c = 
114.1 Å. The Matthews coefficient [36] assuming one molecule in the asymmetric unit was 
3.91 Å3 Da-1 (68.6% solvent content).  
The structure was solved by molecular replacement using PHASER [37] and the human 
GRP structure (PDB code 3B9C) as a search model. The initial model was first refined with 
Refmac5 [38] and alternating manual building with Coot [39]. The final model was obtained by 
repetitive cycles of refinement using PHENIX [37]. Solvent molecules were added 
automatically and inspected visually for chemically plausible positions. The placement of PEG, 
ethylene glycol and sulfate molecules was done using Coot [39]. The quality of the model was 
assessed by the MolProbity software [40], indicating that 99.2% of the residues lie in the 
allowed regions of the Ramachandran plot. Data collection statistics are shown in Table 1. 
Superimpositions were done using the lsq (least-squares) option in Coot, and structural figures 
were drawn with PyMOL (http://www.pymol.org/). 
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Table 1 
Data collection and refinement statistics 
 
Data collection  
Beamline 
Wavelength (Å) 
BL13-XALOC (ALBA) 
0.9794 
Space group I212121 
Unit cell parameters (Å) a = 38.6, b = 106.9, c = 114.1 
Resolution range (Å) 57.04 - 1.55 (1.63 - 1.55) 
No. of observations 300,868 (40,181) 
No. of unique reflections 34,844 (4,882) 
Multiplicity 8.6 (8.2) 
Completeness (%) 99.7 (97.6) 
Mean I/s(I) 12.6 (2.2) 
Rmergea 0.069 (0.977) 
Rmeasb 0.074 (1.043) 
CC1/2c 99.9 (84.8) 
Mosaicity 0.20 
Wilson B-factor 21.62 
Refinement  
Rwork/Rfree 0.168 (0.267) / 0.189 (0.30) 
Working reflections 33,160 (2,285) 
Testing reflections 1,593 (101) 
Protein atoms (non H) 1,064 
PEG and ethylene glycol 36 
Sulfate ions 10 
Water molecules 102 
Mean B factors (Å2)  
Protein 27.23 
PEG and ethylene glycol 57.45 
Sulfate ions 58.01 
Water molecules 42.42 
rmsd bond lengths (Å) 0.008 
rmsd angles (˚) 1.36 
Ramachandran plot statistics  
Favored (%)  99.2 
Outliers (%) 0 
PDB accession ID 5IT6 
Statistics for the highest-resolution shell are shown in parentheses 
aRmerge = ShklSi |Ii(hkl) - <I(hkl)>| / ShklSiIi(hkl), bRmeas= Σhkl (N − 1)−1/2 Σi|Ii(hkl) − <I(hkl)>| / Σhkl Σi
Ii(hkl), where Ii(hkl) is the intensity measured for the ith reflection and (I(hkl)) is the average intensity 
of all reflections with indices hkl. cCC1/2 is the correlation coefficient between two random half datasets 
[83] 
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3. Results and discussion 
 
3.1. GRP on the level of the gene 
 
Genes for galectins are widely present in organisms from hydrozoans to vertebrates so that 
a full-scope search in eukaryotes needed to be performed for GRP. Database mining reveals 
that the presence of the GRP gene is strictly limited to vertebrates. By taking the number of 
studied species on the level of the genome to 123 and on the level of the amino acid sequence 
to 119, as listed in Fig. S1, it is evident that the gene is broadly present in vertebrates (Fig. 1). 
In contrast, occurrence of canonical galectins is known to occur in other organisms such as in 
fungi, nematodes or insects or, in special cases such as galectins-5 or -6, restricted to a single 
species among vertebrates (rat or mouse, respectively) [10,11]. In all studied genomes, the copy 
number of the gene was one, a parameter that is variable among canonical family members and 
species [18]. The chromosomal environment revealed no vicinity to any of the genes for 
canonical galectins in the chicken genome (Fig. S2A). In inter-species comparison, it was quite 
similar (Fig. S2B), an indicator for the gene’s origin prior to intra-vertebrate divergence and a 
lack of positional dynamics. The organization of the gene in exons/introns, shown in Fig. S3, 
reflected its status as a member of the galectin family, as already indicated previously [41]. As 
such, no signal sequence was present to direct the protein to the secretory route. Thus, the GRP 
gene is not a recent acquisition by duplication of an ancestral gene within a distinct species but 
an integral component of the vertebrate genome.
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Fig. 1. Compilation of information on GRP gene in man and 31 vertebrate species from different branches of the taxonomic tree available in databases. Database-retrieved 
information on the genes, present either in forward (+) or in reverse (-) direction, is listed as chromosome or scaffold number together with the number of nucleotides, characterizing 
the precise position and length of the gene. 
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The compilation of predicted amino acid sequences confirmed and extended the 
assumption for a strongly positive selection. The region of the so-called carbohydrate 
recognition domain (CRD) following the N-terminal tail was highly conserved, as was the 
second part of the 36-amino-acid N-terminal section (Fig. S4). A peculiar feature is seen at the 
central position in the CRD of canonical galectins, i.e. the Trp moiety, which establishes C-
H/-contacts to a ligand’s galactose residue: birds, fish and amphibians have this amino acid in 
its place, whereas mammals consistently present a substitution by Arg/Lys (Fig. S4). At other 
positions, GRP sequences appear exceptionally conserved, validating the initial observation 
that human and mouse GRP “only differ in one amino acid, residue 24” [10]. Among the CGs, 
the predicted amino acid sequence of C-GRP is rather distant from those of the three proto-type 
CGs (Fig. 2). Based on these comparisons, it is most closely related to the C-terminal CRD of 
the tandem-repeat-type CG-8, termed CG-8C (Fig. 2). For mammals, the likewisely calculated 
phylogenetic tree had placed GRP in closest vicinity of the C-terminal CRD of tandem-repeat-
type galectin-12 [41]. This family member is not represented in the chicken genome. It is an 
effector of growth regulation via induction of apoptosis and cell cycle arrest at the G1 phase in 
murine 3T3-L1 adipocytes, exhibiting nuclear and cytoplasmic localization and marker status 
in butyrate-induced differentiation of human colon cancer cells [42-44]. Looking at the 
sequence signature for binding lactose, marked deviations yet occur (please see section 3.3. on 
crystallography for details), raising the question on C-GRP’s lectin activity. In order to study 
protein properties such as this feature, recombinant expression of C-GRP had to be established. 
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Fig. 2. Comparison of amino acid sequences of the CRDs for the shortened version of C-GRP, i.e. C-GRP-C 
(amino acid 37 is set to position 1 for alignment), versus the five canonical CGs (top), the respective phylogenetic 
family-tree diagram (middle) and the alignment of the amino acid sequence of the shortened version of human 
GRP, i.e. human GRP-C (amino acid 37 is set to position 1 for alignment) with those of the CRDs of human Gal-
8 and -12, referred to as Gal-8C/-12C (bottom). Strictly conserved (red background) and homologous residues 
(>70% conservation; boxed red letters) are highlighted by coloring. 
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3.2. C-GRP on the level of the protein 
 
Recombinant production led to an inducible expression of a protein at the expected position 
in gel electrophoretic analysis of extracts that failed to bind to the affinity resin commonly used 
for galectin purification (i.e. Sepharose 4B presenting lactose attached to the beads after their 
activation by divinyl sulfone). As consequence, C-GRP purification required its expression as 
fusion protein. Among the tested systems, involvement of GST via a rhinoviral C3 protease-
sensitive cleavage site proved most favorable. It yielded C-GRP of calculated mobility and 
isoelectric point, as measured in gel electrophoretic analysis, at good yield (about 30 mg/mL) 
(Fig. 3). Mass spectrometry took the analysis of the purified protein to the most sensitive level, 
ascertaining the expected mass of the product by MALDI TOF runs as well as the sequence by 
peptide fingerprinting and re/linISD processing (Fig. 4, Fig. S5, Table S1A). 
 
Fig. 3. Documentation of one- and two-dimensional gel electrophoretic analysis of recombinant C-GRP and C-
GRP-C. (A) Electrophoretic mobility of purified C-GRP and C-GRP-C in one-dimensional polyacrylamide gel 
electrophoresis under denaturing conditions in the presence of 2-mercaptoethanol in a 15% running gel. The bands 
for C-GRP and C-GRP-C are shown in pairwise arrangement (60 and 80 ng per lane, respectively). Positions of 
relevant marker proteins are given on the left (ovalbumin, 45 kDa; carbonic anhydrase, 29 kDa; β-lactoglobulin, 
18.4 kDa; lysozyme, 14.2 kDa). (B) The relevant section of a gel after two-dimensional gel electrophoresis and 
staining is shown. The given section presents the spots for C- GRP and C-GRP-C together with those of human 
galectins-1 (pI 5.34) and -2 (pI 5.93). 
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Fig. 4. Sequencing of the N-terminus of C-GRP by reISD and linISD. (A) reISD mass spectrum of C-GRP shows 
the smallest detectable peptide at the c9/c10 and the ensuing stepwise peptide ladder. (B) linISD spectrum shows 
the smallest detectable peptide at c39/c40 and the ensuing stepwise peptide ladder up to c89/90. (C) Sequence 
coverage by ISD. Experimental and calculated mass values are given in Table S1A. 
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To determine its quaternary structure, gel filtration was performed and revealed elution 
nearly exclusively at the position of the monomer (Fig. 5A). Presence of lactose, commonly 
applied in this protocol when exposing canonical galectins to the resin to preclude retardation 
of elution by carbohydrate-dependent interaction of the protein with the beads, did not affect 
the elution volume (Fig. 5A). Thus, C-GRP, formally a proto-type protein based on its sequence 
features, is the first member of this group in chicken, which is monomeric in solution.  
 
Fig. 5. Gel filtration analysis of C-GRP and C-GRP-C. (A) Elution profiles of the physiological protein (C-GRP 
with molecular mass of 19069 Da; please see Fig. S5A for MALDI TOF MS-based information) and (B) its 
shortened version (C-GRP-C with molecular mass of 15339 Da; please see Fig. S6A for respective MS-based 
information) in the absence and in the presence of lactose at increasing concentrations. Black arrowheads indicate 
elution volume of molecular weight markers used for calibration. 
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Considering its monomeric status in solution and its sequence addition to the CRD, C-GRP 
resembles rat galectin-5 from the group of proto-type galectins. Galectin-5, too, is monomeric, 
as measured by gel filtration and nano-electrospray ionization MS [45,46]. This proto-type 
lectin unique for rat is constituted by a short segment of the N-terminal portion of galectin-9 
and the C-terminal CRD of this tandem-repeat-type protein, functionally involved in exosome 
generation and routing during rat reticulocyte maturation [45,47,48]. However, galectin-5 is a 
lectin. It binds lactose and other -galactosides, this activity leading to haemagglutination of 
rabbit erythrocytes at 150-300 µg/mL [45,49]. Similarly, the chimera-type galectin-3 
aggregated erythrocytes at a minimal concentration of 25 µg/mL, pointing to a role of its non-
triple-helical collagen-like repeats in ligand-mediated cell aggregation (for overview on 
structural aspects of this lectin, please see [23]). Tested as further controls, homodimeric proto-
type CG-1A and -2 at concentrations of 10-15 ng/mL or 140-160 ng/mL, respectively, led to a 
positive result, as tandem-repeat-type CG-8 did at around 400-500 ng/mL, corroborating 
published data [15,16]. In contrast, C-GRP was consistently inactive in this assay at 
concentrations up to 500 µg/mL. Obviously, capacity for glycan-dependent cell binding and/or 
aggregation are impaired in the case of C-GRP. Of note, deviations in positions of the signature 
sequence do not necessarily mean that a member of this family will lose its lectin activity. In 
the cases of congerin P, the galectin of peritoneal cells of the conger eel [50], and the third 
protein of the galectin family in the inky cap mushroom Coprinopsis cinerea termed CGL3 
[51], glycan binding is still operative despite such alterations. These precedents prompted us to 
perform further assays using a microarray and cytofluorimetry of cells with defined changes in 
their surface glycomes. 
The microarray presents a total of 642 compounds with about 600 different glycans as 
mono- to oligosaccharides, bacterial (lipo)polysaccharides, glycosaminoglycans and synthetic 
(glyco)peptides to cover a wide spectrum of glycan structures (for complete listing, please see 
Table S2). Human tandem-repeat-type galectins have previously been successfully probed in 
this setting for selectivity among bacterial polysaccharides [52], and CG-1A/-1B/-2 were run 
in parallel as positive controls Under these conditions, few signals with significant intensity 
were obtained by testing: 3´-sulfated Tn antigen (but no other sulfated saccharide or sialylated 
Tn), -linked ribose, a bacterial polysaccharide, the -anomer of the TF antigen (CD176), this 
disaccharide with unnatural 2,6-sialylation at the core and N-acetyllactosamine (but not its 
dimer, which is reactive with all canonical CGs, whereas the disaccharide is not a binder for 
them in the array) (for detailed listing of fluorescence data, please see Table S2). Further 
probing of the labeled protein in a solid-phase assay with glycoprotein (the potent galectin 
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ligand asialofetuin) and proteoglycans revealed absence of reactivity to the -galactoside 
termini of N-glycan chains and indicated weak reactivity to heparin depending on the type of 
microtiter plate (not shown). Evidently, N-acetyllactosamine of N-glycans and in repeats does 
not associate with C-GRP, in contrast to binding to canonical CGs, whereas the disaccharide 
did associate in the array. 
Turning to cell surface binding, flow cytofluorimetry was performed using CHO parental 
cells and four glycosylation mutants, a sensitive set of tools to trace glycan-dependent binding 
activity [53]. Fluorescent C-GRP was found to associate with the surface of CHO cells in a 
concentration-dependent manner (Fig. 6A). Taking note of the fact that the anionic dye 
fluosrescein itself can interact with scavenger receptors and also non-specifically [54], rigorous 
controls were added to document very low-level binding of an inert protein with this label, 
inhibition by lactose for binding of labeled CGs and loss of activity of C-GRP by heat treatment 
(not shown). In contrast to canonical CGs, the extent of binding (measured as percentage of 
positive cells/mean fluorescence intensity) to CHO cells was not affected by all tested glycome 
alterations, i.e. reduced presence of complex/hybrid-type N-glycans (Lec1) (Fig. 6B), 
introduction of 2,6-sialylation to N-glycans, a molecular switch blocking galectin binding 
(Fig. 6C), reduced level of overall sialylation (Lec2) (Fig. 6D) and reduced level of 
galactosylation (Lec8, Lec19; the latter also affecting glycoprotein routing and surface 
presentation [55]) (Fig. 6E,F). In addition to a lack of effect of any tested alteration in the 
surface glycome, cell binding to parental and Lec2/8 cells was not affected at all by presence 
of glycocompounds tested as potential inhibitors, i.e. lactose, N-acetylglucosamine, D-
glucuronic acid, L-fucose, D-mannose, maltose and L-rhamnose at up to 100 mM, heparin at up 
to 250 µg/mL as well as chondroitin sulfate and carageenan at 100 µg/mL (not shown). C-GRP 
reactivity was also measured to human pancreatic carcinoma (Capan-1) cells, which likewise 
was not inhibitable by glycocompounds. Canonical galectins such as CG-8 avidly associate 
with them in a lactose-inhhibitable manner [16,56]. This study part thus provides no evidence 
for a galectin-like reactivity to a common glycan, tested either with glycocompounds or 
glycosylation mutants as ligands (microarray, cell assay) or inhibitor (cell assay). Also, the cell 
assays in the presence of glycans exclude the possibility of an allosteric activation of lactose 
binding by the test substances, revealed previously for mannose in the case of the mentioned 
congerin P [50]. In consequence, C-GRP appears to have lost lectin activity despite the presence 
of the central Trp residue, which separates avian from mammalian GRP (Fig. S4). Considering 
i) the strong sequence conservation that implies a common functionality, ii) this Trp/Arg 
substitution at a central site and iii) availability of structural information on an engineered 
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variant of human GRP by crystallography [57,58], we next set the aim to report such structural 
details for C-GRP.  
 
 
Fig. 6. Semilogarithmic representation of fluorescent cell surface staining by labeled C-GRP. Quantitative data on 
percentage of positive cells (%) and mean fluorescence intensity are given for each curve in each panel. The control 
value (background) is drawn as grey-shaded area. (A) Staining of parental CHO Pro—5 (lacking expression of β1,4-
galactosyltransferase VI) cells measured with increasing concentrations of C-GRP from 2 μg/mL to 5 μg/mL, 10 
μg/mL, 20 μg/mL and 40 μg/mL (from top to bottom) and inhibition of staining (40 μg/mL C-GRP) by a lactose 
concentration of 10 mM (dashed line). (B-F): Staining with 10 μg/mL (dashed line) and 20 μg/mL C-GRP (black 
line). Staining profiles of CHO glycosylation mutant and transfected lines are shown: Lec1 (decreased expression 
of complex- and hybrid-types N-glycans) (B), parental cells overexpressing α2,6-sialyltransferase I (C), Lec2 
(decreased level of sialylation) (D), Lec8 (decreased level of galactosylation) (E) and Lec19 (decreased level of 
galactosylation) (F). 
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3.3. Crystal structure of a C-GRP variant 
 
Initial attempts to crystallize C-GRP were not successful. Whereas crystals of proto-type 
galectins and of separate galectin CRDs had been obtained, presence of sequence extensions of 
a CRD, either in tandem-repeat-type or chimera-type proteins, had proven unfavorable, except 
for a single case: a variant of human galectin-3 constituted by the CRD and a tail of three non-
triple-helical collagen-like repeats and the N-terminal peptide with its two sites for Ser 
phosphorylation [59]. Evidently, for C-GRP, a well-ordered structure of the N-terminal 
extension could not be attained to enable crystal formation.  
Therefore, as previously performed for His-tagged human GRP [60], this sequence portion 
was deleted (total of 36 amino acids) to produce a shortened form termed C-GRP-C, in analogy 
to human GRP-C [57,58]. This variant underwent the same analytical protocols, to prove its 
purity in gel electrophoresis (Fig. 3), its sequence on the level of amino acids (Fig. S6, Fig. S7, 
Table S1B) and its quaternary structure (Fig. 5B). Tested at loading concentrations in the range 
of 0.2 - 2 mg/mL in sedimentation equilibrium analyses, C-GRP and the shortened C-GRP-C 
maintained the same monomeric status, as demonstrated by sedimentation velocity 
experiments. In detail, the calculated sedimentation coefficients were 1.137±0.008 with a 
frictional ratio of 1.52 for C-GRP (Fig. S8A) and 1.161±0.006 S with a frictional ratio of 1.30 
for C-GRP-C (Fig. S8B). The monomer status was independently confirmed by SAXS for C-
GRP-C. Here, experimental data enabled to calculate a monomer with a maximum dimension 
of 48.2 ± 2.3 Å at a molecular mass of 16.2 ± 1.6 kDa, the ab initio model in solution providing 
an internal standard for the crystal structure (Fig. S9). When probed for cell-binding capacity, 
always run in parallel with the physiological form to ensure identical conditions, fluorescent C-
GRP-C showed very similar reactivity (not shown). These data preclude an influence of the 
non-CRD portion for this property.  
The crystal structure of C-GRP-C was determined at 1.55 Å resolution by molecular 
replacement (for details on refinement statistics, please see Table 1). The typical galectin fold 
is composed of two anti-parallel five-stranded (F1-F5) and six-stranded (S1-S6) -sheets, along 
with a short 310 helix between the F5/S2 strands (Fig. S10). As in solution, C-GRP-C in crystals 
is monomeric. Human GRP-C, in gel filtration also monomeric [57,58], formed a dimer [57] or 
a dimer of dimers [58] in crystals, depending on the actual experimental conditions. Such a 
sensitivity of quaternary structure on the environment had been reported in the case of human 
galectin-1 and its appearance as dimer of dimers in an aprotic solvent [61]. In terms of the root-
mean-square difference (rmsd) for positions of the C atoms, values between 1.07 Å and 1.54 
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Å relative to the structures of CG-8N (1.07 Å; [62]), CG-2 (1.33 Å; [63]), CG-1A (1.42 Å; [64]) 
and CG-1B (1.54 Å; [65]) underscore the close relationship. The superimpositions of the C-
GRP-C fold with that of the listed canonical CGs, however, disclosed notable differences in 
several regions involving loops that are between adjacent -strands in the concave face of the 
groove, the site of accommodation of lactose in canonical CGs (Fig. 8). In detail, the S3-S4 
loop, which connects anti-parallel -strands F3-F4, is five amino acids longer in C-GRP-C (and 
CG-8N) than in proto-type CGs, for whom (CG-1A/B) the S4-S5 loop is extended (Fig. S11). 
Looking at the equivalent of the contact site for lactose in canonical CGs, the sequence 
signature for operative binding (His45, Asn47, Arg49, Asn58, Trp65, Glu68 and Arg70 for 
example in CG-2 [63]) is turned into Glu49, Lys51, Val53, Asn62, Trp69, Glu72 and Ser74 in 
C-GRP-C. Only three of seven positions are thus maintained (Fig. 7). As shown in Fig. 8, the 
set of contacts of the 4’, 6’-hydroxyls of galactose will be conspicuously reduced (in 
comparison to CG-2), and – as in human GRP-C with rmsd values of 1.06 Å - 1.59 Å relative 
to galectins-1, -3 and -7 [57,58] – Lys51 protrudes to an extent that disfavors a snug fit for 
lactose so that not even the presence of Trp69 can compensate this distortion, these factors 
explaining the loss of lectin activity. The prominent Lys51 position, along with a comparative 
view on the electrostatic surfaces and absence (C-GRP-C)/presence (CG-2/CG-8N) of a tunnel-
like cavity hosting galactose, is illustrated in Fig. 9. That binding to lactose is no longer possible 
at this site does not mean that C-GRP(-C) is devoid of capacity for specific interactions. A close 
look into the literature attests that new virtues are acquired by a sequence remodeling of 
galectins.  
In fact, illustrating the plasticity of the galectin fold to serve as platform for building 
complementarity to protein surfaces, this route has likely been taken in the development of 
coronavirus spike protein N-terminal domains, after they were imported from the host [66,67]. 
A constellation with hydrophilic/hydrophobic patches, as it is also seen in C-GRP-C, is 
suggestive to facilitate a contact area for a specific, binding partner. The case study of the 
galectin fold of mouse hepatitis coronavirus, describing details of its interaction with murine 
carcinoembryonic antigen-related cell adhesion molecule 1a, teaches the lesson that hydrogen 
bonding and a bifurcated salt bridge “help bring the adjacent hydrophobic patches into place” 
[66]. Other examples of protein-protein interactions by the galectin fold concern mammalian 
galectins-1, -3 and -7, with oncogenic Ras proteins or anti-apoptotic Bcl-2/pro-apoptotic Bax, 
in this case likely involving the central Trp residue for contact [68-72]. Similarly, the 
micronemal protein 1 (MIC1) of the protozoan parasite Toxoplasma gondii harbors a galectin-
like fold in its C-terminal portion, which binds the micronemal protein 6 by protein-protein 
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recognition, as likewise seen for MIC2/MIC2AP binding [73,74]. Most intriguingly in view of 
the close relationship between GRP and galectin-8’s C-terminal CRD, this CRD of the human 
lectin associates with the cargo receptor NDP52 in the process of inducing anti-bacterial 
autophagy, again via protein-protein recognition [75,76]. 
 
 
 
Fig. 7. Close-up view of the putative contact site for a β-galactoside in C-GRP-C. Respective residues in C-GRP-
C and an ethylene glycol molecule are show in ball-and-stick mode, water molecules are depicted as red spheres. 
The observed electron density map 2Fo-Fc is contoured at 1.0 σ. 
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Fig. 8 Superposition of the structure of the contact site for a β-galactoside in CG-2 with the structurally 
equipositioned of C-GRP-C shown in Fig. 7. Amino acids of CG-2 are colored in yellow and those of C-GRP-C 
in cyan. Residues making contact to lactose of CG-2 and those of equivalent positions of C-GRP-C (Glu49, Lys51, 
Val53, Asn62, Trp69, Glu72 and Ser74) are shown in ball-and-stick mode, and their carbon atoms are colored in 
white and cyan, respectively. Lactose is shown in stick mode. 
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Fig. 9. Electrostatic surface potential maps of C-GRP-C (A), CG-2 (B) and CG-8N (C), contoured from -10 kT/e 
(intense red) to +10 kT/e (intense blue). Differences in distribution of acidic residues between C-GRP-C and the 
two canonical CRDs as well as absence of a tunnel-like cavity present in CG-2 and CG-8N, which accommodates 
the galactose ring, are readily noted. Lactose and 3’-sialyllactose are shown in stick mode. 
 
Equally important, already a single-site sequence deviation, and this far away from contact 
positions to the ligand, can alter a galectin’s functionality. This principle is illustrated for a 
natural variant of human galectin-8 arising by single nucleotide polymorphism (F19Y), 
measured in terms of thermodynamics of ligand binding, its association with autoimmune 
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disease (rheumatoid arthritis, myasthenia gravis) and reduction in its bridging capacity [77-79]. 
Sequence conservation at this high level, as seen for the GRP genes in vertebrates (Fig. S4), is 
a sign for the development of a distinct function in the monomeric protein at the expense of the 
canonical lectin activity. Conceptually, this insight and the given detailed biochemical 
characterization of the chicken protein pave the way to advance the galectin fingerprinting in 
this model organism from the canonical CGs to define the where of C-GRP expression, and this 
in relation to all canonical CGs. This endeavor will at the same time likely teach instructive 
lessons for the understanding of more complex systems. Moving from localizing a single 
galectin to increasing the scope of analysis to other family members in disease states already 
attests the potential of this approach for human galectins [80,81]. 
 
Conclusions 
 
A detailed view on GRP genes reveals its presence exclusively in vertebrates, and here 
with high-level sequence conservation. In contrast to most other proto-type galectins, C-GRP 
is monomeric. In bead, microarray, solid-phase and cell assays used to probe into glycan-
binding activity, no activity was detected. C-GRP thus is the first member of the CG family 
without lectin activity. In consequence, its place in the listing of galectins in the phylogenetic 
tree is best as proto-type-like GRP, in analogy to proteins with C-type lectin-like domains that 
have lost capacity to bind sugars but gained reactivity to other types of epitopes [82]. The next 
step toward tracing GRP’s mission that explains the absence of usual sequence drifts among 
vertebrate species will now be to define the expression pattern of C-GRP in tissues and its 
relation to the five canonical CGs as well as to trace tissue reactivity.  
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ABSTRACT 
 
Background: Galectin-related protein (GRP), present in vertebrates, is special within this family 
of adhesion/growth-regulatory proteins due to its strong positive selection and loss of canonical 
lectin activity. 
Methods: RT-PCR and Western blotting together with flow cytofluorimetry and immunocyto- 
and histochemistry monitor expression and localization of chicken GRP. The promoter 
sequence of the GRP gene is processed computationally to detect putative sites for binding 
transcription factors. The labeled protein is applied as probe to detect binding sites on cells and 
in sections, along with glycocompounds to test inhibition of the association. 
Results: Expression of GRP in chicken is limited to bursa of Fabricius, immunohistochemically 
found in B cells, also in bursal epithelium and vessels. Presence in B cells is shared with only 
one canonical galectin, i.e. CG-8. Binding to a chicken lymphoma line was specific and 
saturable, not affected by lactose but completely blocked by heparin, as also seen in sections. 
Conclusions: Expression monitoring initiated for GRP reveals a distinct site of localization in 
chicken, much more restricted than for any of its canonical galectins. 
 
Keywords: B cells  bursa  lectin  lymphocytes  promoter 
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1. Introduction 
 
Their increasingly emerging physiological significance justifies efforts to detect, to 
structurally characterize and correspondingly classify animal and human lectins [1,2]. The 
resulting formation of families gives direction to aim first at accomplishing a complete listing 
of the members of each family on the genomic level, next at defining biochemical properties of 
each protein. Measuring their expression and localization profiles and then performing a 
detailed network analysis are the following steps. This work will relate the evolutionary course 
of gene/sequence diversifications to characteristics of the individual homologous proteins from 
their structure to their cell/tissue presence and localization. When applying this concept to the 
adhesion/growth-regulatory galectins, to bring the status of knowledge for the galectin-related 
protein (GRP), an integral part of the phylogeny of this class of lectins [3,4], to the same level 
as already attained for canonical proteins was an obvious necessity. In this case, the indications 
for an exceptionally high level of sequence conservation among vertebrates [3], the loss of 
binding to the common ligand lactose for human GRP [5,6] and the general status of the five 
canonical chicken galectins (CGs) as model suited for comprehensive network analysis of 
general relevance [7] had prompted detailed biochemical characterization of chicken GRP (C-
GRP) [8]. Except for the occurrence of C-GRP-specific mRNA in bursal lymphocytes [3], no 
information on expression of this gene was available for this sixth member of the galectin 
family in chicken or for any other vertebrate. 
In this report, monitoring of C-GRP expression in 4-week-old chickens is documented on 
the level of mRNA (RT-PCR) and of protein (Western blotting) as well as of its localization in 
tissue sections and isolated/cultured cells. Using the full set of non-cross-reactive anti-CG 
antibodies, C-GRP positivity is set into relation to the corresponding properties for each 
canonical CG. A computational inspection of the promoter region flanked the experimental 
work to track down putative regulatory sites for a tissue-specific expression. In addition to the 
immunocyto- and histochemical monitoring, labeled C-GRP, along with the labeled forms of 
the other family members, is introduced as tool to detect sites in the C-GRP-positive tissue/cells, 
which are reactive with this protein. The combined results of the biochemical [8] and cyto- and 
immunohistochemical [this study] investigations shape the notion for C-GRP to be an 
acquisition to the galectin family with strong positive selection, a unique binding capacity and 
its own, very particular profile of expression. The documented data initiate GRP localization 
and detection of cellular binding sites as a step toward functional characterization. Equally 
important, the addition of C-GRP to the network of canonical CGs is assumed to have relevance 
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beyond this model organism, prompting detailed comparative analysis for GRP among 
vertebrates. 
 
2. Materials and methods 
 
2.1. Materials 
 
The monoclonal antibody AV20 against the chicken B cell marker chB6 [9,10] was kindly 
provided by S. Härtle (Chair of Animal Physiology, Faculty of Veterinary Medicine, Ludwig-
Maximilians-University, Munich, Germany), FITC-labeled anti-mouse IgG1 was a generous 
gift from H. Ammer (Institute of Veterinary Pharmacology and Toxicology, Faculty of 
Veterinary Medicine, Ludwig-Maximilians-University, Munich, Germany). CGs and C-GRP, 
which were purified after recombinant production using affinity chromatography on 
lactosylated Sepharose 4B as crucial step (CGs) or as fusion protein (C-GRP) as described 
[8,11,12], were labeled under activity-preserving conditions with the N-hydroxysuccinimidyl 
derivative of biotin, fluorescein isothiocyanate or the succinimidyl ester derivative of the Alexa 
Fluor® 488 dye (Invitrogen, Darmstadt, Germany), as described previously [13]. The fungal 
(Polyporus squamosus) lectin (PSL) was purified, controlled for purity and labeled as described 
[14-16]. Extent of labeling was routinely determined by mass spectrometry [17], labeled lectins 
were rigorously checked for activity and maintained specificity by haemagglutination (CGs) 
and by binding assays using asialofetuin as matrix or mammalian cells, especially Chinese 
hamster ovary (CHO) parental cells and mutant lines altered in distinct aspects of glycosylation 
(for details, please see [8]). The solid-phase assay for assessment of binding of surface-
presented C-GRP (using 0.1 µg/mL, 0.25 µg/mL and 0.5 µg/mL for coating) to biotinylated 
CGs (titrations with 5-40 µg/mL) was performed under identical conditions. Biotinylated plant 
lectins (MAA-I, Maackia amurensis agglutinin-I; Phaseolus vulgaris erythroagglutinin, PHA-
E; Phaseolus vulgaris leukoagglutinin, PHA-L; Jacalin, JAC; peanut agglutinin, PNA) and 
Texas-Red Avidin D® for visualizing their binding were purchased from Vector Laboratories 
(distributed by Enzo Life Sciences, Lörrach, Germany). DT40 B lymphoma cells (avian 
leukosis-induced bursal lymphoma line; ATCC® CRL-2111™) [18,19] were kindly provided 
by S. Härtle and B. Kaspers (Chair of Animal Physiology, Faculty of Veterinary Medicine, 
Ludwig-Maximilians-University, Munich, Germany). 
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2.2. Tissue preparation and isolation of bursal B cells 
 
Bursae of Fabricius were dissected from the proctadael region of the cloaca of five 4-week-
old chickens, snap frozen in liquid nitrogen and then further processed for RNA isolation, 
extract preparation for Western blotting and cryo-sectioning. Bursal B cells were routinely 
obtained from freshly dissected tissue that was cut into small pieces in ice-cold phosphate-
buffered saline, pH 7.2 (PBS). These pieces were placed on a stainless steel mesh screen (pore 
size: 75 µm) and gently pressed through the screen using the plunger of a 10 mL syringe into a 
petri dish, whose surface was covered with ice-cold PBS. The resulting suspension was 
transferred to a 50 mL tube and filled up to 50 mL with PBS. After 5-10 min on ice, the 
supernatant was gently poured into a new 50 mL tube and centrifuged for 10 min at 225 x g, 
the resulting cell pellet was resuspended in 10 mL PBS and this suspension layered on top of 
an equal volume of Ficoll solution (density: 1.077 mg/mL; Biocoll Separating Solution, 
Biochrom AG, Berlin, Germany). Following a centrifugation step at room temperature for 12 
min at 400 x g, the cell-containing interphase was collected and washed twice with ice-cold 
PBS. Thereafter, the cell pellet was suspended in RPMI 1640 medium (containing 8% fetal calf 
serum (obtained from Life Technologies, Darmstadt, Germany), 2% chicken serum (Sigma-
Aldrich, Munich, Germany) and antibiotics) to give 2.5 x 107 cells/mL, 10 µL of this suspension 
were carefully pipetted onto microscope slides, cells were fixed in cold acetone for 10 s and 
used for cytochemical staining. Cells were also pelleted, snap frozen and used for RNA isolation 
and Western blotting, respectively. 
 
2.3. Expression profiling by RT-PCR 
 
Isolation of total RNA from bursa of Fabricius tissue and purified B cells as well as the 
ensuing preparation of cDNA were done, as described previously for tissues of 6-month-old 
chickens [12,20]. PCR amplification of C-GRP-specific mRNA was directed by the sense 
primer 5´-TCTAGAATGGCGGGGACCGTG-3´ and the antisense primer 5´- 
AAGCTTTCAGCCAAGTTTTGTAAG-3´ as described [8]. The mRNAs of the canonical CGs 
used primer sets as in previous studies [12,20]. In detail, CG-1A-specific mRNA was amplified 
with the sense primer 5´-GGATCCATGGAGCAAGGACTG-3´ and the antisense primer 5´-
GAATTCAATTTTCTCCATGCCCAGCCG-3´, CG-1B-specific cDNA by the sense primer 
5´-ATGTCTTGTCAGGGACCA-3´ and the antisense primer 5´-
TTACTCCCAGCTGACAGACCG-3´, CG-2-specific cDNA by the sense primer 5´-
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AGAATGTTTGAAATGTTCAAC-3´ and the antisense primer 5´-
TCACTCCACCTTGAAGGAG-3´, CG-3-specific cDNA by the sense primer 5´- 
CCCGGCGTACCCTGGATA-3´ and the antisense primer 5´- 
AAATCATGGAGGTCAAAACAC-3´, and CG-8-specific cDNA by the sense primer 5´-
ATGATGTCCTTGGATGGA-3´ and the antisense primer 5´-CTACCAGCTCCTCACATC-
3´. The lengths of amplified cDNAs for C-GRP, CG-1A, CG-1B, CG-2, CG-3, and CG-8S/L 
are 516 bp, 351 bp, 408 bp, 399 bp, 627 bp, and 891/948 bp, respectively. The reaction mixture 
for the PCR reactions was prepared, as recommended by the distributor of the Taq DNA 
polymerase (Qiagen). In general, the analyses were carried out in a volume of 20 μL containing 
2.5 µg cDNA, 0.5 U Taq polymerase, 50 μM dNTPs, 1×PCR-buffer (commercial mixture of 
Tris-HCl, KCl, (NH4)2SO4, 1.5 mM MgCl2, pH 8.7), at 20 °C, 1×Q-Solution and 0.1 μM of 
sense and antisense primers. Amplification of the galectin-specific cDNAs was started with an 
initial denaturation step at 94 °C for 4 min, then 29 consecutive cycles of the following series 
of steps were performed: denaturation at 94 °C for 45 s, annealing at 52 °C (CG-1B, CG-2, CG-
3, CG-8, actin) or 60 °C (C-GRP, CG-1A) for 45 s and extension at 72 °C for 1 min. The final 
extension step was carried out at 72 °C for 10 min. PCR products and reagents were separated 
in 2% agarose gel electrophoresis at 80 V for 40 min. The loading control with chicken -actin-
specific mRNA was established with the sense primer 5´-ATGGCTCCGGTATGTGC-3´ and 
the antisense primer 5´-ACCGTGTTCAATGGGGT-3´. The length of amplified cDNA was 
185 bp. 
 
2.4. Extract preparation and Western blotting 
 
Tissue pieces from bursae of Fabricius and isolated bursal B cells were processed in lysis 
buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl and 1% (w/v) NP-40). Polyclonal antibody 
preparations were obtained using recombinant C-GRP (full length)/CGs as antigens in rabbits 
as described [20,21]. In detail, immunization was started with 200 µg recombinant C-GRP in 
an emulsion of 0.5 mL PBS mixed with Freund’s complete adjuvant (0.5 mL; Sigma-Aldrich) 
and pursued with booster injections in three-to-six-week intervals using Freund’s incomplete 
adjuvant (Sigma-Aldrich). The titer was regularly monitored by ELISAs with the antigen. The 
immunoglobulin G (IgG) fraction obtained by affinity chromatography over protein A-
Sepharose 4B was rigorously examined for cross-reactivity by Western blotting/ELISAs using 
each of the canonical CGs/C-GRP as bait, followed by removal of respective activity by 
chromatographic depletion on resin presenting the respective CG and subsequent controls to 
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verify complete removal [22]. The content of protein after coupling to divinyl sulfone-activated 
Sepharose 4B varied for the CGs between 4.5 mg/mL and 12 mg/mL resin. Western blot 
analyses were performed following an optimized protocol previously applied to CG-8 detection 
in extracts of bursal tissue from 6-month-old chickens [20]. Briefly, proteins (100 g of cell 
and tissue lysates, 12 ng of purified recombinant C-GRP as positive control and a 25fold excess 
of each of the canonical CGs (300 ng)) were separated on a discontinuous SDS polyacrylamide 
gel (4% stacking gel, 10% running gel), and proteins were transferred by tank blotting onto a 
nitrocellulose membrane (0.2 μm pore size; Schleicher & Schuell, Dassel, Germany). Residual 
sites on the matrix for binding protein were saturated by incubation with a solution of Tris-
buffered saline (TBS, pH 7.5) containing 0.1% Tween 20 (TBS-T) and 5% powdered milk. 
Membranes were routinely incubated overnight at 4 °C with IgG fractions against C-
GRP/canonical CGs (anti-C-GRP: 0.5 µg/mL; anti-CG-1A: 1.0 µg/mL; anti-CG-1B: 0.25 
µg/mL; anti-CG-2: 1.0 µg/mL; anti-CG-3: 0.25 µg/mL; anti-CG-8: 2.0 µg/mL) in blocking 
solution. Following a washing step with TBS-T, membranes were incubated with goat anti-
rabbit IgG-horseradish peroxidase conjugate (0.5 gmL Sigma-Aldrich) in blocking solution 
for 1 hour at room temperature and developed using enhanced chemiluminescence detection, 
driven by a substrate mixture with 1.25 mM sodium salt of luminol in 2 mL 0.1 M Tris-HCl 
(pH 8.6), 0.2 mL of a 6.7 mM p-coumaric acid solution in dimethyl sulfoxide and 0.6 L H2O2 
(30% vv) at room temperature. Exposure time of the processed blots to CL-XPosureTM X-ray 
film (Pierce, Bonn, Germany) was set from 2 to 10 minutes to yield optimal signal intensity at 
minimal background. 
 
2.5. Immuno- and (ga)lectin cyto- and histochemistry 
 
Snap-frozen bursae of Fabricius were cut into serial sections of about 5-10 m thickness 
using a CryoStar NK70 (Thermo Fisher Scientific, Dreieich, Germany). They were mounted on 
Superfrost® Plus slides (Menzel, Braunschweig, Germany), fixed for 10 min in ice-cold acetone 
and then air-dried. For immunostaining of tissue sections and fixed B cells (please see 2.2), 
processing started with washing in 10 mM PBS followed by saturation of sites for non-specific 
protein binding by an incubation step with a solution of 1% (w/v) carbohydrate-free bovine 
serum albumin (BSA) in PBS also containing 5% (v/v) normal goat serum (Enzo Life Sciences). 
Incubation with antibody was done in PBS/1% BSA solution containing one of the six anti-C-
GRP/CG IgG fractions (anti-C-GRP: 0.5-2.0 µg/mL; anti-CG-1A: 0.25-2.0 µg/mL; anti-CG-
1B: 0.5-2.0 µg/mL; anti-CG-2: 1.0-2.0 µg/mL; anti-CG-3: 0.25-1.0 g/mL; anti-CG-8: 1.0-4.0 
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g/mL) overnight at 4 °C in a humid chamber. The sections were carefully rinsed with PBS and 
thereafter incubated in the dark with Alexa Fluor® 568-labeled goat anti-rabbit IgG (whole 
molecule) conjugate (1.0 gmL Sigma-Aldrich) for one hour at room temperature in a humid 
chamber, also containing 4′,6-diamidine-2′-phenylindole dihydrochloride (DAPI). When 
visualizing presence of C-GRP/CG-8 together with the chB6 marker by double staining, 
incubations with the polyclonal anti-C-GRP/CG-8 IgG fraction and second-step reagent 
(without adding DAPI) were performed as described above. The PBS/1% BSA solution 
containing the monoclonal antibody AV20 (2.5-5.0 µg/mL) was applied to the sections 
overnight at 4 °C in a humid chamber. After a washing step, the sections were incubated with 
a solution of PBS/1% BSA containing FITC-labeled anti-mouse IgG1 (1.0 µg/mL) and DAPI 
(1.0 µg/mL). Stringent controls including omission of first-step reagent and antibody blocking 
(up to 20-fold molar ratio of antigen to antibody) were carried out with tissue sections and fixed 
B cells together with processing sections from organs known for positivity/negativity for 
canonical CGs to exclude any antigen-independent staining.  
For lectin histochemistry with biotinylated plant/fungal lectins, tissue sections or fixed B 
cells were treated for 1 hour at room temperature in a humid chamber with a 2% (w/v) solution 
of BSA in 10 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid buffer (HEPES, pH 
7.5) to saturate non-specific protein-binding sites. Subsequently, after carefully rinsing the 
sections with HEPES buffer, incubation with the respective biotinylated plant/fungal lectin 
(PSL: 0.125-2.0 µg/mL; MAA-I: 0.5-1.0 µg/mL; JAC: 1.0-4.0 µg/mL; PNA: 0.25-1.0 µg/mL; 
PHA-E: 0.5-1.0 µg/mL; PHA-L: 0.125-4.0 µg/mL) was performed in HEPES/2% BSA solution 
overnight at 4 °C. Thereafter, washing steps with HEPES buffer to remove unbound lectin and 
with 10 mM PBS, pH 7.2, preceded the incubation step with a solution of PBS/1% BSA 
containing Texas-Red Avidin D® (30 µg/mL; Enzo Life Sciences) and DAPI (1.0 µg/mL). 
Controls included haptenic inhibition with mono- or disaccharides (JAC: 800 mM galactose; 
PNA: 200 mM galactose) to ascertain carbohydrate dependence of binding.  
Processing for double staining to visualize presence of C-GRP/CGs and of accessible sites 
reactive with C-GRP/CGs in sections was started with exposing them for 1 hour at room 
temperature in a humid chamber to a 1% (w/v) solution of BSA in PBS containing 5% goat 
serum to saturate sites for non-specific binding of protein. Subsequently, the sections were 
incubated with PBS/1% BSA containing anti-C-GRP or anti-CG IgG fractions (with 
concentrations, as given above) in a humid chamber overnight at 4 °C. After three thorough 
washing steps with PBS, Alexa Fluor® 568-labeled goat anti-rabbit IgG (whole molecule) 
antibody conjugate (1.0 gmL Sigma-Aldrich) was applied for 1 hour at room temperature in 
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a humid chamber in the dark. Then, after a washing step with PBS, sections were incubated 
with solutions of Alexa Fluor® 488-labelled C-GRP or CG (C-GRP: 2.5-5.0 µg/mL; CG-1A 
and -1B: 1.0-5.0 µg/mL; CG-2: 2.0-8.0 µg/mL; CG-3: 0.5-5.0 µg/mL; CG-8: 2.0-10.0 g/mL) 
adding DAPI overnight at 4 °C in a darkroom. Controls included haptenic inhibition of CG 
binding with 200 mM lactose. For inhibition of binding of Alexa Fluor® 488-labelled C-GRP 
to tissue sections and fixed B cells, heparin (Biomol, Hamburg, Germany) and further 
polysaccharides were applied as tested for a human heparin-binding protein [23]. 
In all cases, processed sections were mounted in antifade medium (Vectashield; Enzo Life 
Sciences), and microphotographs during fluorescence microscopy were recorded using an 
AxioImager.M1 microscope (Carl Zeiss MicroImaging, Göttingen, Germany) equipped with an 
AxioCam MRm digital camera and the software AxioVision version 4.6.  
 
2.6. Transmission electron microscopy 
 
Immediately after removal, small pieces (1 mm side length) of bursa of Fabricius tissue 
were fixed by immersion in Karnovsky´s solution (2.5% glutaraldehyde and 2% 
paraformaldehyde) for 24 hours at 4 °C. Thereafter, tissue blocks were treated with 1% osmium 
tetroxide (Plano, Wetzlar, Germany)/1.5% potassium ferrocyanide (Sigma-Aldrich), 
dehydrated in a graded series of ethanol (50%, 70%, 90% and absolute ethanol, each step 30 
minutes) and embedded in Polyembed 812 BDMA (Polysciences, Eppelheim, Germany). 
Semithin sections of 1 µm were prepared and stained with Richardson’s solution [24]. Ultrathin 
sections were cut with an ultramicrotome equipped with a diamond knife (Reichert-Labtec, 
Wolfratshausen, Germany), placed on 150-mesh copper grids (Polysciences), stained with 
uranyl acetate (Scientific Ltd., Stansted, UK) and lead citrate (Agar Aids, Stansted, UK), then 
examined by a transmission electron microscope (EM 902; Zeiss) to record microphotographs. 
 
2.7. Flow cytofluorimetry 
 
Quantitative determination of carbohydrate-dependent lectin binding was performed by 
flow cytofluorimetry in a FACS Calibur instrument (Becton-Dickinson, Heidelberg, Germany). 
Solutions with 2 x 105 cells per sample were carefully washed to remove any interfering serum 
compounds, the extent of non-specific protein binding was reduced by using a solution of 0.1% 
carbohydrate-free BSA in Dulbecco’s PBS. Fluorescent C-GRP/CGs or anti-C-GRP/CG 
antibodies (2.0 µg/mL) were incubated with the cells for 30 min at 4 °C to minimize endocytic 
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uptake. Fluorescent anti-rabbit IgG (1:100 dilution; Sigma-Aldrich) was used for detection of 
binding of the primary antibody, as described previously [25]. For intracellular staining, cells 
were fixed with 4% paraformaldehyde for 25 min at room temperature, followed by an 
incubation step in the presence of 0.5% saponin (Roth, Karlsruhe, Germany) for 30 min at room 
temperature to permeabilize the cell membrane. Control experiments without the incubation 
step with labeled antibody/lectin or in the presence of glycocompounds to block carbohydrate-
dependent lectin binding as well as systematic titrations to define optimal concentrations were 
run in each case, routinely using aliquots of the same cell batch in comparative analysis. 
 
2.8. Promoter analysis 
 
Computational identification of sequence motifs that satisfy criteria of a binding site for 
transcription factors were performed, as described previously [26,27], using the program 
MatInspector, which minimizes redundant matches by arranging similar and/or functionally 
related transcription-factor-binding sites into matrix families [28]. The MatInspector software 
(http://www.genomatix.de/index.html) identifies matches by comparing the proximal promoter 
sequence with weighted matrix descriptions of functional binding sites based on the 
TRANSFAC® database and on the MatInspector-inherent 634 matrices grouped into 279 
families (Matrix Library 9.3, released March 2015). The optimized threshold of a weight matrix 
was defined as the matrix similarity threshold that allows a maximum of three matches in 10 
kb of non-regulatory test sequences. By scanning the imported sequence against the relative 
frequency of each nucleotide at a particular position in the program-based distribution profile, 
the matrix similarity was calculated on-the-run. Only sites with a core similarity of 1.0, which 
is reached only if the sequence analyzed is completely identical to matrix-inherent sequence 
sections with highest degree of conservation, were considered to be of putative significance. 
With the algorithms provided by this program, the manually edited proximal promoter 
sequences (-2500 bp upstream of the translation start, applying the sequence text view tool 
implemented in NCBI Gene [29]) of five genes for B cell markers, i.e. activation-induced 
cytidine deaminase, (AICDA, Gene ID: 418257) [30], B cell-activating factor receptor (BAFF 
receptor)/tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C, Gene ID: 
417983) [31], CD40 (Gene ID: 395385) [32], CD79B (Gene ID: 419940) [33], chloride 
intracellular channel 2 (CLIC2, Gene ID: 422178) [34], and genes for C-GRP (Gene ID: 
421278), and CG-8 (Gene ID: 430948) were used for analysis. In the case of the transmembrane 
activator and CAML interactor (TACI)/tumor necrosis factor receptor superfamily, member 
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13B (TNFRSF13B, Gene ID: 770275) [35], the processed promoter sequence was -2500 bp 
upstream of the transcription start.  
 
3. Results and discussion 
 
3.1. Expression profiling 
 
Screening of C-GRP expression on the level of mRNA was performed with cDNA 
preparations of a panel of organs from 2-day-old, 4-week-old and 6-month-old chickens. 
Flanked by a loading control, positivity was defined as appearance of a band at the calculated 
size, as exemplarily shown in Fig. 1. In the documented case, this signal was detectable, and 
negativity after processing of material from frozen liver extracts served as control to exclude 
false-positive data. cDNAs from bursa, heart, kidney and thymus were consistently positive, 
cDNAs from other organs such as small intestine led to signals in up to two stages of 
development, while cDNA from liver was always negative. A similar picture with broad 
positivity had emerged for expression of the human and murine GRP genes based on entries to 
expressed sequence tag listings [3]. Extracts from chicken bursa had previously been reported 
to produce a strong signal for the mRNA specific for CG-8L (the isoform of the tandem-repeat-
type protein with long (L) linker maintaining an exon relative to the short (S) form) and also 
for CG-3 [12,20]. This evidence was confirmed and extended to positivity for all five canonical 
CGs (not shown). 
 
 
 
Fig. 1. Expression profiling of C-GRP by RT-PCR. The presence of C-GRP-specific mRNA was detected in 
samples from tissues and isolated bursal B cells of 4-week-old chickens as band at 516 bp. Probing of mRNA for 
actin served as positive control. Positions of markers are indicated (left). 
 
In order to bring the analysis to the level of the protein, an antibody preparation against C-
GRP was raised and ensured to be devoid of cross-reactivity to any canonical CG by affinity 
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chromatography using resin-immobilized CGs. When then probing for protein presence in 
extracts of organs from 4-week-old animals by Western blotting, occurrence of positivity was 
found to be restricted to bursa and isolated bursal B cells (Fig. 2A). Evidently, C-GRP was 
present in this organ at its stage of full maturation. In contrast to the canonical CGs, which are 
expressed in various adult organs with individual distribution profiles (for overview, please see 
[7,36]), immunohistochemistry with this antibody preparation detected no evidence for C-GRP 
positivity in any other tested tissue. Having obtained signals for the mRNAs of the five 
canonical CGs, the next question to address was the representation of canonical CGs in this 
tissue and its B cells. Presence of CG-8L, already described previously in whole-tissue extracts 
[20], was confirmed so that the respective analysis found both CG-8L and C-GRP in extracts 
of bursal B cells (Fig. 2). Systematic investigation by Western blotting disclosed signals for all 
canonical CGs in bursa extracts but, except for CG-8L, not in extracts of bursal B cells (Fig. 2). 
When examining the signals for CG-1A, staining was observed at the positions of the mono- 
and dimers under denaturing conditions, as for example reported for murine regulatory T cells 
[37]. Evidently, i) presence of C-GRP in amounts detectable by Western blotting appears 
specific for bursa of Fabricius at its full stage of maturation and ii) this organ contains the full 
set of canonical CGs, making it to an ideal study object to define the localization profiles of the 
six family members in one organ. 
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Fig. 2. Expression profiling of C-GRP and the canonical CGs by Western blotting. Detection of C-GRP (A)/CGs 
(B) in extracts from tissue samples (100 µg total protein; liver, kidney, heart, bursa of Fabricius for C-GRP, bursa 
of Fabricius for canonical CGs) and isolated bursal B cells (50 µg and 100 µg total protein) of 4-week-old chickens 
using polyclonal IgG fractions against C-GRP/CGs (anti-C-GRP: 0.5 µg/mL; anti-CG-1A: 1.0 µg/mL; anti-CG-
1B: 0.25 µg/mL; anti-CG-2: 1.0 µg/mL; anti-CG-3: 0.25 µg/mL; anti-CG-8: 2.0 µg/mL), each free of any cross-
reactivity to the other five proteins. Positions of molecular weight markers are indicated, a control with purified 
C-GRP (12 ng) is included (A, left), origin of extract (A) and the type of the detected CG (B) given. 
 
3.2. Immunocyto- and histochemical and cytofluorimetric profiling 
 
Initial immunohistochemical experiments with different organs were carried out to prove 
specificity and to preclude missing a specific signal by titrations. In detail, sections of an organ 
panel including bursa, heart and kidney were processed to ascertain correlation of Western 
blotting data with positivity in immunohistochemistry. Antibodies against canonical CGs 
served as positive control to exclude false-negative results. Systematic experiments were run 
with a series of concentrations of the antibody preparations for C-GRP and the canonical CGs. 
In full agreement to the data from Western blotting, C-GRP positivity was present in sections 
of bursa but no other tissue, when testing of 4-week-old animals. Obtaining the known regional 
selectivity for canonical CGs, as documented for example in sections of kidney previously 
[7,38], ensured the reliability of the technical procedure. These immunohistochemical series 
thus solidified the focus on this tissue type. In order to attain an optimal signal-to-background 
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ratio, titrations were performed for each antibody preparation on serial sections, setting the 
stage for the network monitoring. A scheme of the bursa’s morphological organization along 
with its actual appearance in a section is presented in Fig. 3 to provide an orientation for readers. 
As follows, localization profiles with individually distinct characteristics will be presented for 
C-GRP and each of the canonical CGs in Figs. 4A-C, G-I, M-R, together with electron 
microscopical documentation on relevant cell types with CG positivity (Figs. 4D-F, J-L) (for 
detailed explanations to each illustration, please see legend to this figure; for overview of 
staining profiles, please see Table 1). 
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Fig. 3. The bursa of Fabricius (A) is a blind sac-like diverticulum in the dorsal wall of the cloaca. The mucosal 
layer in the inner surface forms multiple folds (one such fold or plica bursalis, as marked by a dotted orange line 
is shown enlarged (B)). These folds contain lymphoid tissue organized into nodules, also called bursal follicles. 
The area depicted inside the blue dotted line is shown enlarged as a microphotograph of a hemalaun-stained tissue 
section (C; scale bar: 100 µm) and as a scheme of the same section (D). The follicles which contains B cells 
(arrowheads) are covered by interfollicular surface epithelium (IFE, a) or, when in direct contact with the 
epithelium, by follicular-associated epithelium (FAE, b). The tissue between the follicles is made up of 
interfollicular connective tissue (c). The follicles consist of a cortex or pars lymphoreticularis (d), a cortico-
medullary border which is formed by numerous capillaries (e) and a cortico-medullary epithelium (f), and a 
medulla or pars lymphoepithelialis (g). 
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Fig. 4. Immunohistochemical localization of C-GRP and canonical CGs by fluorescence microscopy and 
identification of specific cell types on the electron microscopical level in sections through follicles (A-L) as well 
as follicle-associated epithelium (FAE) and interfollicular epithelium (IFE) (M-R) of bursae of Fabricius from 4-
week-old chickens. Because these illustrations establish the basis for the summary given in Table 1, each 
microphotograph is explained in thorough detail. (A, M) C-GRP presence in reticular epithelial cells (arrowheads, 
staining intensity prominent at the cortico-medullary border), in B cells (at different stages of their lineage, dot-
like staining pattern in the Golgi apparatus) both in medulla and cortex. Strong staining intensity is observed in 
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the endothelium of blood vessels (arrows) located in the capillary layer at the cortico-medullary junction and in 
the lamina propria (A). In the FAE, strong reactivity was observed supranuclearly (asterisks), whereas basal cells 
(arrowheads) were stained only weakly (M). (B, N) Intense reactivity of CG-1A-specific antibodies in the basal 
lamina and in the endothelium of capillaries (arrows) located at the cortico-medullary border and between follicles, 
in the lamina propria (Lp) and in mesenchymal reticular cells of the cortex (B, arrowheads). FAE/IFE were 
negative (N). (C, O) CG-1B presence in the lamina propria (Lp, C) and supranuclearly (asterisks) in epithelial 
cells (O). On the electron microscopical level, micrographs D-F illustrate details of C-GRP/CG-positive cells and 
structures. (D) Reticular cells (arrow) showed their typical irregular shape with filopodia (arrowheads), and 
nucleoli (Nu) of lymphoblasts were prominent. (E) Separation of medulla and cortex by the cortico-medullary 
border, which consists of the basal lamina (arrowheads, CG-1A positive, please see B) and the cortico-medullary 
epithelial cells (arrow, CG-3 positive, please see H). (F) Ultrastructure of interfollicular tissue (positive for CG-
1A, CG-1B, please see B, C). Collagen fibers (arrowheads) and a fibroblast (arrow) in its typical shape are shown. 
(G-I; P-R) Fluorescent staining patterns after applying anti-CG-2 (G, P), anti-CG-3 (H, Q) and anti-CG-8 (I, R), 
respectively. CG-2 presence is confined to endothelial cells in capillaries (arrowheads) at the cortico-medullary 
border and in blood vessels (arrows) embedded in the lamina propria (G). Cells lining the FAE/IFE were negative 
(P). (H, Q) Reactivity for anti-CG-3 was observed in cortico-medullary epithelial cells (arrowheads) at the cortico-
medullary border and in reticular epithelial cells disseminated throughout the whole medulla (Me, H). Strong 
immunopositivity for CG-3 was found in the cells of the FAE/IFE (Q). (I, R) CG-8 presence is confined to 
medullary and cortical B cells (I; inset: control without first-step antibody), and with weaker intensity to the 
cytoplasm of basal cells in the FAE/IFE (R). (J, K) Electron micrographs of reticular epithelial cells (arrowheads, 
CG-3 positive, please see H) surrounded by B lymphoblasts (arrows, with prominent nucleoli; C-GRP and CG-8 
positive, please see A, I) or a capillary vessel on the bottom right edge (Ca, K; CG-1A-, CG-2-positive, please see 
B, G) and in the vicinity of a macrophage (Ma) containing a large amount of phagocytosed material (K). (L) 
Ultrastructure of cells in the FAE (positive for C-GRP, CG-1B, CG-3, CG-8, please see M, O, Q, R). Thin 
microvilli (arrows) on the cells´ surface and supranuclear secretory granules (arrowheads) are clearly visible. 
Concentrations of antibodies used were 1.0 µg/mL for anti-CG-1A IgG, anti-CG-1B IgG as well as for anti-CG-3 
IgG, 2.0 µg/mL for anti-C-GRP IgG and anti-CG-2 IgG, and 4.0 µg/mL for anti-CG-8 IgG. Nuclei were 
counterstained with DAPI. The scale bars are 1 µm (D-F; J-L), 20 µm (A-C; G-I; M-R) or 50 µm (inset to I). 
 
Immunomonitoring for C-GRP reveals a distinct pattern with positivity in the follicle-
associated and interfollicular epithelia (FAE/IFE) as well as in B cells, capillary vessels and 
reticular epithelial cells (Figs. 4A, M), in close correspondence with the electron microscopical 
characterization of cell features. As summarized in Table 1, staining was cytoplasmic, here 
often supranuclear. In this respect, the protein can share intracellular functionality with other 
members of this family, for example in counterreceptor routing, growth regulation, or splicing 
[39,40]. The parallel testing of the specific antibody preparations for each canonical CG 
disclosed non-redundant expression profiles. As could be expected due to the positive Western 
blot data (Fig. 2), each CG could be localized: CG-1A in basal lamina and vessels (Figs. 4B, 
N), CG-1B in lamina propria and the IFE (Figs. 4C, O), CG-2 mostly in capillaries (Figs. 4G, 
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P), CG-3 strongest in epithelial cells (Figs. 4H, Q) and CG-8, in contrast to CG-3 and the three 
proto-type CGs but similar to C-GRP, in medullary and cortical B cells (Figs. 4I, R). 
Pinpointing cell types/regions of overlapping positivity, C-GRP shares positivity in vessels with 
CG-1A, in IFE/FAE with CG-3 and CG-1B (IFE) and in B cells with CG-8 (Table 1). Because 
solid-phase assays (but not gel filtration) revealed a tendency for self-association of C-GRP and 
for association of this protein with CG-3, less with CG-8 and proto-type CGs (not shown), as 
first noted for surface-presented human galectin-9 in self-association and association with 
galectins-3 and -8 but not galectin-1 [41,42], an in situ interaction between C-GRP and CG-3 
in a suited structural context could be possible in epithelia. Turning to the case of C-GRP/CG-
8, Cell-type-specific co-expression of C-GRP with CG-8 had already been indicated when 
probing B cell extracts by Western blotting (Fig. 2). Owing to the potential of functional 
significance of this co-expression, considering that the two murine galectins-1 and -8 are both 
expressed by B cells and cooperate to promote plasma cell formation [43], we further validated 
this result by colocalization of C-GRP/CG-8 and a B cell marker, hereby also examining the 
cellular distribution in more detail.  
 
 
 
 
 
Results Publication 3 106
 
	
Table 1 
Immunocyto- and histochemical profiles of presence of C-GRP and the five canonical CGs 
 
       
 C-GRP CG-1A CG-1B CG-2 CG-3 CG-8 
cell type       
       
epithelium       
interfollicular epithelium (IFE) +a/++b - ++b - +++f +f 
follicle-associated epithelium 
(FAE) 
+a/++b - - - +++f - 
basal lamina - +/++ - - - - 
lamina propria       
interfollicular tissue - + ++ - - - 
blood vessels ++c ++e - ++c - - 
cortex       
B cells +d - - - - ++g 
mesenchymal reticular cells - + - - - - 
macrophages - - - - - - 
cortico-medullary border       
epithelial cells + - - - - - 
capillary vessels ++c +++e - +c - - 
medulla       
B cells +d - - - - ++g 
reticular epithelial cells - - - - + - 
dendritic cells - - - - - - 
isolated B cells ++d - - - - ++ 
Signal intensity was semiquantitatively grouped into the categories: - negative, + weak but significant, ++ medium, 
+++ strong; acytoplasm of basal cells, bsupranuclear positivity, cendothelium, ddot-like staining pattern at the Golgi 
apparatus, eendothelium and smooth muscle layer, fcytoplasmic, gsurface associated. 
 
 
The staining patterns of the antibodies against C-GRP and CG-8 (red; Figs. 5A, D) were 
separately superimposed with the distribution of green signals obtained by applying a 
monoclonal antibody against a pan B cell marker, i.e. the cell surface chB6 epitope (Figs. 5B, 
E). Intriguingly, the resulting overlay for the sections through follicular medulla revealed no 
apparent overlap between C-GRP and chB6, due to cytoplasmic (C-GRP) and cell surface 
(chB6) presence (Fig. 5C). In contrast, staining patterns for CG-8 and the marker clearly show 
an overlap in the sections (Fig. 5F). The same procedure was performed for isolated B cells 
from bursal tissue and provided evidence for a lower extent of colocalization in the pairing of 
the B cell marker with C-GRP (Figs. 5G-I) than with CG-8 (Figs. 5J-L). The other CGs were 
not detectable immunocytochemically under these conditions (not shown). These results 
enabled to add this information on isolated B cells to Table 1 and to conclude that the 
localization profiles of C-GRP and CG-8 are different in B cells. 
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Fig. 5. Colocalization of C-GRP (red) and CG-8 (red) with the pan B cell marker, the chB6 (Bu-1) (green) surface 
molecule, in sections through the medulla of a follicle (A-F) and in isolated B cells (G-L). Anti-C-GRP/CG-8-
specific first-step antibodies were applied in combination with Alexa Fluor® 568-labeled second-step goat anti-
rabbit IgG. Mouse monoclonal antibody AV20 to detect chB6 was combined with FITC-labeled goat anti-mouse 
IgG1 as a second-step reagent. (A-F) Positivity for C-GRP and the membrane-associated staining pattern of the 
chB6 surface molecule in follicle-associated (A, B) and isolated B cells (G, H) were not colocalized (C, I). In 
contrast, staining for CG-8 overlaps clearly with the pattern of the marker both in the follicular tissue (D-F) and in 
isolated B cells (J-L), indicating CG-8 presence on the cell surface. For concentrations of antibodies used, please 
see legend to Fig. 4; monoclonal antibody AV20 was applied at 2.5 µg/mL. Nuclei were counterstained with DAPI. 
The scale bars are 10 µm. 
 
As a means to further study this aspect on cells, we carried out flow cytofluorimetric 
measurements on native and permeabilized bursal lymphoma (DT40) cells. Under these 
conditions and testing CG-1B as control, cells were only very weakly positive for presence of 
C-GRP on the surface, in comparison more frequently and more intensely seen in the cytoplasm 
after treatment of cells with detergent for membrane permeabilization (Fig. 6). As seen in tissue 
sections and B cells, this protein is present within cells also for the cultured line. In comparison, 
the contributions to positivity indicated a relative shift of staining to the cell surface in the case 
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of CG-8 (Fig. 6). Thus, these two members of the galectin family are present in virus-
transformed chicken B cells with differences in quantitative aspects of sites of their localization. 
Having hereby revealed where C-GRP can be detected in bursa, identifying B cells as major 
site, and expression in normal and malignant B cells, questions on putative regulatory sequences 
in the promoter arise and are addressed. 
 
 
Fig. 6. Semilogarithmic representation of fluorescent staining of cells of the chicken DT40 cell line by rabbit 
polyclonal antibodies directed against C-GRP (black line), CG-1B (grey line) and CG-8 (dashed line). Antibodies 
were used at a concentration of 2 µg/mL. (A) Cell surface staining and (B) staining of cells after permeabilization 
by addition of 0.5% saponin to the incubation buffer. The control value without antibody addition is given as 
shaded area. Numbers characterizing staining (percentage of positive cells/mean florescence intensity) are given 
in each panel.  
 
3.3. Computational profiling of the promoter region 
 
Applying search and assessment algorithms to the promoter region of the C-GRP gene (-
2500 bp upstream of the translation start), the set of putative binding sites for transcription 
factors (TFs) can be established. The respective list, given in Table S1, is the basis for 
comparative considerations, as a guideline for experimental work. When applied to the question 
on C-GRP expression in B cells, a starting point for tracing functionally relevant sequences is 
a comparison to a respective compilation for the CG-8 gene, based on the disclosed co-
expression in B cells. In addition, spotting identities to promoter sequences of genes of chicken 
B cell-associated products can provide further guidance. Therefore, a set of six genes meeting 
this criterion was selected and their promoter sequences processed accordingly. As shown in 
Table 2, a total of 11 structural motifs that are classified as binding sites for transcription factors 
(TFBS) is encountered in all these promoter regions, and, moreover, further sequence elements 
with putative reactivity to TFs were found, if one, two or three genes were not part of the 
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comparison (Table 2). Obviously, these sequences are candidates for detailed experimental 
testing of their impact on actual expression. That this search uncovered a series of similar motifs 
also encourages to examine promoter sequences of the GRP gene in other vertebrates, keeping 
the high-level sequence conservation in mind. 
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Table 2 
Shared sequences in the promoters of the genes for C-GRP, the canonical CG-8 and six B cell-associated 
proteins (AICDA, BAFF-R, CD40, CD79B, CLIC2, and TACI)  
 
 TFBS in 8/8 
promoters 
TFBS in 7/8 
promoters 
(incl. C-GRP + 
CG-8)
TFBS in 6/8 
promotors 
(incl. C-GRP + 
CG-8)
TFBS in 5/8 
promoters 
(incl. C-GRP + 
CG-8) 
 
Transcription 
factor (TF) 
 
ETV1a, 
Lactoferrina, 
MYODa, MZF1a, 
NFAT5a, NF-κBa, 
OLIG2a, PAX5a, 
PRDM1a, SPI1a, 
TCFE2Aa 
 
MAZa, MAZRa, 
NFATa, OCT1a, 
TLX1b, VMYBa, 
WHNa, ZBTB7a, 
ZNF202a, 
ZNF219b 
 
ARID5Ab, BCL6a, 
FOXP1_ESa, 
GATA1a, JUNBa, 
MEL1a, MYBL1a, 
RBPJKa, STAT3a 
 
 
EVI1a, HHEXb, 
HOX1-3a, 
BLIMP1b, 
STAT1a, RFX4a 
a unmarked TFs show a common distribution within analyzed promoter regions of B cell-associated and 
CG genes 
b TFs marked in grey are putative interesting factors, because their binding site is mainly detectable in 
B cell-associated promoter regions 
 
The distribution of putative transcription factor binding sites (TFBS) for TFs expressed in cells of the immune 
system are shown for C-GRP, CG-8 and genes, that are known to be expressed in B-cells, such as AICDA, BAFF-
R, CD40, CD79B, CLIC2, and TACI. Names of transcription factors: ARID5A: AT rich interactive domain 5A 
(MRF1-like); BCL6: B-cell CLL/lymphoma 6; BLIMP1: Transcriptional repressor B lymphocyte-induced 
maturation protein-1; ETV1: Ets variant 1; EVI1: EVI1-myeloid transforming protein; FOXP1_ES: Alternative 
splicing variant of FOXP1 activated in ESCs; GATA1: GATA-binding factor 1; HHEX: Haematopoietically 
expressed homeobox, proline-rich homeodomain protein; HOX1-3: Hox-1.3, vertebrate homeobox protein; JUNB: 
Transcription factor Jun-B; Lactoferrin: Lactotransferrin and delta-lactoferrin; MAZ: Myc-associated zinc finger 
protein; MAZR: MYC-associated zinc finger protein related transcription factor; MEL1: MEL1 (MDS1/EVI1-like 
gene 1) DNA-binding domain 2; MYBL1: V-myb avian myeloblastosis viral oncogene homolog-like 1 (AMYB); 
MYOD: Myogenic regulatory factor MyoD (myf3); MYOGENIN: Myogenic bHLH protein myogenin (myf4); 
MZF1: Myeloid zinc finger protein; NFAT: Nuclear factor of activated T-cells; NFAT5: Nuclear factor of 
activated T-cells 5; NF-κB: Nuclear factor κB; OCT1: Octamer-binding transcription factor-1, POU class 2 
homeobox 1 (POU2F1); OLIG2: Oligodendrocyte lineage transcription factor 2; PAX5: Paired box protein 5, B-
cell-specific activator protein; PRDM1: PRDI (positive regulatory domain I element) binding factor 1; RBPJK: 
Mammalian transcriptional repressor RBP-Jκ/CBF1; RFX4: Regulatory factor X, 4; SPI1: SPI-1 proto-oncogene; 
hematopoietic transcription factor PU.1; STAT1: Signal transducer and activator of transcription 1; STAT3: Signal 
transducer and activator of transcription 3; TCFE2A: transcription factor E2a (E12/E47); TLX1: T cell leukemia 
homeobox 1; VMYB: v-Myb, variant of AMV v-myb; WHN: Winged helix protein; ZBTB7: Zinc finger and BTB 
domain containing 7A; ZNF202: Zinc finger 202; ZNF219: Kruppel-like zinc finger protein 219. 
 
Of course, expression profiling and GRP localization will need to be defined in other 
vertebrates, before these comparisons should be performed. Experimentally, a salient aspect of 
GRP activity can next be characterized due to the availability of the protein. Having determined 
the loss of the typical lectin activity in C-GRP and seen binding to mammalian cells without 
inhibitability by a panel of glycans [8], the availability of labeled C-GRP enables to use the 
protein as tool to monitor sections of chicken bursa and isolated B cells for reactivity. As 
routinely done by lectin histochemistry, the labeled protein can then associate to accessible 
binding partners. This technique enables a comparison between staining profiles of C-GRP and 
CG-8, which can be extended to all canonical CGs, thus establishing a comprehensive 
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fingerprinting of reactivity to the six proteins, and it can additionally characterize aspects of the 
glycome, relevant for CG-8 binding. 
 
3.4. (Ga)lectin cyto- and histochemical and cytofluorimetric profiling 
 
The respective experiments with C-GRP and CG-8 were performed by double labeling 
visualizing the protein (in red) and reactive sites (in green), and this pair of cyto- and 
histochemical illustrations is presented (Figs. 7A, D, G, J, for immunolocalization, Figs. 7B, E, 
H, K for localization of C-GRP/CG-8 reactivity and Figs. 7C, F, I, L for overlay). As done for 
antibodies, systematic titrations had been performed for the labeled proteins to define a 
concentration that will generate an optimal signal-to-background ratio. In addition, applying 
lactose as additive to the lectin-containing solution proved the canonical-galectin-dependent 
staining to be inhibitable (insets to Figs. 7E, K). C-GRP reactivity was found in distinct sites, 
as summarized in Table 3. Whereas capillary vessels were immunopositive (Figs. 4A, 7A), 
weak reactivity for the labeled protein was seen at these sites (Fig. 7B). Labeled C-GRP was 
found to bind to the IFE/FAE more strongly, yielding a similar intensity as reached in 
immunohistochemistry (Fig. 7B). Yellow staining in superimposition was thus present in the 
apical part of cells in the IFE and also in capillary vessels of the cortico-medullary border (Fig. 
7C). The reactivity for CG-8 was rather similar in the epithelium, matching immunopositivity 
in IFE (Table 3, Fig. 4R, Fig. 7D) so that the overlap with sites of lectin presence mostly resided 
in B cells (Fig. 7F). In isolated B cells, signal overlap, too, was apparent, here more on the cell 
surface for CG-8 than C-GRP (Figs. 7G-L). These data showed that both labeled proteins are 
sensors for binding sites in the tissue and encouraged to extend the analysis to the other 
canonical CGs. 
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Fig. 7. Combined histo- and cytochemical staining using anti-C-GRP IgG/fluorescent C-GRP and anti-CG8 
IgG/fluorescent CG-8, respectively, in sections of follicles (A-F) and in isolated bursal B cells (G-L). Staining 
with Alexa Fluor® 568 (red)-labeled second-step antibody to detect C-GRP (A, G)/CG-8 (D, J) presence and Alexa 
Fluor® 488 (green)-labeled C-GRP (B, H)/CG-8 (E, K; insets: controls by inhibition with cognate sugar) to detect 
accessible binding sites was performed. Positivity for C-GRP (A, G) and C-GRP-binding sites (B, H) led to overlap 
(yellow) in double staining in the apical part of cells of the IFE (C, arrowheads). A weak overlap was detected in 
capillary vessels (C) and also in isolated bursal B cells (I). Overlap of CG-8 presence and accessible binding sites 
was found in bursal B cells (in tissue sections and isolated cells) to various degrees (F, L), and also in the apical 
part of the IFE (F), which is reactive with labeled CG-8 (E). For concentrations of antibodies used, please see 
legend to Fig. 4. Concentrations of fluorescent C-GRP and CG-8 used were 10 µg/mL. Nuclei were counterstained 
with DAPI. The scale bars are 10 µm (G-L), 20 µm (A-F, inset to K) or 50 µm (inset to E). 
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Table 3 
Cyto- and histochemical profiles of binding of fluorescent C-GRP and the five canonical CGs 
 
       
 C-GRP CG-1A CG-1B CG-2 CG-3 CG-8 
cell type       
       
epithelium       
interfollicular epithelium (IFE) +/++a +c ++d - ++/+++c +/++d 
follicle-associated epithelium 
(FAE) 
+/++a +c -/+a - ++c +/++d 
basal lamina - - - - - - 
lamina propria       
interfollicular tissue -/+ - + - - - 
blood vessels -/+b - - - - - 
cortex       
   B cells + - - - - + 
mesenchymal reticular cells - - - - - - 
macrophages - - - - - - 
cortico-medullary border       
epithelial cells + - - - - - 
capillary vessels +b - - - - - 
medulla       
B cells + - - - - + 
reticular epithelial cells - - - - - - 
dendritic cells - - - - - - 
isolated B cells  +/++ - - - - +/++ 
Signal intensity was semiquantitatively grouped into the categories: - negative, + weak but significant, ++ medium, 
+++ strong; acytoplasmic, bendothelium, csupranuclear, dapical.  
 
These experiments revealed different patterns of reactivity, as also summarized in Table 3. 
Weak binding of CG-1A was detected in the FAE/IFE (Fig. 8A), without apparent overlap to 
its immunolocalization, as documented by seeing no yellow signal in superimposition (Fig. 8B). 
In contrast, such an overlap was strong for CG-1B in the IFE but not in the FAE (Figs. 8C, D), 
and CG-2 served as negative specificity control (Figs. 8E, F). The two types of CG-3-dependent 
stainings led to marked overlap in IFE/FAE (Figs. 8G, H). Tested on isolated bursal B cells, 
application of none of these canonical galectins yielded a significant staining (not shown). B 
cells, positive for C-GRP and CG-8, are yet reactive with both C-GRP and CG-8, arguing in 
favor of a functional pairing in situ. Looking at mammalian B cells, the fact that they express 
also other types of lectins and bind them gives reason to add a monitoring of the glycophenotype 
to our study. As a relevant example, the siglec CD22 (siglec-2) or siglec-G, a B-cell-restricted 
surface protein in man and mouse, binds 2,6-sialylated N-glycan chains [1,44-48]. The 
emerging functionality of certain glycans by lectin recognition (for recent reviews, please see 
[49,50]) prompted us to perform lectin histochemistry, in addition to galectin histochemistry. 
As tools, plant and fungal lectins with specificities for common N- and O-glycans were selected, 
facilitating to map profiles of a series of biorelevant glycan epitopes given in Table 4 [51,52]. 
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Fig. 8. Galectin histochemical staining using labeled CGs and its overlay with the immunohistochemical profile. 
CG-specific binding sites were visualized using ALEXA Fluor® 488-labeled CG-1A, CG-1B, CG-2 and CG-3 (A, 
C, E, G), double staining with respective immunohistochemical profile are given in (B, D, F, H). In the case of 
fluorescent CG-1A no overlap to CG-1A presence (please see also Fig. 4B) in basal lamina, in the endothelium of 
capillaries at the cortico-medullary border and between follicles, in the lamina propria and in mesenchymal 
reticular cells of the cortex was seen with CG-1A-binding sites, present supranuclearly (asterisks) in FAE/IFE (A, 
B). Fluorescent CG-1B (C) showed distinct overlap (in orange/yellow) apically in the IFE (arrowheads, D) and to 
a limited extent (orange) in the lamina propria (Lp). Weak reactivity for labeled CG-1B was seen in the FAE 
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(arrows). (E, F) CG-2 presence was found in capillary vessels, whereas no accessible binding sites were detected. 
(G, H) Binding sites for fluorescent CG-3 were detected supranuclearly in IFE/FAE (G; inset: control by inhibition 
with cognate sugar) leading to marked overlap (H). Concentrations of fluorescent CGs used were 10 µg/mL for 
CG-1A, 2.0 µg/mL for CG-1B, and 8.0 µg/mL for CG-3. Nuclei were counterstained with DAPI. The scale bars 
are 20 µm or 50 µm (inset to G).  
 
The set of six plant/fungal lectins to map aspects of glycosylation was thus tested under 
identical conditions. Their glycan specificities, starting with 2,6-sialylated N-glycans as 
compiled in Table 4, enable to probe for presence of epitopes relevant for reactivity to galectins 
and other types of lectin. For example, 2,6-sialylation of N-glycans, besides being a CD22 
ligand, abolishes galectin reactivity, unless repeats of N-acetyllactosamine are present (in the 
case of galectin-3) [53-55]. The lectin from the fungus Polyporus squamosus is exquisitely 
specific for this branch-end modification of N-glycans [16,56]. 
 
Table 4 
Specificity profile of fungal/plant agglutinins used for glycophenotyping 
 
Species  Abbreviation Monosaccharide 
specificity 
Potent glycan ligands 
Polyporus squamosus  
(polypore mushroom) 
PSL a Neu5Acα6Galβ4Glc(NAc) (over 
300-fold more active than LacNAc, 
not reactive with free Neu5Ac); 6´-
sulfation tolerated; 6ʼ-sialyl Tn not 
reactive 
Maackia amurensis-I 
(leukoagglutinin) 
MAA-I a Neu5Ac3Gal4GlcNAc/Glc, 3´-
sulfation tolerated 
Phaseolus vulgaris 
erythroagglutinin 
(kidney bean) 
PHA-E a Bisected complex-type N-glycans: 
Galβ4GlcNAcβ2Manα6(GlcNAcβ2-
Manα3)(GlcNAcβ4)Manβ4GlcNAc 
Phaseolus vulgaris  
leukoagglutinin (kidney 
bean) 
PHA-L a Tetra- and tri-antennary N-glycans 
with β6-branching 
Artocarpus integrifolia 
(jack fruit) 
Jacalin (JAC) Gal/GalNAc Galβ3GalNAcα; sialylation of T/ Tn 
antigens tolerated 
Arachis hypogaea 
(peanut) 
PNA Gal Galβ3GalNAcα/β 
ano monosaccharide known as ligand. 
 
The staining of B cells by the fungal lectin in sections and cell preparations, documented 
in Figs. 9A, G (for a detailed description of staining properties, please see legend to this figure), 
indicates presence of 2,6-sialylation. The MAA-I binding in the FAE, shown in Fig. 9B, 
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reveals presence of the branch-end isomer, i.e. 2,3-sialylated N-glycans. The N-terminal 
domain of CG-8 could target this epitope [57,58], and also mammalian siglecs such as 
sialoadhesin (siglec-1) target this epitope. Isolated B cells were negative (Fig. 9H). Complex-
type N-glycans with core modifications, e.g. allowing branching to reach tri- and tetraantennary 
status or modulating lectin reactivity (Table 4), are also candidates for galectin binding, 
presence of these epitopes presenting regional specificity (Figs. 9C, D, I, J). Concerning core 1 
O-glycans, 2,3-sialylation shows similar regional selectivity, and B cells lack this reactivity, 
as they also were shown not to bind MAA-I, which is specific for 2,3-sialylated (type II) N-
glycans (Figs. 9E, H, K). The T antigen, in contrast, is present on B cells (Figs. 9F, L), indicating 
a regulation in the status of terminal glycosylation for mucin-type O-glycans. This aspect has 
been thoroughly studied for mammalian T cells, where changes occur upon activation [59]. As 
technical aspect, the illustrated combination of applying tissue and plant/fungal lectins reveals 
the chicken proteins to serve as versatile probes exactly as the commonly used plant proteins 
do, encouraging standard application.  
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Fig. 9. Lectin histo- and cytochemical localization of selected glycan determinants applying biotinylated 
plant/fungal lectins and Texas-Red Avidin D® as second-step reagent in sections through follicles (A-F) and in 
isolated B cells of bursae of Fabricius (G-L) from 4-week-old chickens. (A, G) Staining by Polyporus squamosus 
lectin (PSL) in B cells (different stages of their lineage) of medulla and cortex, cortico-medullary epithelial cells 
(arrowheads), basal lamina and endothelial cells (vessels in the capillary layer at the cortico-medullary border and 
in the lamina propria, arrows). Comparatively reduced intensity of staining for PSL was found in the FAE 
(asterisk) (A). Isolated B cells were strongly positive (G). (B, H) Positivity for Maackia amurensis-I 
(leukoagglutinin) (MAA-I) was observed in cortico-medullary epithelial cells (arrowheads, B) and with strong 
intensity in the FAE (asterisks, B), whereas isolated B cells were negative (H). (C, I; D, J) Binding sites for 
Phaseolus vulgaris erythroagglutinin (PHA-E)/leukoagglutinin (-L) were found in B cells located in the medulla 
(Me), in endothelial cells (capillary layer at the cortico-medullary border, arrows), in the lamina propria (Lp), 
mesenchymal reticular cells (arrowheads) in the cortex (Co) and, especially for PHA-L, supranuclearly (asterisk) 
in the IFE (C, D). Isolated B cells showed a heterogeneous profile (I, J). (E, K) Reactivity for Artocarpus 
integrifolia agglutinin (jacalin, JAC) was mainly confined to the basal lamina and endothelial cells of the capillary 
layer at the cortico-medullary border (arrows, E), to the lamina propria (Lp) and mesenchymal reticular cells 
(arrowheads) in the cortex (Co), isolated B cells were negative (K). (F, L) Peanut agglutinin (PNA) positivity was 
found in B cells and, based on their morphological appearance, in bursal secretory dendritic cells, mainly of the 
medulla (Me), as well as in the intrafollicular capillary layer, also in the apical part (asterisk) and basal cell layer 
(arrowhead) of the IFE (F; inset: control by inhibition with cognate sugar). Isolated B cells were positive to 
variable extents (L). Concentrations of lectins used were 4.0 µg/mL for PHA-L, 2.0 µg/mL for PSL, 1.0 µg/mL 
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for MAA-I, JAC as well as PNA, and 0.5 µg/mL for PHA-E. Nuclei were counterstained with DAPI. The scale 
bars are 10 µm (G-L), 20 µm (A-F) or 50 µm (inset to F). 
 
Considering reactivity of chicken B lymphocytes from blood to the canonical galectins CG-
1A and CG-2 in flow cytofluorimetry [60] and the detection of C-GRP/CG-8 in the DT40 line 
(Fig. 6), probing for reactive sites with the chicken proteins was performed also in this cell 
system. Binding of C-GRP and the canonical CGs was saturable, and no difference was 
detectable when using C-GRP/C-GRC-C as probes (not shown). The observation that the N-
terminal section is apparently not relevant for cell binding, as noted for staining of mammalian 
cells [8], may indicate a role of the tail in C-GRP routing, as reported for the N-terminal section 
and for its serine phosphorylation in the case of the chimera-type galectin-3 [61,62]. Similar 
functionality can be assumed in the cases of tailed proto-type C. elegans galectins, which have 
extensions of 37-50 amino acids at their C-termini [63,64]. As given in detail in the 
accompanying report [8], special care was taken to exclude a non-specific (dye-dependent) 
staining. Susceptibility of the signal (measured as percentage of positive cells/mean 
fluorescence intensity) to presence of lactose was only seen for the canonical CGs, here 
reaching a pronounced level of reduction (Fig. 10). The cultured malignant B cells, in contrast 
to isolated bursal B cells in cytochemistry, have obviously gained reactivity to canonical CGs. 
This may be linked to viral transformation. In fact, genetic alterations are known to affect the 
glycome [65]. When testing a series of glycocompounds, extent of GRP-C (and C-GRP-C) 
binding to the chicken cells was reduced by the presence of heparin, less by other proteoglycans 
or sulfated polysaccharides (Figs. 11A-D). Heparin activity to diminish cell surface binding 
was significant already at µg/mL concentrations (Fig. 11D). Remarkably, heparin also proved 
inhibitory to C-GRP binding in sections of chicken bursa and isolated B cells (Figs. 11E-H), 
whereas no effect on CG-8 binding was seen (not shown). These results imply differences in 
the biochemical nature of binding site(s) for C-GRP and CG-8. Also noteworthily, C-GRP 
binding to mammalian cells was not sensitive to heparin presence [8]. In contrast, binding to 
normal and malignant chicken B cells was, without an influence of the presence of the N-
terminal extension of C-GRP. These data reveal a species-dependent difference and underscore 
to give preference to work in the homologous system. If secreted by a non-classical route, as is 
common for galectins [66], C-GRP may therefore exert functionality via specific cell surface 
binding. 
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Fig. 10. Staining of cells of the chicken DT40 line with fluorescent C-GRP or canonical CGs in the absence (black 
line) or presence of 10 mM (grey line) and 100 mM (dashed line) lactose, respectively. The control value without 
lectin addition is given as shaded area. Panels recorded with aliquots of the same cell batch illustrate data for: (A) 
C-GRP (10 µg/mL), (B) CG-1A (2 µg/mL), (C) CG-1B (10 µg/mL), (D) CG-2 (10 µg/mL), (E) CG-3 (10 µg/mL) 
and (F) CG-8S (2 µg/mL). 
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Fig. 11. Inhibition of cell surface binding of C-GRP (10 µg/ml, black line) to chicken DT40 cells by 
glycosaminoglycans and anionic sugar/polysaccharides. The control value without lectin addition is given as 
shaded area. Numbers characterizing staining (percentage of positive cells/mean fluorescence intensity) in each 
panel are always given in the order of the given listing from top to bottom. (A) Testing of fucoidan (1 mg/mL), D-
glucuronic acid (50 mM), dextran sulfate (1 mg/mL) and dextran (1 mg/mL), (B) 0.25 mg/mL heparin, chondroitin 
sulfate and carrageenan, (C) same substances as in (B) at a concentration of 0.05 mg/mL, (D) concentration-
dependent inhibition of C-GRP binding by decreasing concentrations of heparin (25, 12.5, 6 and 1.5 µg/mL). (E-
H) Histochemical detection of accessible binding sites for fluorescent C-GRP in sections through a follicle and in 
isolated B cells in the absence (E, G) or presence (F, H) of heparin (50 µg/mL). Staining of follicle associated (E) 
and isolated (G) B cells by Alexa Fluor® 488 (green)-labeled C-GRP (5 µg/mL), was completely abolished in the 
presence of heparin both in tissue sections (F, arrowheads) and in isolated B cells (H), whereas IFE (F, asterisks) 
and epithelial cells of the cortico-medullary border (F, arrows) showed a strongly reduced but still significant 
signal intensity. Nuclei were counterstained with DAPI. The scale bars are 10 µm (G, H) or 20 µm (E, F). 
4. Conclusions and perspectives 
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The high-level sequence conservation of GRP among vertebrates nourishes assumptions 
for a not yet defined functionally fundamental role. As a step toward its elucidation we here 
initiated the characterization of GRP distribution in vivo. At the same time, this work on C-
GRP enabled to set this information in relation to the complete galectin network. Compared to 
all canonical CGs, C-GRP’s profile of expression is special in being restricted to a single organ, 
that is to the bursa of Fabricius. Presence in and binding to B cells is shared by CG-8, an activity 
modulator of diverse blood cells such as plasma cells, T cells, megakaryocytes and neutrophils 
[43,67-69]. In view of the network concept for tissue lectins, the hypothesis of a functional 
cooperation between these two members of the galectin family deserves to be tested. That 
activated human T cells are responsive to three proto-type galectins via different mechanisms 
of caspase recruitment [70] and that a functional cooperation between galectins, then causing 
severe degeneration, appears to be operative in osteoarthritis [71,72] supports this assumption. 
Involvement of distinct counterreceptors is likely in these cases. Owing to the detection of 2,6-
sialylated N-glycans attention should then be given, too, to characterizing expression of the 
siglec with respective specificity, i.e. CD22, for which an expressed sequence tag is known in 
chicken (EST 3109241). On the phylogenetic level, taking monitoring expression of GRP from 
chicken to mammals can lead to shape ideas for functional correlations in order to explain why 
this protein’s sequence is kept constant in vertebrates to the extraordinary extent documented 
in [8]. 
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5. DISCUSSION 
 
Two non-canonical galectins, namely C-GRP and C-GRIFIN, complete the galectin 
protein family in chicken. Thorough database mining (NCBI nucleotide BLAST browser, 
Ensembl genome browser) revealed no further ESTs, partial or complete nucleotide sequences 
(on mRNA and genomic level) encoding further galectin-like or galectin-related proteins in 
chicken. The amino acid sequences of GRP are highly conserved in vertebrates (18 amino acid 
exchanges between chicken and man, only one amino acid exchange between mouse and man, 
please see phylogenetic analysis in Publication 2) and, due to deviations from the key residues 
of the characteristic sequence signature of galectins (two to five depending on the species; 
chicken possesses four deviations), sugar binding is abolished (loss of hydrogen bonds to 6´-
hydroxyl- and 4´-hydroxyl-group as present in D-galactose). Such a loss is also reported for rat 
GRIFIN [123] and human galectin-10 (Charcot-Leyden crystal protein) [121]. Interestingly, 
and in contrary to canonical galectins, GRP was not found in the genomes of invertebrates.  
Despite the presence of mRNA detected from total RNA isolated from a series of 
embryonic and adult chicken organs (heart, kidney, small intestine and thymus) the protein was 
only detected by Western Blotting and localized immunohistochemically (visualization with 
fluorophores) in sections of the bursa of Fabricius (please see Publication 3). In spite of the lack 
of binding to lactose (affinity chromatography on a lactose-Sepharose 4B gel matrix is the 
crucial step in the purification of recombinant canonical galectins) – the purification of 
recombinant C-GRP depends on a GST-Tag procedure – and the deviations of strictly 
conserved amino acid residues in the contact site which result in the loss of characteristic 
hydrogen bonding, we were able to inhibit binding of fluorescently labeled C-GRP to the cell 
surface of the B-cell line DT40 (a chicken B cell line derived from an avian leucosis virus 
(ALV)-induced bursal lymphoma [128]) by the glycosaminoglycan (GAG) heparin (a polymer 
consisting of repetitions of the basic disaccharide unit [-4GlcNAcα1-4GlcAβ1-]n, with diverse 
presence of sulfations, among them, the rare 3-O-sulfation [129].  
To get a proper idea about the mode of interaction, one of the next experiments could be 
the tryptic fragmentation of C-GRP bound to heparin which is for its part coupled to Sepharose 
4B (affinity matrix) with subsequent identification of heparin-binding peptides by mass-
spectrometric identification [130]. Inhibition by heparin in FACScan and lectin cytochemical 
analysis does not necessarily mean that this GAG is a counterreceptor. It may, for example, 
associate to a positively charged and (somehow) matching region of C-GRP and cover the real 
site for counterreceptor interaction by spatial blocking not competitive inhibition. Noticeably, 
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the purification of a heparin-binding lectin [131] from human placenta revealed a protein whose 
properties were not in line with galectins. Interactions with GAGs are not unique for C-GRP. 
The potential of GAGs to operate as ligands for galectins was already assessed using the 
technique of frontal affinity chromatography [129,132]. Galectins (especially -3, -7 and -9) 
bound to 6´-O-desulfated -Gal/GalNAc containing GAGs, such as keratan sulfate, chondroitin 
and dermatan presenting the typical hydroxyl groups constellation (4´-OH, 6´-OH from 
Gal/GalNAc, 3-OH from Glc/GlcNAc). No retardation with resin-immobilized galectins was 
seen with N-acetylheparosan and hyaluronan, which lack the hydroxyls’ display. 
The sequence alterations in GRPs can also have other consequences: the shape of the 
binding site changes in a way that other sugars than -galactosides act as bioactive ligands. This 
was shown for human galectin-10 (four deviations in key residues of the contact site) with 
mannose as ligand [121] and for the fungal (Coprinopsis cinerea) galectin (-like protein) CGL3 
(R81W), in which the central tryptophan was changed to arginine (as it is in mammalian GRP), 
where binding activities were proven for chitooligosaccharides or also for LacdiNAc [133].  
Only for C-GRP, localization and expression in the epithelium and intracellularly in B 
cells of the bursa of Fabricius and of the B cell line DT40 could be clearly described. The next 
step should be an immunocyto- and histochemical study on human material (tumor and 
carcinoma cell lines; sections of cancer specimen) as done for C-GRP (surprisingly, sequence 
conservation did not ensure immunological cross-reactivity: so we have to start raising an 
antibody to human GRP), it is first necessary to see GRP’s expression profile in mammalian 
tissue. GRP, being monomeric in solution such as rat galectin-5, may thus have a special 
function at a special site such as this rat protein has for exosomal sorting and routing during rat 
reticulocyte maturation [134]. The biochemical nature of the underlying recognition is a fully 
open issue.  
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Fig. 14: Detailed part of the CRD of C-GRIFIN (provided by F. Ruiz and A. Romero, Madrid, Spain). Hydrogen 
bonds are depicted in magenta dashed lines. 
 
In C-GRIFIN (Fig. 14) which is – on the contrary to GRIFIN in mammals – a -
galactoside-binding lectin, valine replaces the key residue arginine at position 72 (Arg72Val) 
(Fig. 14). Compared to chicken galectin-2 [20] this substitution results in a loss of hydrogen 
bonding to the 3-hydroxylgroup of Glc/GlcNAc. Obviously, hydrogen bonding with Arg51 and 
Glu70 (Fig. 14) is sufficient to fix energy-minimized conformers of the ligand in the contact 
site. Why do mammalian GRIFINs not bind to a sugar ligand? Here, an additional exchange at 
position 49 from asparagine to lysine exists. An explanation could be, that the binding of lactose 
is prevented through spatial hindrance by the lysine side chain impairing the formation of 
hydrogen bonding to the 4`-hydroxyl group of galactose.  
The only site of localization of C-GRIFIN (also mammalian GRIFINs) is the eye lense, 
as seen by RT-PCR, Western blotting and immunohistochemistry, the latter showing a 
characteristic expression pattern different from the ones obtained when localizing the canonical 
galectins in this tissue. This highly restricted presence of GRIFIN, confined to a single tissue 
type, indicates that expression of GRIFIN genes should be under a strict regulation mechanism.  
The function of these non-canonical galectins is far from clear. As galectins exert their 
effects after pairing with counterreceptors (please see Table 1 in section 2.4), a reasonable 
approach to obtain an indication of the functional capacities of C-GRP and C-GRIFIN is to 
purify and structurally characterize bioactive counterreceptors. Initially, recombinant protein 
(high amounts of both proteins can be isolated from E. coli cultures) can be coupled with high 
density to gel matrices. Thus, we will be able to selectively enrich (glyco)proteins from extracts 
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of bursal B cells and of cells of the B cell line DT40 (in the case of C-GRP) or from extracts of 
embryonic/adult lenses (in the case of C-GRIFIN). Also, magnetic separation of C-GRP/C-
GRIFIN-associated complexes by tosyl-activated dynabeads coated with recombinant C-GRP 
or C-GRIFIN can be a valuable option to serve this purpose. (Glyco)proteins with reactivity to 
C-GRP or C-GRIFIN will be separated by two-dimensional gel electrophoresis and identified 
by mass spectrometric fingerprinting (including Orbitrap analysis [46]). 
When performing the search on bioactive counterreceptors for GRIFIN and GRP we have 
to consider that our approach should also address the question whether both proteins are 
engaged in protein-protein interaction. That applies all the more so since both proteins displayed 
intracellular (cytoplasmic) expression in line with other e.g. galectin-1/-3 which cooperate 
intracellularly in tumor proliferation with cytoplasmic proteins such as oncogenic H-/K-Ras 
[135, 136] or in spliceosome assembly in vivo with nuclear Gemin4 [109] (please see also Table 
1 in section 2.4). More recently, it was shown that galectin-8 recruits NDP52, an autophagy 
cargo receptor [137, 138] and that galectin-3 associates with Alix forming a complex which 
negatively regulates CD4+ T-cell activation [139]. A more in depth functional characterization 
of both proteins could be achieved when in silico performed analyses to map transcription factor 
binding sites in the nucleotide sequences of the promoter sections (please see Publications 1 
and 3) will be implemented in experimental approaches such as luminescence-based reporter 
assays and/or chromatin immunoprecipitation (ChIP) experiments. First results, obtained 
performing reporter assays, in the case of the C-GRIFIN’s promoter sequence showed that lens-
specific transcription factors such as MafB and L-Maf direct the transcription of C-GRIFIN 
(personal communication by Dr. Sebastian Schmidt), presumably in an early period of lens 
development. This is supported by recent detection of presence of C-GRIFIN in the developing 
lens of 3-day chicken embryos. L-Maf [140] activates downstream in the process of lens 
development, c-MAF (early in lens development) and MafB (later in lens development, in 
differentiating lens fibers) and the genes for crystalline proteins [141]. In turn, the crystalline 
proteins interact presumably with C-GRIFIN, CG-1A as well as with CG-3 (both canonical 
CGs expressed in lens), as part of a network whose components have lens-specific transcription 
factor binding sites in common. 
In chicken, only up to five canonical and two non-canonical galectins can participate in 
such networks, whereas in man evidently 16 galectin genes [142], several gene duplica-
tions/triplications [80] and splice variants [19,80] arrange in more complex network which 
makes it difficult to unravel the functions of the individual galectins. The comparatively small 
avian “galectinome” enables comprehensive galectin and immunohistochemical mapping in 
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embryogenesis to connect galectins to developmental processes in a non-mammalian organism. 
Of note, recent observations of the involvement of the avian galectin-1 ortholog (CG-1A) in 
cell self-organizing dynamics within cartilage maturation [143] and limb skeletal 
morphogenesis, together with spatially and temporally restricted galectin reactivity, supports 
the concept of this CGs’ network involved in developmental processes. CG-1A/CG-8 recipro-
cally increase their expression, CG-1A promotes pre-cartilage condensations, CG-8 antago-
nizes it. Monitoring the CGs’ network in progressing limb development (beyond developmental 
day five) additionally, CG-1B/-3 became part of the network [80] in these tissues (long bone, 
cartilage).  
Not only in embryonic/fetal development but also in the development and progression of 
diseases galectin networks appear to be involved. Exemplarily, networks contribute to the 
regulation of processes driving cancer growth and progression such as adhesion (pro-/anti-
adhesive galectins), homotypic aggregation of tumor cells, metastasis [144], invasion, 
angiogenesis [145] and apoptosis. Main features of such an orchestrated cooperation in these 
processes are:  
(i) More than one galectin participates, the predominant galectin depends on tumor type 
and stage (please see [146] for review). Also it must be defined whether the interactions 
between galectins are synergistic or antagonistic. The main task in preclinical and clinical 
studies is to perform galectin-fingerprinting and then to dissect the role of each individual 
galectin (canonical/non-canonical) in the network. For example, in prostate cancer, galectin-3 
strongly influences metastasis and angiogenesis, galectin-8 controls anoikis due to a 
reorganization of the cytoskeleton and supports homotypic aggregation of prostate cancer cells, 
thus ensuring the survival of the cancer cells in the blood circulation, an important requirement 
for invasion and forming of metastases [147]. A further example for a galectin network was 
unraveled in several clinical studies with patients suffering from hepatocellular carcinoma. 
Overexpressing galectin-1 [148] and/or nuclear galectin-3 [149] led to a poor prognosis and the 
overall survival was definitely reduced, whereas upregulation of galectin-9 in the same tumor 
type served as positive prognostic factor with a comparably enhanced survival rate [150].  
(ii) Glycans presented by counterreceptors often act as molecular switches for galectin 
reactivity, e. g. α-2,6 sialylation functions as a switch off signal in the pancreatic carcinoma 
cell-line Capan-1 reconstituted with the tumor suppressor p16INK4a and in the glioblastoma cell 
line U87, preventing binding of galectin-1, which acts either pro-apoptotic (Capan-1 cells) or 
pro-invasive (U87 cells) (please see section 2.4). 
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(iii) Intracellular pathways participate in these networks either by outside-inside signaling 
triggered through association of galectins with surface-associated counterreceptors and/or 
cytoplasmic/nuclear interaction of galectins with molecules of such activated pathways 
[135,151]. Genetically engineered model cell lines with glycomic profiles deliberately shifted 
in degree of sialylation either resistant to pro-malignant galectin properties or susceptible to 
pro-apoptotic galectin activities will be valuable tools to perform experiments in this context.  
The involvement of galectins in diseases as described above and in section 2.4 raises the 
question on possible therapeutic options to inhibit the activities of galectins. Genetic knock-
down (e.g. shRNA, CRISPR/Cas9) of e.g. galectin-1 is a possible approach as shown in the 
case of human glioblastoma (U87) cells when interactions of the cells with galectin-1 promotes 
invasiveness, and in clinical terms account for a poor patients’ prognosis. Up-regulation of 
ST6Gal-I (please see section 2.4) in the same cell line by genetic engineering in order to 
enhance 2,6-sialylation may result in a reduced susceptibility to galectin-1 and a loss of 
invasiveness. Here, the influence of 2,6-sialylation as switch-off signal for galectin binding 
as potential therapeutic approach to prevent invasiveness will be defined. Further possibilities 
to prevent binding of galectins to surface-associated counterreceptors may be application of 
anti-galectin antibodies, galectin-derived blocking peptides or defective galectin variants which 
cannot elicit post-binding effects. Employing tailor-made synthetic inhibitory bi- to oligovalent 
glycoclusters with lactose as headgroups [152] is a further option to interfere with 
galectin/carbohydrate pairing. In a preclinical histochemical test system, resembling 
physiological conditions, sections of paraffin-embedded tissues were used to test the inhibitory 
potencies of such glycoclusters taking as a measure the reduction of staining intensities [153]. 
Remarkably, besides genetic engineering, an appealing idea to get new therapeutics is to use 
glycodendrimersomes (GDs) (please see section 2.4). Applying GDSs with appropriate sugar 
headgroups accordingly, they can be used as nanoparticle-sized decoy receptor to scavenge 
(harmful) galectin, e.g. in osteoarthritis, where Gal-1 is a driving force of the pathogenesis by 
inducing a pro-degradative/inflammatory gene signature [154] or in the above described 
examples of cancer. Loading the dendrimers with sugar ligands with special affinity to a 
galectin, e.g. LacdiNAc or A-tetrasaccharide, will obviously make scavenging selective. 
Further preclinical and clinical studies are undoubtedly necessary to ascertain future therapeutic 
application of these procedures. 
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6. SUMMARY 
Chicken (Gallus gallus) as Model for Network Analysis of  
Adhesion-/Growth-regulatory Galectins. 
Biochemical characterization of C-GRIFIN/C-GRP and first complete histochemical 
analysis for the galectin family in bursa of Fabricius 
 
Lectins (carbohydrate-binding proteins) translate glycan-encoded information of cellular 
glycoconjugates into effects, hereby being involved in many physiological and pathological 
processes. A class of adhesion-/growth-regulatory lectins, the galectins, share binding 
specificity for -galactosides, -sandwich folding and key amino acid residues in the contact 
site (including a central tryptophan), forming a characteristic sequence signature. In addition to 
their carbohydrate specificity, the topological mode of presentation of their carbohydrate 
recognition domain(s) (CRD) is assumed to play a key role for their bioactivities. Three types 
of structural design are known, classified as proto-type (homodimeric), chimera-type (CRD in 
combination with an N-terminal proline-rich tandem repeat domain) and tandem-repeat-type 
(two CRDs connected by a linker peptide). To proceed to a comprehensive study of galectin 
expression, a model with complete representation of these types of design and a minimal 
number of individual proteins is most suited. Chicken fulfills the given prerequisites with a set 
of five canonical galectins. In detail, it comprises three proto-type chicken galectins (CGs) (the 
paralogue pair CG-1A/B and CG-2), chimera-type CG-3 and tandem-repeat-type CG-8. 
Moreover, on the genomic level we found (partial) sequences of two non-canonical (deviations 
in the sequence signature) members, not yet characterized, namely C-GRIFIN and C-GRP. Both 
proteins are encoded by a single copy gene, are highly conserved and their presence is restricted 
to vertebrates. Recombinant expression of both proteins, mass spectrometric (MS) analysis and 
gel filtration identified C-GRIFIN as a homodimeric, C-GRP as a monomeric protein. In the 
case of C-GRIFIN, the key amino acid residue in the contact site arginine at position 72 was 
replaced by valine. In spite of this exchange, C-GRIFIN is able to bind -galactosides, 
especially histoblood group B-tetrasaccharide. Two lactose binding peptides after tryptic 
digestion on lactose-Separose 4B beads were identified by MS. Analysis of mRNA and protein 
expression demonstrated presence restricted to the lens, immunohistochemically the protein 
was detected in the semicircular fibers of the main lens body. C-GRP exhibited four deviations 
(e.g. asparagine at position 51 was exchanged by lysine) and did not bind -galactosides, the 
crystal structure indicates that the side chain of lysine at position 51 prevents a snug fit of 
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galactose in the binding pocket. RT-PCR demonstrated the occurrence of C-GRP’s mRNA in 
numerous tissues whereas protein bands in Western blots were only observed in tissue extracts 
from bursa of Fabricius (also immunopositive for the five canonical CGs). Histochemically, C-
GRP presence was limited to bursa of Fabricius and localized in bursal B cells, epithelial cells 
of the interfollicular epithelium (IFE)/follicle-associated epithelium (FAE) and blood vessels. 
The full set of canonical galectins could be localized in the bursa of Fabricius: CG-1A in basal 
lamina and vessels, CG-1B in lamina propria and IFE, CG-2 in endothelium of capillaries, CG-
3 in epithelial cells, CG-8 in medullary and cortical B cells. C-GRP presence overlaps with CG-
1A (endothelium of vessels), CG-1B (IFE), CG-3 (IFE/FAE) and CG-8 (B cells). The binding 
of fluorescently labeled C-GRP to B cells can be blocked by heparin, not necessarily meaning 
that the contact site(s) is the putative CRD. Future perspectives are arising now from the 
availability of the full set of canonical/non-canonical galectins in chicken, allowing us to 
proceed with network analyses in embryonic development. The isolation of bioactive 
counterreceptors for human/chicken GRIFIN/GRP is mandatory to clearly define functions and 
to clarify their involvement in physiological and pathological processes.  
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7. ZUSAMMENFASSUNG 
Analyse eines Netzwerks von Adhäsions- und Wachstum-regulierender 
Galektine im Modellsystem Huhn (Gallus gallus). 
Biochemische Charakterisierung von C-GRIFIN/C-GRP und erste vollständige 
histochemische Analyse einer Galektinfamilie in der Bursa Fabricii 
 
Lektine sind kohlenhydratbindende Proteine, die die in Glykanen zellulärer 
Glykokonjugate festgelegten Informationen dazu nutzen, um eine Vielzahl physiologischer und 
pathologischer Vorgänge zu beeinflussen. Eine Klasse dieser Lektine, stellen die Galektine, die 
Adhäsion und Wachstum regulieren, dar. Sie haben die spezifische Bindung von -
Galaktosiden, die -sandwichartige Anordnung von 5-6 -Faltblättern, und eine 
charakteristische Anordnung bestimmter Aminosäurereste in der Bindungsstelle 
(Sequenzsignatur) gemeinsam. Dabei ist nicht nur die Bindung zu spezifischen Zuckern von 
Bedeutung, sondern auch die Anordnung der kohlenhydratbindenden Domänen (CRD). Die 
drei möglichen Anordnungen der CRDs sind der Proto-Typ (Homodimer), der Chimera-Typ 
(CRD kombiniert mit N-terminaler Prolin-reicher Tandem-Repeat Domäne), und der Tandem-
Repeat-Typ (zwei CRDs verbunden durch einen Linkerpeptid). Um eine umfassende Studie zur 
Expression von Galektinen anzufertigen wird ein Modell benötigt, das die komplette Anzahl 
der möglichen Anordnungen der CRDs mit einer möglichst geringen Anzahl individueller 
Proteine vereint. Das Huhn erfüllt die entsprechenden Voraussetzungen. Im Hühnergenom 
finden sich die Gene für lediglich fünf kanonische Galektine. Im einzelnen sind drei Galektine 
vom Proto-Typ (die paralogen Proteine CG-1A/1B und CG-2), jeweils eines vom Chimera-Typ 
(CG-3) und eines vom Tandem-Repeat-Typ (CG-8) vorhanden. Darüber hinaus konnten auf 
genomischer Ebene Sequenzabschnitte von zwei noch nicht charakterisierten nicht-
kanonischen (Abweichungen bei den Aminosäuren, die für die Sequenzsignatur relevant sind) 
Galektinen, ermittelt werden.  
Beide Proteine werden jeweils von einem single-copy-Gen kodiert, sind hoch konserviert 
und kommen nur bei Vertebraten vor. Rekombinante Expression beider Proteine, 
Massenspektrometrie und analytische HPLC-Gelfiltration identifizierten C-GRIFIN als 
homodimeres, C-GRP als monomeres Protein. Im Falle von C-GRIFIN liegt ein Austausch der 
Aminosäure Arginin gegen Valin an Position 72 vor. Trotz dieser Abweichung kann C-GRIFIN 
-Galaktoside, insbesonders das Blutgruppen-Tetrasaccharid B binden. Mithilfe der massen-
spektrometrischen Analyse konnten zwei Lactose-bindende Peptide identifiziert werden. Die 
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Untersuchung der mRNA- und der Proteinexpression zeigte, dass C-GRIFIN lediglich in der 
Augenlinse vorhanden ist. Immunhistochemisch konnte das Protein in den halbkreisförmigen 
Fasern des Linsenkörpers nachgewiesen werden. Bei C-GRP sind vier Abweichungen von der 
Sequenzsignatur der Galektine (u.a. ein Austausch von Asparagin durch Lysin an Position 51) 
festzustellen. Das Protein ist nicht -Galaktosid-bindend. Die Kristallstrukturanalyse zeigte, 
dass die hervorstehende Seitenkette des Lysinrestes an Position 51 verhindert, dass Galaktose 
in die Bindungsstelle eingepasst werden kann. Die RT-PCR Analyse ergab, dass die spezifische 
mRNA weitverbreitet in zahlreichen Geweben vorkommt, der Proteinnachweis gelang jedoch 
nur in Organextrakten der Bursa Fabricii (ebenso konnte hier der Proteinnachweis auch für die 
fünf anderen kanonischen CGs geführt werden). Auch in der histochemischen Untersuchung 
konnte C-GRP nur in der Bursa Fabricii, und zwar in den B-Zellen, den Epithelzellen des 
interfollikulären Epithels (IFE) bzw. des follikel-assoziierten Epithels (FAE) und in 
Endothelien der Blutgefässe lokalisiert werden. Ebenso treten die fünf kanonischen CGs in der 
Bursa Fabricii auf: CG-1A in der Basallamina und Endothelien der Blutgefässe, CG-1B in der 
Lamina propria und den Epithelzellen des IFE, CG-2 in Kapillaren, CG-3 in Epithelzellen und 
CG-8 in B-Zellen des Cortex und der Medulla. Ein gemeinsames Vorkommen von C-GRP und 
jeweils eines kanonischen CGs erfolgte in Endothelien der Blutgefässe (CG-1A), in den 
Epithelzellen des IFE (CG-1B, CG-3) und des FAE (CG-3) sowie in B-Zellen der Bursa (CG-
8). Die Bindung von fluoreszenz-markiertem C-GRP an B-Zellen konnte durch Heparin 
blockiert werden, was nicht notwendigerweise bedeutet, dass die Bindung über die vermutliche 
CRD erfolgen muss. Zukünftige Untersuchungen bestehen darin, die Rolle der einzelnen 
kanonischen/nicht-kanonischen Galektine als Bestandteil eines Netzwerks in der embryonalen 
Entwicklung zu definieren. Die Isolierung von Liganden für GRIFIN und GRP (sowohl bei den 
menschlichen als auch den aviären Proteinen) ist zwingend notwendig, um deren Funktionen 
und ihre Beteiligungen an physiologischen und pathologischen Prozessen zu bestimmen.  
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Fig. S1: Molecular phylogenetic 
analysis by the Maximum Likelihood 
method using the complete set of 
GRIFIN sequences currently available 
from the NCBI (last search performed 
May 2016)  and ENSEMBL (release 
84 – March 2016) databases (77 
species). Amino acid sequences were 
deduced from coding sequences 
annotated on the genomic level, except 
for human GRP, C-GRIFIN, rat 
GRIFIN and zebrafish GRIFIN, where 
the information on the level of the 
protein is available. Deduced amino 
acid sequence for a Caenorhabditis 
elegans galectin Lec-6 (BAA09794) is 
used as an outgroup to display a rooted 
tree. 
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Fig. S2: Comparative documentation of the chromosomal environment of the C-GRIFIN gene with those of the 
five genes for canonical CGs and C-GRP (blue box, A, chromosome localization is indicated) and with GRIFIN 
genes of five selected species (orange box, B; Hs, Homo sapiens, chromosome 7; Mm, Mus musculus, chromosome 
5; Am, Alligator mississippiensis, unplaced scaffold; Xn, Xenopus tropicalis, unplaced scaffold; Dr, Danio rerio, 
chromosome 3). Gene orientation is indicated by arrows; box lengths and spacers are not drawn to scale. Gene 
abbreviations: ACTN2, actin α2; AFTPH, aftifilin; BRAT1, BRCA1-associated ATM activator 1; CARD10, 
caspase recruitment domain family member 10; CDC42EP1, CDC42 effector protein Rho GTPase binding 1; 
CHST12, carbohydrate (chondroitin 4) sulfotransferase 2; CHST12a, carbohydrate (chondroitin 4) 
sulfotransferase 2a; DLGAP5, discs, large (Drosophila) homolog-associated protein; EDARADD, EDAR-
associated death domain; EIF3B, eukaryotic translation initiation factor 3, subunit B; ERO1LB, ERO1-like β (S. 
cerevisiae); FBX034, F-box protein 34; GGA1, Golgi-associated, -adaptin ear containing, ARF binding protein 
1; HEATR1, HEAT repeat containing 1; LFNG, LFNG O-fucosylpeptide 3-β-N-acetylglucosaminyltransferase; 
LOC101733830, probable G-protein coupled receptor No18; LOC101883165, neuropeptide FF receptor 2-like; 
LOC102566652, galanin receptor type 1-like; LOC771154, urotensin-2 receptor-like; MAPK1IP1L, chromosome 
14 open reading frame 32;; Peli1, pellino E3 ubiquitin protein ligase; SEPT11, septin 11; Sertad2, SERTA domain 
containing 2; SH3BP1, SH3-domain binding protein 1; SHROOM3, shroom family member 3; SOCS4, suppressor 
of cytokine signaling 4; SOWAMB, sosondowah ankyrin repeat domain family member B; STBD1, startch 
binding domain 1; TTYH3, tweety family member 3; Vps54, vacuolar protein sorting 54 homolog (S. cerevisiae). 
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Fig. S3: Organization of the genes for C-GRIFIN, CG-3, C-GRP, the respective parts of the gene for CG-8 
separated into its C- and N-terminal CRDs and finally the gene for CG-1A, given in the degree of vicinity based 
on sequence aligments, as shown in Fig. 2. Exons are graphically displayed as boxes (5′/3′-untranslated exon parts 
in white, coding exons in gray, the exon encoding the CRD underlined in red, size proportional to exon lengths), 
and introns are shown as lines (size not proportional to intron lengths). Roman numbers above exon boxes define 
the spatial order of exon occurrence. The lengths of exons and introns are given in base pairs (bp). 
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Fig. S4: Comparison of amino acid sequences of C-GRIFIN with those of the CRDs for the five canonical CGs 
and the shortened version of C-GRP, i.e. C-GRP-C (amino acid 37 is set to position 3 for alignment). 
 
 
Fig. S5: Illustrations of multiple sequence alignments for predicted GRIFIN proteins, edited in Jalview (vs. 2.7): 
Please view online and/or download using the link given above. 
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Fig. S6: Sequence analysis of the N-terminus of C-GRIFIN by relISD. Mass spectrum of C-GRIFIN using 
sinapinic acid (SA) as matrix presents the smallest detectable peptide at the c15/c16 position and the ensuing 
peptide ladder. 
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Fig. S7: Sequence analysis of the N- and C-termini of C-GRIFIN by reISD and linISD. Mass spectra of C-GRIFIN 
using super 2,5-dihydroxybenzoic acid (sDHB) as matrix show the smallest detectable peptide at the c9/c10 (A) 
and 7/8 (z+2) (B) positions and the ensuing stepwise peptide ladder. (C) LinISD spectrum using sinapinic acid 
(SA) as matrix shows the smallest detectable peptide at c40/c41 and the ensuing stepwise peptide ladder up to 
c68/69. (D) Sequence coverage by ISD shown by shaded sections. Experimental and calculated mass values are 
given in Table S2A and S2B. 
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Fig. S8: Gel filtration analysis of C-GRIFIN. Elution profiles of C-GRIFIN in the absence and in the presence of 
100 mM lactose. Black arrowheads indicate elution volume of molecular weight markers used for calibration. 
 
Table S1: Compilation of genomic orthologs/paralogs of the GRIFIN gene: 
Please view online and/or download using the link given above. 
 
Table S4: Glycan microarray data for C-GRIFIN: 
Please view online and/or download using the link given above. 
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Fig. S1: Molecular phylogenetic analisis by the Maximum Likelihood method using the complete set of GRP 
sequences currently available (last search performed at 13.01.2016) from the NCBI and ENSEMBL databases 
(119 species). 
Please view online and/or download using the link given above. 
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Fig. S2: Comparative documentation of the chromosomal environment of the C-GRP gene with those of the five 
genes for canonical CGs (blue box, A) and with GRP genes of five selected species (orange box, B; Hs, Homo 
sapiens, chromosome 2; Mm, Mus musculus, chromosome 11; Am, Alligator mississippiensis, unplaced scaffold; 
Xn, Xenopus laeviensis, unplaced scaffold; Dr, Danio rerio, chromosome 1). Gene orientation is indicated by 
arrows; box lengths and spacers are not drawn to scale. Gene abbreviations: ACTN2, actin α2; AFTH, aftifilin; 
CARD10, caspase recruitment domain family member 10; CDC42EP1, CDC42 effector protein Rho GTPase 
binding 1; DLGAP5, discs, large (Drosophila) homolog-associated protein; EDARADD, EDAR-associated death 
domain; ERO1LB, ERO1-like β (S. cerevisiae); FBX034, F-box protein 34; GGA1, Golgi-associated, -adaptin 
ear containing, ARF binding protein 1; HEATR1, HEAT repeat containing 1; LOC100858460, arf-GAP with dual 
PH domain-containing protein 1-like; LOC771154, urotensin-2 receptor-like; LOC771207, pyrodoxal phosphate 
phosphatase-like; MAPK1IP1L, chromosome 14 open reading frame 32; Mb, myoglobin; PELI, pellino E3 
ubiquitin protein ligase; SEPT11, septin 11; Sertad2, SERTA domain containing 2; SH3BP1, SH3-domain binding 
protein 1; SHROOM3, shroom family member 3; SOCS4, supressor of cytokine signaling 4; SOWAMB, 
sosondowah ankyrin repeat domain family member B; STBD1, startch binding domain 1; Vps54, vacuolar protein 
sorting 54 homolog (S. cerevisiae). 
 
  
Supplementary Material  157 
 
	
 
Fig. S3: Organization of the genes for C-GRP, CG-1A, the N- and C-terminal domains of CG-8, and the C-terminal 
domain of human galectin-12. Exons are graphically displayed as boxes (5′/3′-untranslated exon parts in white, 
coding exons in gray, the exon encoding the CRD underlined in red, size proportional to exon lengths), and introns 
are shown as lines (size not proportional to intron lengths). Roman numbers above exon boxes define the spatial 
order of exon occurrence. The lengths of exons and introns are given in base pairs (bp).  
 
Fig. S4: Illustrations of multiple sequence alignments for predicted GRP proteins, edited in Jalview (vs. 2.7; 
Waterhouse et al. 2009 [25]).  
Please view online and/or download using the link given above. 
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Fig. S5: MALDI TOF MS of C-GRP. (A) Molecular mass determination. The two peaks represent its singly and 
doubly charged molecular ions (calculated mass: 19068.9 Da). (B, C) Peptide mass fingerprinting by MALDI TOF 
MS. The list of detected peptides with their calculated (calc) and experimentally measured (exp) mass values (B) 
and the sequence coverage (C) are shown. 
 
Supplementary Material  159 
 
	
 
 
Fig. S6: MALDI TOF MS of C-GRP-C. (A) Molecular mass determination. The two peaks represent its singly 
and doubly charged molecular ions (calculated mass: 15338.8 Da). (B, C) Peptide mass fingerprinting by MALDI 
TOF MS. The list of detected peptides with their calculated (calc) and experimentally measured (exp) mass values 
(B) and the sequence coverage (C) are shown. 
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Fig. S7: Sequencing of the N-terminus of C-GRP-C by reISD and linISD. (A) reISD mass spectrum of C-GRP-C 
shows the smallest detectable peptide at the c12/c13 and the ensuing stepwise peptide ladder. (B) linISD spectrum 
shows the smallest detectable peptide at c39/c40 and the ensuing stepwise peptide ladder up to c69/c70. (C) 
Sequence coverage by ISD. Experimental and calculated mass values are given in Table S1B. 
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Fig. S8: Analytical ultracentrifugation experiments of C-GRP and C-GRP-C in solution. Sedimentation velocity 
at 2.0 mg/mL monitored by absorbance at 280 nm. The differential coefficient distribution c(s) curves suggest that 
both C-GRP (A) and C-GRP-C (B) are predominantly monomeric in solution with sedimentation coefficients of 
1.137 ± 0.008 S and 1.161 ± 0.006 S for C-GRP and C-GRP-C, respectively. The apparent molecular weights of 
19045 Da (C-GRP) and 16551 Da (C-GRP-C) were calculated from the c(s) distribution. 
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Fig. S9: Fitting of data of a SAXS experiment with C-GRP-C (represented as a surface with the electrostatic 
potential) using the ab initio SAXS model (grey) as platform. 
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Fig. S10: Overall structure of C-GRP-C. The C-GRP-C monomer presents a jelly roll topology typical of the 
galectin family. The strands of the two β-sheets are labeled, and a short 310 helix placed between strands F5 and 
S2. 
 
 
Fig. S11: Superposition of the fold C-GRP-C (yellow) and of four CRDs of canonical CGs, i.e., CG-1A (cyan; 
1QMJ), CG-1B (purple; 3DUI), CG-2 (green; 2YMZ) and CG-8N (orange; 4WVW), highlighting the major 
structural differences in two regions involving connecting loops at the concave face of the carbohydrate-binding 
pocket. 
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Table S1A: Calculated and experimental masses of c-ions observed in the reISD spectra for C-GRP. 
Please view online and/or download using the link given above. 
 
Table S1B: Calculated and experimental masses of c-ions observed in the reISD spectra for C-GRP-C. 
 
Table S2: Glycan microarray data for C-GRP 
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Table S1: MatInspector-based search for putative transcription-factor-binding sites in the promoter region (- 2500 
bp upstream of translation start) of the C-GRP gene (using the following setting: core similarity = 1.0), listed 
alphabetically. 
 
can be found and downloaded via the following link: 
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Because of the large size of the table, an implementation into this text is problematic, we kindly 
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